Biochemical Characterization of a Novel Mammalian Polyphosphate Dependent Glucokinase by Ali, Antasar Mohamed
University of Huddersfield Repository
Ali, Antasar Mohamed
Biochemical Characterization of a Novel Mammalian Polyphosphate Dependent Glucokinase
Original Citation
Ali, Antasar Mohamed (2016) Biochemical Characterization of a Novel Mammalian Polyphosphate 
Dependent Glucokinase. Doctoral thesis, University of Huddersfield. 
This version is available at http://eprints.hud.ac.uk/id/eprint/32663/
The University Repository is a digital collection of the research output of the
University, available on Open Access. Copyright and Moral Rights for the items
on this site are retained by the individual author and/or other copyright owners.
Users may access full items free of charge; copies of full text items generally
can be reproduced, displayed or performed and given to third parties in any
format or medium for personal research or study, educational or not­for­profit
purposes without prior permission or charge, provided:
• The authors, title and full bibliographic details is credited in any copy;
• A hyperlink and/or URL is included for the original metadata page; and
• The content is not changed in any way.
For more information, including our policy and submission procedure, please
contact the Repository Team at: E.mailbox@hud.ac.uk.
http://eprints.hud.ac.uk/
i 
 
 
 
 
 
BIOCHEMICAL CHARACTERIZATION OF A NOVEL 
MAMMALIAN POLYPHOSPHATE DEPENDENT GLUCOKINASE 
 
By 
Antasar Mohamed Ali 
Supervisor 
Dr.Shamus Burns 
A thesis submitted to the University of Huddersfield in partial fulfilment of the requirements 
for the degree of Doctor of Philosophy 
The University of Huddersfield 
(2016) 
  
ii 
 
Declaration 
I hereby declare that this submission is my own work and that, to the best of my knowledge 
and belief, it contains no material previously published or written by another person nor 
material which has been accepted for the award of any other degree or diploma of the 
university or other institute of higher learning, except where due acknowledgment has been 
made in the text. 
  
iii 
 
Acknowledgement 
I am indebted to many people who have helped me throughout the course of this thesis. I have 
had a huge opportunity to learn and apply my theoretical and practical knowledge in 
accomplishing this research.  
First of all I would like to thank my family for giving me inspiration and support all the way 
through and for patiently helping me to handle the stress in critical stages of this thesis.  
I would like to pay my heartiest gratitude to my great supervisor Dr Shamus Burns for his 
continuous support, guidance and advice to complete the research.  
His directions and cooperation enlightened me to accomplish this thesis to fulfil particular 
research objectives. Therefore, I’m really indebted to him.  
I pay heartiest gratitude to my friends and my fellow workmates for giving me inspiration and 
continuous support in way of completing this thesis.  
Finally, thanks to everyone whoever, directly and indirectly supported me in completing my 
thesis. Without their support and contribution, it would be hard to complete my research.  
 
 
 
 
 
 
 
iv 
 
Abstract 
Hexokinases are a family of enzymes that catalyse the phosphorylation of glucose by 
transferring the γ- phosphoryl group from adenosine triphosphate (ATP) to the sixth position 
hydroxyl group of glucose to generate Glucose 6-phosphate (G6P). 
Until now, five isozymes of mammalian hexokinase (HK) have been described: types I, II, III 
and IV, all of them ATP dependent, and type V which is ADP-dependent. The present thesis 
describes a novel hexokinase, we have designated as PPGKm. The enzyme is strictly 
polyphosphate (pp) dependent, is correctly defined as a glucokinase (GK), by virtue of its 
kinetics and is present in mammalian tisues, at high activity in liver. The enzyme does not use 
ATP and ADP and indeed appears to be inhibited by them. As far as can be ascertained this is 
the first description of a mammalian enzyme using inorganic polyphosphate as a phosphoryl 
donor. Polyphosphate is used as phosphoryl donor in bacterial systems and is quite well 
characterized, although only two micro-organisms have been shown to be strictly pp-
dependent like the one described here. 
This novel enzyme (PPGKm) also showed unique features, differing from the others 
hexokinases in having a longer half-life and can be stored for several months at -20˚C without 
loss of activity. However, thermal stability was lower than other hexokinases studied.  
The enzyme activity is concentrated in the hepatocyte nucleus has a higher molecular weight 
compared to Hexokinases 1, 2 and 3. The full biological significance of the enzyme is as yet 
unclear, and attempts to purify and sequence it have been only partly successful. Its specific 
role in cellular, and especailly nuclear metabolism remains unknown. 
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Chapter 1 
Introduction 
 Part One: Evolution of Hexokinases Isoenzymes and their regulatory role 
Phosphorylation of glucose by hexokinases (EC 2.7.1.1) using ATP or ADP as a 
phosphoryl donor occurs in all eukaryotic, prokaryotic, and plant cells (Wilson, 
2004). This reaction is considered as the first step in glucose utilization. The 
formation of glucose 6-phosphate (G6P) by hexokinase sequesters glucose inside 
the cell, and as a consequence, directs glucose to alternative metabolic pathways: 
the formation of glycogen and short-term carbohydrate storage in liver; immediate 
use in energy production by glycolysis; and the formation of pentose phosphates 
for anabolic purposes (Cárdenas., 2004). 
Hexokinases were first described in yeast by Meyerhof; 1927 (Racker., 1946). 
There are three isoenzymes PI, PII and glucokinase (Maitra, 1970; Gancedo et al., 
1977). In animal species, the activity of hexokinase isoenzymes was studied for the 
first time in rodents’ livers (González et al., 1964). Further investigations in other 
animal species have shown isoenzyme activity in all animals, including humans 
(Cárdenas., 2004). Most invertebrates also show hexokinases activity. Four 
hexokinase isoenzymes are found in various vertebrates’ tissues: I, II, III, and IV 
(Cárdenas., 2004). 
In addition, hexokinases have been reported to be found in green plants – two types 
of glucose- and fructose-phosphorylating enzymes have been discovered in plants: 
hexokinases (HKs) and fructokinases (FKs) (Millerd et al, 1951; Saltman, 1953; 
Medina and Sols., 1956). Several HK and FK (EC 2.7.1.4) isozymes have been 
identified in protein extracts of various plant species. While FK activities have been 
found to be specific to fructose, the HKs from various species have been found to 
be capable of phosphorylating glucose, fructose, mannose, and glucosamine, but 
not galactose (Saltman., 1953), similar to fungal, mammalian, and protozoan HKs 
(Cárdenas et al., 1984; Fekete et al., 2004; Rui and Hahn., 2007). 
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Isozymes capable of phosphorylating glucose have often been identified as 
glucokinases. However, unlike in the fungal kingdom, no glucose-specific 
glucokinase has been found in plants (Dai et al., 2002b). Therefore, in plants, 
glucose can be phosphorylated only by HK while fructose can be phosphorylated 
either by HK or FK. Therefore, HK and FK are the gateways for most organic 
metabolism in plants. These enzymes catalyze irreversible reactions and therefore 
may play important roles in the regulation of plant sugar metabolism. 
1.1.1 Sugar specificity and naming conventions 
Sugar specificity, of hexokinases in different organisms. Glucose is the preferred 
substrate of hexokinases, but hexokinases can still phosphorylate other hexoses to 
some degree. Only a few species like bacteria are known to contain hexokinases 
that predominantly or solely phosphorylate glucose (Ureta et al., 1987). 
This has led to a lot of confusion in the naming of these enzymes. Generally 
speaking microbiologists call a hexokinase, glucokinase, if it predominantly or only 
phosphorylates glucose. However, in man and rodent species in which metabolic 
studies have been conducted to better understand glucose metabolism and insulin 
sensitivity, the name glucokinase has been reserved for Hexokinase D (IV) because 
this enzyme plays a pivotal role in glucose homeostasis as the part of glucose sensor 
in the beta cells, and in glucose uptake in the liver. 
This creates potential confusion, because the microbiological community is largely 
separated from the metabolic and diabetes community, and certainly with respect 
to hexokinases. 
This has also led to the inappropriate naming of of an ADP-dependent hexokinase 
as a glucokinase (Ronimus & Morgan., 2004) when it clearly exhibits non- 
sigmoidal kinetics and has a low Km for glucose :the whole point in naming 
mammalian HK D (IV) glucokinase is that it has sigmoidal kinetics and a very low 
affinity for glucose with an S0.5 of approximately 8mM ( within the physiological 
range of 4.4-6.1mM).The misnamed ADP-dependent enzyme has a Km of about 
0.5mM glucose , far too low to have any influence on glycemic regulation . 
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Clearly, this needs to be addressed at the highest level to attempt a uniform naming 
convention. 
The discovery of a real pp-dependent glucokinase, described in this thesis, will only 
make appreciation of these conventions more problematic for most workers 
unaware of these naming conventions and conflicts. 
The following table (1.1-1) summarizes different species categorized according to 
their hexokinases specificity. It is concluded that more specific enzymes are 
generally found in simpler organisms, while higher animals with more complicated 
metabolic systems lack enzymes with high specificity for phosphorylation of 
glucose, mannose, or fructose (Cárdenas et al., 1998). 
 
Table 1.1–1 Different species categorized according to their hexokinase sugar 
specificity. 
Note: Reprinted from “Evolution and Regulatory Role of the Hexokinases,” by M. 
L. Cárdenas et al., 1998, Biochimica et Biophysica Acta, 1401, 242–264.  
 Taxon High specificity Intermediate specificity Low specificity 
 Archaea Pyrococcus furiosus   
 Bacteria Streptococcus mutans Leuconostoc meserentoides E.coli 
  E. coli Streptomyces violaceruber  
  Bacillus stearothermophilus E. coli  
  Zymomonas mobilis   
  Aerobacter aerogenes   
  Rhodospirillum rubrum   
  Pseudomonas saccharophila   
  BreÍibacterium fuscum   
 
Lower 
eukaryotes 
Euglena gracilis Saccharomyces cerevisiae Sac. cerevisiae 
  Dictyostelium discoideum Torulopsis holmii Neurospora cross 
  Candida sp Saprolegnia litoralis Entamoeba histolytica 
  Sap. litoralis  Trypanosoma equiperdum 
 Green plants Pisum sativum (peas)  Triticum (wheat) 
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1.1.2 Molecular mass of hexokinases in different phyla 
It has been suggested that the evolution of vertebrates’ hexokinases resulted from 
the duplication and fusion of the 50 kDa ancestral hexokinase, which is similar to 
the recent yeast and mammalian hexokinase IV size. 
 
Table 1.1–2 showing molecular mass of different hexokinases belongs to different 
organisms 
In figure 1.1 a phlogenetic relationship of different hexokinase was illustrated 
showing the family of enzymes present in a variety of living organisms including 
plants, bacteria, yeast and vertebrates. The mutations / duplication or fusion, that 
happened along in the course of evolution of these organisms were indicated. 
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Figure 1.1–1 Structural similarities of hexokinases and phylogenetic relationships 
between hexokinases 
Note: Reprinted from “Evolution and Regulatory Role of the Hexokinases,” by M. 
L. Cárdenas et al., 1998, Biochimica et Biophysica Acta, 1401, 242–264.  
 
1.1.3 Tissue distribution of hexokinase isoenzymes in mammalian systems 
a) Types I, II, III, and IV (Kawai et al., 2005) are expressed in different organs of 
the body.  
b) The liver contains all four types of hexokinases, while the kidney and intestine 
contain three (I–III). 
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c) Types I and II are found in epididymal fat pad, skeletal muscle, the brain, and 
the heart. 
However, Type I is predominantly present in brain and kidney and Type II is 
predominant in skeletal muscle and epididymal fat pad (Iynedjian., 2009).  
According to Katzen and Schimke, (Katzen et al., 1965) the properties of different 
types of hexokinase do not vary from tissue to tissue. Instead, they are present in 
variable amounts depending on age, stability of the enzyme, and nutritional status. 
Different metabolic pathways can be linked to tissue specificity in the body, and 
therefore, these differences may be correlated to the differences between the 
structures; affinity for substrates and inhibitors; and subcellular localization of the 
isozymes of hexokinase, for example, HKI and HKII have a hydrophobic leader 
sequence that is important in binding hexokinase to mitochondria. On the other 
hand, HKIII and HKIV do not contain this leader sequence and are nottherefore, 
bound to mitochondria. This suggests that these isozymes may be involved in 
metabolic pathways other than glycolysis as illustrated in Figure 1.1.2. 
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Figure 1.1–2 Phosphorylation, catalysed by hexokinase, is the initial step in common 
pathways of glucose metabolism. 
1.1.4 Subcellular Distribution of Isoenzymes  
Type I–III have a molecular mass of 100 kDa while Type IV, also known as 
glucokinase has a molecular mass of 50 kDa. HK Types I–III are thought to have 
evolved by the duplication and fusion of an ancestral gene that encodes a 50 kDa 
hexokinase (Kamata et al, 2004), the result of which is N- and C-terminal halves of 
similar sequence (Kogure et al., 1993).  
In spite of the sequence similarity, the N- and C-terminal halves have different 
functions for the isozyme Types I–III. For isozyme II, both halves have a catalytic 
function, whereas for isozymes I and III, the C-terminal half has catalytic functions 
and the N-terminal has a regulatory function (Tsai and Wilson, 1996). All three 
isozymes are inhibited by the product Glucose-6-phospate (G6P). It has been 
hypothesized that inhibition by G6P is the regulatory function of the N-terminal 
half of HKI and HKIII. 
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Other differences between the three isozymes are substrate affinity, the role of 
inorganic phosphate (Pi) in regulation, and sub-cellular location. Of the four 
isozymes, HKIII has the highest affinity for glucose and lowest affinity for ATP. 
G6P inhibits isozyme IIII, but Pi antagonizes inhibition by G6P in the Type-I 
isozyme only; further, it is an inhibitor of isozymes II and III. Isozymes I and II 
have a conserved hydrophobic leader sequence at the N-terminus. Isozyme III lacks 
the hydrophobic leader sequence. 
 
Table 1.1–3  Cellular and molecular properties of the human hexokinase enzymes: 
*Glucokinase (HKIV) does not exhibit Michaelis-Menten kinetics, and its substrate 
affinity is defined by its half-saturating glucose concentration (S0.5) (Wilson J.E, 
2003). 
Immunolocalization studies have shown the association of isozymes Types I and II 
with mitochondria, whereas the Type-III isozyme is co-localized with the envelope 
of the nucleus (Amparo et al., 2011). It is thought that the hydrophobic leader 
sequence for the Types I and II isozymes confer mitochondrial binding properties, 
 
Properties HKI HKII HKIII HKIV 
MW (KD) 100 100 100 50 
Tissues Brain, kidney, 
RBCs 
Skeletal 
muscle, fat 
Liver, intestine, 
kidney 
Liver, 
pancreas 
Km 0.03 0.3 0.003 6-8 
Glc (mM) 
Km 0.5 0.7 1 0.6 
ATP (mM) 
Function, N-
terminal 
Regulatory Catalytic Regulatory - 
half 
Function, C-
terminal 
Catalytic Catalytic Catalytic - 
half 
Inhibition by Yes Yes Yes No 
Glc-6-P 
Pi relief Yes No No - 
Subcellular Mitochondria Mitochondria Nuclear 
periphery 
Shuttles 
between 
nucleus and 
cytoplasm. 
localization 
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which allow the association between the outer mitochondrial membranes to occur 
by selective targeting (Wilson., 2004). 
A voltage dependent anion channel (VDAC) – also called Porin – is located in the 
mitochondrial membrane. The function of this channel is to control the flux of 
metabolites across the membrane and interact with hexokinase I. The channel may 
facilitate the phosphorylation of glucose by providing a sufficient supply of ATP 
from oxidative phosphorylation inside mitochondria (Tsai and Wilson., 1995). 
In cancer cells, HK (mainly II) is upregulated and its binding to the mitochondria 
through the VDAC channel plays an important role in the growth and survival of 
cancer cells. This happens in most aggressive tumors, such as glioma and hepatoma 
(Pastorino and Hoek., 2003). 
These phenomena contribute to the Warburg effect (Pedersen., 2007), which is 
considered as the hallmark of cancer. In addition, it facilitates the evasion of 
apoptosis by cancer cells through increased expression of hexokinase II and 
antiapoptotic proteins of the BCL-2 family. This in return protects the cancerous 
cells against mitochondria-mediated cell death (Mathupala, Ko, and Pedersen., 
2006).  
Glucokinase (HKIV) shuttles between the nucleus and cytoplasm of hepatcoytes 
according to the cellular glucose concentration. The mechanism of translocation is 
highly sophisticated, is under allosteric control, and is thought to be ciritcal to the 
regulation of blood glucose in mice, rats and man. This is considered in detail in 
section 1.1.4.3 below. 
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Figure 1.1–3 Interaction between hexokinase and mitochondria and their involvement 
in the maintenance of cancer cell survival (glucose and ATP are delivered to 
hexokinase II) (Galluzzi, Kepp, Tajeddine, and Kroemer, 2008). 
1.1.4.1 Recent advances in hexokinase isozymes  
In addition to the previously mentioned hexokinases, a hexokinase II pseudo gene 
has been identified (Malkki et al., 1994), which maps to chromosome Xq21. It has 
no introns, and this may indicate that it has been derived from cDNA by reverse 
transcription from mRNA, and contains internal stop codon that would prevent the 
synthesis of functional protein (Malkki et al., 1997; Ardehali et al., 1995). 
Further, bioinformatics analysis and genomic search has been conducted (Irwin and 
Huanran., 2008), and the results of these searches have identified five hexokinase-
like genes (HKDC1). The data obtained from these studies also revealed that 
HKDC1 is ubiquitously expressed and its sequence has been conserved among 
different vertebrate species and retains amino acid residues responsible for 
hexokinase activity. The phylogenetic analysis showed a very close relationship 
HHHH 
Glucose 
transporter HKII 
Key player 
In cancer 
Lactate 
Glucose 
Lactate 
Lactate 
transporter  
Membrane 
precursor 
biosynthesis 
Pentose 
phosphate 
pathway 
DNA 
,RNA 
Glu-
Pyruva
ATP 
ADP 
Citrate 
Citrate 
transport
TCA 
7-Pyruvate 
transporter 
ADP 
ATP 
VDAC 
ATP 
synthase 
Adenine 
nucleoti
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between HKDC1 and hexokinase I, which indicates that HKDC1 is more likely to 
be a hexokinase family member. 
1.1.4.2 ADP ribokinases and polyphosphate kinase 
A new family of kinases with glucose phosphorylation activity was established 
initially from bioinformatics searches: these are ADP-dependent kinases (the first 
incorrectly coined ‘glucokinase') and also phosphofructokinase; these two enzymes 
are homologous and little sequence similarity to the known ATP- dependent 
enzymes described above (Guixe and Merino., 2009).  
Three-dimensional structural studies of ADP-dependent enzymes allowed them to 
be classified as a member of the ribokinase family (Guixe and Merino., 2009).  
Further structural studies have revealed that the ribokinase superfamily also 
contains enzymes that can transfer ү-phosphate of ATP to some vitamins involved 
in B6 synthesis, such as pyridoxal kinase (Li et al., 2002). 
This superfamily can be classified into three major groups: ATP-dependant sugar 
kinase, ATP-dependent vitamin kinases and the ADP-dependent sugar kinase 
(Zhang et al., 2004). 
Some homologous kinases have been identified in the genome of higher 
eukaryotics. The gene present in the genome of Mus musculus was cloned and 
expressed in E. coli – characterisation of the enzyme revealed that it is a monomer 
and quite specific for glucose, classifying it as an ‘ADP-dependent glucokinase’, 
(It is a hexokinase with a Km of 0.5mM and is not involved in glycemia regulation), 
whose physiological function is suggested to be effective during ischemia/hypoxia 
(Ronimus and Morgan., 2004). 
These genes are expressed in different mammalian tissues, including man, 
suggesting that they may be housekeeping genes. Furthermore, ADP-dependent 
glucokinase has been found to be highly expressed in prostate cancer (Ronimus and 
Morgan., 2004). 
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1.1.4.3 Glucokinase (EC 2.7.1.2) 
Glucokinase (GK) is a hexokinase isozyme related homologously to the other three 
hexokinases (Kawai et al., 2005). Human glucokinase is a monomeric protein of 
465 amino acids with a molecular weight of about 50 kD. There are at least two 
clefts: one for the active site binding glucose and Mg2+- ATP, and the other for a 
putative allosteric activatorthat has not yet been identified (Kamata et al., 2004). 
This hexokinase is half the size of the other mammalian hexokinases, which 
preserve a degree of dimeric structure, a number of sequences, and the three-
dimensional structure of the key active sites. The binding domain for ATP is shared 
with hexokinases, bacterial glucokinases, actin and Hsc70, the common structure 
they share is the actin fold (Holmes et al., 1993). 
All of the hexokinases can catalyse the phosphorylation of glucose to glucose 6-
phosphate, which is the first step of both glycogen synthesis and glycolysis 
pathways. However, glucokinase is encoded by a different gene, and its unique 
kinetic properties allow it to perform a completely different function. Glucokinase 
has a lower affinity for glucose than the other hexokinases do, and its activity is 
confined to a few cell types, such as those of the liver, pancreas, gut, and brain of 
humans and most other vertebrates. In each of these organs, it has an important role 
in the regulation of carbohydrate metabolism by acting as a glucose sensor, creating 
shifts in metabolism/ cell function as a result of glucose concentrations changes 
(Kawai et al., 2005). 
Under specific conditions, glucokinase, like other hexokinases, can induce 
phosphorylation of other hexoses (six carbon sugars) and similar molecules 
(Cárdenas., 2004). Therefore, the general glucokinase reaction is more preciesly 
described as: 
Hexose + MgATP2- → Hexose-PO32- + Mg ADP- + H+ 
 Hexose substrates phosphorylated by glucokinase are mannose, fructose, and 
glucosamine, but the affinity of glucokinase for these needs concentrations not 
usually found in cells for significant activity (Magnuson and Matschinsky, 2004). 
 
 13 
 
1.1.4.4 Glucokinase genetics 
Human glucokinase is coded for by the GCK gene on chromosome 7. This single 
autosomal gene has 10 exons (Matsutani et al., 1992; Stoffel et al., 1992). Genes 
for glucokinase in other animals are homologous to human GCK (Wilson, 2004; 
Bell Cuesta-Munoz, & Matschinsky., 2002). 
A distinctive feature of the gene is that it begins with two promoter regions 
(Iynedjian, Jotterand, Nouspikel, Asfari, and Pilot., 1989). The first exon from the 
5'-end contains two tissue-specific promoter regions. Transcription can take place 
at both promoters (depending on the tissue type) so that the same gene can provide 
a slightly different molecule in the liver and in other tissues. The two isoforms of 
glucokinase vary only by 13–15 amino acids at the N-terminal end of the molecule, 
which results in only a minimal variation in structure. The two isoforms have a very 
similar kinetic and functional characteristic (Iynedjian., 2009). 
The first promoter from the 5'-end, referred to as the “upstream” or neuroendocrine 
promoter, is active in pancreatic islet cells, neural tissue, and enterocytes (small 
intestine cells) to yeild the “neuroendocrine isoform” of glucokinase (Iynedjian et 
al., 1989). The second promoter, the “downstream” or liver promoter, is active in 
hepatocytes and directs production of the “liver isoform” (Iynedjian et al., 1989). 
The two promoters have little or no sequence homology and are separated by a 30 
kbp sequence which has not yet been shown to sustain any functional discrimination 
between isoforms (Iynedjian., 2009). The two promoters are functionally exclusive 
and controlled by distinct sets of regulatory factors, so that glucokinase expression 
can be regulated separately in different tissue types (Iynedjian., 2009). The two 
promoters correspond to two large categories of glucokinase function: In the liver, 
glucokinase play a role in the “bulk processing” of available glucose, while in the 
neuroendocrine cells, it acts as a glucose sensor. (Cárdenas et al., 1998). The 
glucose sensing mechanism initiated as the level of glucose increases, this in return 
triggers a number of cellular responses: glucose enters the cell via glucose 
transporter 2 (GLUT 2), then it is phosphorylated by glucokinase. As a consequence 
the cytosolic ATP/ADP ratio elevates leading to the closure of K+ATP channels, 
neuronal depolarization and entry of Ca2+ ions through Ca2+ channels causing the 
release of neurotransmitter. (Backer et al., 2016). 
 14 
 
1.1.4.5 Clinical significance 
About 200 mutations of the human glucokinase gene GCK have been identified, 
which can affect and alter the effectivness of glucose binding and phosphorylation, 
the sensitivity of beta cells to  increase or decrease insulin secretion in response to 
glucose, and resulting in clinically significant hyperglycaemia or hypoglycemia 
(Arden et al., 2007). 
1.1.4.5.1 Diabetes 
Around 190, of these mutations affect the functional effectivness of the glucokinase 
molecule. Heterozygotes for the alleles with low enzyme activity have a higher 
threshold level for insulin secretion and persistent, mild hyperglycemia. This 
condition is known as maturity onset diabetes of the young, type 2 (MODY2). 
Homozygosity for GCK alleles with lowered function can result in severe 
congenital insulin deficiency, the outcome of this termed as persistent neonatal 
diabetes (Matschinsky and Magnuson., 2004). 
Chronic hyperglycemia will result in a number of complications if it remains 
untreated. The main consequences of hyperglycemia are nephropathy, neuropathy 
(damage to the peripheral nerves), cardiovascular disease, retinopathy (damage to 
the blood vessels in the eye, which may cause blindness), and in the long term, 
stroke and comma (Matschinsky and Magnuson, 2004). 
1.1.4.5.2 Hyperinsulinemic hypoglycemia 
As of 2004, five mutations have been identified which stimulate insulin secretion. 
Heterozygous for gain of function mutations reduces the threshold level of glucose 
that enhances insulin release. This produces hypoglycemia of varying patterns, 
including transient or persistent congenital hyperinsulinisim, or fasting or reactive 
hypoglycemia appearing in old age. 
1.1.4.6 Hepatic glucokinase 
Most of the glucokinase in mammals is present in the liver, although its presence in 
pancreatic beta cells, the small intestine, and the brain play a crucial integrative role 
in glycemic regulation.  
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Glucokinase can be rapidly stimulated and inhibited in hepatocytes by a regulatory 
protein (glucokinase regulatory protein or GKRP), which functions to maintain an 
inactive reserve of GK that can be made quickly available in response to increasing 
levels of portal vein glucose (Cárdenas and Maria., 1995). 
GKRP shuttles between the nucleus and cytoplasm of the hepatocytes and may be 
attached to the microfilament cytoskeleton (Payne et al., 2007 and Shin et al., 2007). 
It forms reversible 1:1 complexes with GK and can transport it from the cytoplasm 
into the nucleus. It acts as a competitive inhibitor with glucose, therfore the enzyme 
activity is declined to near-zero when it is bound. GK–GKRP complexes are 
sequestered in the nucleus while glucose and fructose levels are low. Nuclear 
retention of GK may act as a protective mechanism from degradation by 
cytoplasmic proteases (Cardenas & Luz., 1995). GK can be released very fast from 
GKRP as a result of increasing levels of glucose. Contrary GK in beta cells, GK in 
hepatocytes is not associated with mitochondria (Zhang et al., 2006). Fructose in 
micromolar concentration (after phosphorylation by fructokinase EC 2.7.1.4, to 
fructose 1-phosphate (F1P) EC 4.1.2.13 dissociates GK from GKRP. This 
sensitivity to the occurence of small amounts of fructose enables GKRP, GK, and 
ketohexokinase EC 2.7.1.3 to act as a “fructose sensing system”, which indicates 
that, a mixed carbohydrate meal is being digested and enhances the utilization of 
glucose. However, fructose 6-phosphate (F6P) stimulates the binding of GK by 
GKRP. F6P decreases phosphorylation of glucose by GK when glycogenolysis or 
gluconeogenesis is taking place. F1P and F6P both bind to the same site on GKRP. 
It is suggested that they produce two different conformations of GKRP: one able to 
bind GK and the other not (Futamura et al., 2006). 
Regulation takes place at several levels and speeds and is affected by many factors 
that influence mainly two general mechanisms: 
1. Glucokinase activity can be increased or decreased in minutes by the influence 
of the glucokinase regulatory protein. The roles of this protein are influenced 
by small molecules such as glucose and fructose. 
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2. The amount of glucokinase can be increased by the nuclear sequestration system 
far beyond that which could be produced through the period of post-prandial 
transcriptional activiation by insulin (Murphy et al., 2003, Iynedjian, 2009). 
3. The perivenous concentration of glucokinase also enables the liver to respond 
quickly when changing from the fasting to early post-prandial state: glucose 
uptake can occur in the perivenous cells even whilst the periportal cells are still 
producing glucose via gluconeogenesis (Burns et al., 1996, Burns et al., 1997 
and Murphy et al., 2003). The overall weight of these two processes, periportal 
glucose output from gluconeogenesis, and perivenous glucose uptake 
determining net glucose uptake or output, according the kinetics of glucokinase 
and the concentration of the enzyme stored in the perivenous hepatocytes 
nucleus (Burns et al., 1997, Burns et al., 2001). The architecture of the liver 
lobule provides a system for fetal programming of the weighting of these two 
groups of cells and generates an epigenetic glucostat in the liver architecture 
(Burns et al., 1997, Burns et al., 2000b). 
1.1.4.7 Pancreatic glucokinase 
Although most of the glucokinase in the body is in the liver, smaller amounts are 
present in beta and alpha cells of the pancreas, certain hypothalamic neurons, and 
specific cells (enterocytes) of the gut, which play a significant role in regulation of 
carbohydrate metabolism. Regarding glucokinase function, these cell types are 
referred to as neuroendocrine tissues, and they share some aspects of glucokinase 
regulation and function, especially the common neuroendocrine promoter. Of the 
neuroendocrine cells, the beta cells of the pancreatic islets are the most studied and 
best understood. It is likely that many of the regulatory relationships discovered in 
the beta cells will also exist in the other neuroendocrine tissues with glucokinase. 
In islets beta cells, glucokinase activity serves as the principal control for the 
secretion of insulin in response to rising levels of blood glucose. As G6P is 
consumed, increasing amounts of ATP initiate a series of processes that result in 
release of insulin. One of the immediate consequences of increased cellular 
respiration is a rise in the NADH and NADPH concentrations (collectively referred 
to as NAD (P) H). This shift in the redox status of the beta cells results in increasing 
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intracellular calcium levels, closing of the KATP channels, depolarization of the 
cell membrane, merging of the insulin secretory granules with the membrane, and 
release of insulin into the blood (Moukil et al., 2001). 
1.1.4.8 Hypothalamic glucokinase 
Glucokinase has been found in the brain mostly in the same areas that contain 
glucose-sensing neurons, including both of the hypothalamic nuclei. Inhibition of 
glucokinase negatively affects the ventromedial nucleus response to a meal. 
However, brain glucose levels are lower than plasma levels – typically 0.5–
3.5 mmol/L. Although this range matches the sensitivity of the glucose-sensing 
neurons, it is below the optimal inflection sensitivity for glucokinase (Roncero et 
al., 2000). These workers speculated that neuronal glucokinase is somehow exposed 
to plasma glucose levels even in the neurons, since hypothalamic glucose-sensing 
neurons involve subgroups of cells in the lateral, arcuate and ventromedial parts of 
hypothalamus, these neurons are inhibited or excited according to the changes in 
extracellular glucose (Wang et al., 2004). 
1.1.4.9 Glucokinase distribution in species belong to different nutritional categories 
Liver glucokinase occurs widely but not universally throughout vertebrate species. 
The gene structure and amino acid sequence are highly conserved among most 
mammals (e.g., rat and human glucokinase is more than 80% homologous). 
However, there are some unusual exceptions: For example, it has not been 
discovered in cats, ruminants and bats (Ballard., 1965, Irwin et al., 2013), though 
some reptiles, birds, amphibians, and fish have it.  
Whether glucokinase occurs similarly in the pancreas and other organs has not yet 
been determined. It has been postulated that the presence of glucokinase in liver 
reflects the ease with which carbohydrates can be included in the animals' diets 
(Irwin et al., 2013). 
A comparative study has been done by Ballard in 1965, between different 
mammalian animals belonging to different dietary categories (omnivorous, 
carnivorous and herbivorous) to evaluate their glucokinase activity. The data 
obtained from this study revealed that, omnivorous animals like rat and pig showed 
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high glucokinase activity and an increased rate of glycogenesis, whereas 
carnivorous animals such as dogs and cats, showed either high glucokinase activity 
in dogs or lower activity in cats (Ballard., 1965). In ruminants, which belong to the 
herbivorous category, the data obtained showed no glucokinase activity, the lowest 
hexokinase activity and low rates of glycogenesis.  
1.1.5 Glucose metabolism in ruminants 
Gluconeogenesis is a continual and critical process in ruminants to maintain a 
steady blood glucose level, because almost all dietary carbohydrates are fermented 
to volatile fatty acids in the rumen by ruminal micro flora (Aschenbachet et al., 
2011). 
Therefore ruminants are only able to absorb about 10% of dietary glucose from the 
gut (Emmanuel., 1981), as a consequence this may explain the absence of any 
glucokinase activity in ruminant liver (Ballard., 1965; Ureta., 1982). 
Many surveys examined hexokinases activity from livers of numerous species, and 
their chromatographic profiles indicated that some mammals including ruminants 
(cow, ovine) bats and cats have little if any glucokinase activity (Vandercammen & 
Van Schaftingen., 1993; Ureta., 1982). Furthermore, the same studies also reported 
that the other hexokinases (I, II, III) are expressed normally in these species, 
suggesting that the absence of glucokinase activity was not compensated by up 
regulation of other hexokinases. 
Bioinformatics studies showed that mutations that inactivate glucokinase function 
seems to be unlikely, on the other hand mutations in the GKRP have been reported 
(Irwin et al., 2013). As ruminants have not been reported to show any symptoms of 
diabetes or impaired glucose metabolism, it is more likely that they handle glucose 
metabolism differently. Glucose is not normally present in their blood at high 
concentrations, and therefore ruminants are less dependent on GK to remove excess 
glucose. On the other hand glucose required by other tissues is produced in the liver 
and its production is regulated by the hormones insulin and glucagon. 
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This also suggests that the control of glucose steady state in the circulation of these 
species may be more geared to glucose production (gluconeogenesis) rather than 
glucose uptake (absorption from the gut) (Wang et al., 2013). 
Studying glucose metabolism in ruminants, specifically ovine is challenging since 
it has been reported previously that they are lacking glucokinase activity in their 
liver extracts, furthermore studies have shown that the glucokinase regulatory 
protein is mutated in this species (Irwin et al., 2014). 
The previous studies on ovine GK misinterpreted the very high blank background 
absorbance at high glucose concentration, subtracting it from GK activity and 
concluding this enzyme was absent. However, the high ‘blank’ absornabnce has 
been shown to the result of an ATP-indepdendent hexokinase enzyme which has 
been proven to phosphoryale glucose using 13C labelled glucose using NMR 
(Bursn et al., unpublished data). The current thesis takes this observation and 
discovers two key new pieces of information: that the phosphorylation substrate is 
polyphosphate, and that the enzyme is inhibited by Adenosine phospahtes such as 
ATP and ADP. This data has allowed the enzyme to be measured in a variety of 
mammalian tissues including rat liver, which show that existing assay methods 
must now take account fo this enzyme and remove it from total phosphorylating 
capacity to obtain true ATP- and ADP-depdendent hexokinases and glucokinases 
in particular in muscle and liver tissue.  Successful purification of the enzyme and 
sequencing will shed the light on the relevance of this novel enzyme, and any other 
similar enzymes in mammals and therefore help to elucidate their physiological 
function and probably their implications in the pathophysiology of certain 
metabolic disorders such as diabetes. 
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 Part Two: Introduction to polyphosphate 
Inorganic polyphosphate (Poly-Pi), a linear polymer of tens to hundreds of 
phosphate residues is linked together by ‘high-energy’ phosphoanhydride bonds. 
The molecular structure of Pi is shown in Figure 1.2-1 below: 
Inorganic phosphate can be found in the cytoplasm like many others inorganic ions 
but in living organisms it is predominantly found as Pi or bound to organic 
molecules. 
 
Figure 1.2–1  shows the linear molecular structure of inorganic polyphosphate, “n” is 
the number of [PO3−], residues vary from tens to thousands, (n=10-1,000). 
Poly-Pi etc. can be formed from (ortho)-phosphate salts by dehydration at high 
temperature, which occurs under some special geological conditions like volcanoes 
and deep-oceanic steam vents. Hence, many scientists have concluded that Poly-Pi 
may have been involved in prebiotic evolution; it resembles a source of stored 
energy in a pre-ATP world (Jones & Lipmann., 1960; Schwartz., 2006). 
In 1904 “volutin”, a type of ‘metachromatic granule”, or intracellular particle that 
could be stained pink by basic blue dyes, was first observed in yeast and deemed to 
be nucleic acid (Meyer., 1904). 
Many years later, with analytical techniques such as electron microscopy, these 
granules were identified to be Poly-Pi (Wiame., 1947).  
Yet due to a lack of sensitive and accurate analytic methods to determine its 
functions, Poly-Pi was regarded as a “molecular fossil” for a long time. During the 
past couple of decades, a variety of techniques have been developed that have 
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enabled researchers to explore the various forms and functions of Poly-Pi in cells, 
the results show that it is present in every cell in nature: archaea, bacteria, fungi, 
plants and animals( Kulaev & Vagabov., 1983; Kumble & Kornberg 1995; Zhang 
& Kornberg., 2002). 
1.2.1 The main functions of polyphosphate in cells of living organisms 
Polyphosphates are involved in many biological functions associated to their 
chemical structure and properties, being found acting as chelator, buffer or energy 
source and reservoir, explained in more detail below. Although more work is 
required, especially in mammals, the importance of polyphosphate in some 
biological processes has been demonstrated, including Ca2+ channels, basic 
metabolism, biofilm formation, cell capsule, SOS response, sporulation and 
motility, osmotic regulation, ATP substitute and energy source, buffer against 
alkali, apoptosis, bone formation, blood coagulation, and regulation of mTOR. 
1.2.1.1 Substitute and energy source  
The amounts of Poly-Pi in cells are much higher than those of ATP. Under normal 
conditions, the cellular ATP levels are around 5-10mM. However, the vacuoles of 
yeast cells may contain more than 200mM of Poly –Pi (200mM PO3- units joined 
as polyphosphate chains of variable length), and in E. coli, Poly-Pi levels may 
increase to 50mM in a response to stress (Ault-Riche et al., 1998).  
It has been shown that Poly-Pi may serve as a substitute for ATP, acting as a 
phosphate-containing substrate for several enzymatic reactions including Poly-
Pi/ATP dependent NAD kinase and Poly-Pi/ATP dependent glucokinase 
(Kornberg, 1995). Most remarkably, in combination with polyphosphate kinase 1 
(PPK1), Poly P: AMP phosphotransferase may regenerate ATP from AMP. 
Considering the key role of ATP and the high level of Poly-Pi in cells, Poly-Pi plays 
an important role as a substitute for ATP as a phosphate donor and energy source 
(Van Veen et al., 1994). 
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1.2.1.2 Reservoir for phosphate 
A constant amount of phosphate is crucial for metabolism and cell growth. Poly-Pi 
may act as a reservoir for phosphate, which can be hydrolyzed to phosphate by the 
actions of phosphatase enzymes (e.g. exopolyphosphatase, Ppx) to maintain a stable 
level of phosphate within the cell. As long chain Poly-Pi can bind and form 
complexes with many multivalent counter-ions simultaneously, it has little effect 
on cellular osmotic pressure while at the same time act to preserve a constant level 
of crucial metabolite such as free Pi and ATP. (Harold., 1966). 
1.2.1.3 Metal Ions Chelator  
The long-chain phosphate residues allow Poly-Pi to powerfully chelate metal ions 
inside the cells. The Poly-Pi-metal complexes have been shown to play multiple 
roles in the cell. In Lactobacillus plantarum, the Mn2+-Poly-Pi complexes act as an 
inorganic superoxide dismutase (Archibald & Fridovich., 1982). Within the 
vacuoles of yeast, the chelation of Ca2+ by Poly –Pi act as Ca2+ sink (Dunn, Gable 
& Beeler., 1994). In the cell walls of gram-positive bacteria, the complexes of Poly-
Pi, Ca2+ and Mg2+ play an antibacterial role of Poly-Pi (Lee et al., 1994). 
1.2.1.4 Buffer system against alkali 
The ability of Poly-Pi to act as a buffer against alkali has been demonstrated in one 
study involving a species of algae (Weiss, Bental & Pick., 1991). Similar to yeasts, 
Poly-Pi is accumulated in vacuoles within algal cells. In Dunaliella salina, a type 
of halophilic green algae, the levels of Poly-Pi can be as high as 1M. In an alkaline 
environment, Poly-Pi is hydrolyzed to tri-Poly-Pi by specific endopolyphosphatase 
to neutralize amines within the vacuoles. Thus, Poly-Pi can act as a high-capacity 
buffer to maintain the pH stability of the intracellular environment. 
1.2.1.5 DNA entry Channels 
Chemical transformation facilitates the entry of exogenous DNA into cells. Its 
mechanism has been shown to involve PHB (polyhydroxybutyrate)/calcium/Poly –
P complexes. During the process of competent cell preparation, the addition of Ca2+ 
leads to the formation of PHB/calcium/Poly-Pi complexes in the membranes of the 
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competent cell, which cause profound physical changes and facilitate DNA entry. 
However, many details of the transport process are still unclear (Reusch & Sadoff., 
1988). 
1.2.1.6 Metabolism 
Poly-Pi plays an important role in the regulation of metabolism. Kusano and 
Ishihama showed that Poly-Pi could tightly bind to the RNA polymerase of E. coli 
in the stationary growth phase and selectively reduce the transcription of the genes 
that were dominant in the exponential growth phase (Kusano & Ishihama 1997). 
Poly-Pi interacts with ribosomes, mainly through its binding to specific ribosomal 
proteins, which plays an important role in maintaining the fidelity of translation 
(McInerney, Mizutani & Shiba 2006).  
Another significant discovery is that Poly-Pi can form complexes with the Lon 
protease to stimulate the degradation of free ribosomal proteins when the cell 
undergoes amino acid starvation (Kuroda et al., 2001).  
This process is illustrated in Figure 1.2—2 below 
Poly-Pi formed in large amounts in response to amino acid starvation ‘capture’ the 
Lon protein from DNA, forming a Poly-PiLon complex. The binding of Poly P 
specifically activates the hydrolytic (proteolytic) activity of Lon towards free 
ribosomal proteins, resulting in them being degraded to amino acids. These amino 
acids can then be used for the synthesis of many housekeeping proteins in the cell. 
This pathway is of great importance for cell survival during periods of amino acid 
starvation, as it promotes the synthesis of key proteins/enzymes. 
Further studies have revealed that in addition to its effects on the protease activities 
of Lon, Poly -Pi also affects the DNA-binding abilities of Lon. The major reason is 
that the affinity of Lon to Poly -Pi is higher than its affinity to DNA. This means 
Poly -Pi effectively competes with DNA for Lon protein binding, thereby inhibiting 
the formation of DNA-Lon complexes (Nomura et al. 2004). In addition, the Poly -
Pi-Lon complex has been shown to be involved in the degradation of nucleoid 
proteins under certain conditions (Kuroda et al., 2006). 
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Figure 1.2–2 The proteolysis of ribosomal proteins activiated by the Poly Pi-Lon 
complex in response to amino acid starvation. 
This figure is taken from Rao, NN, et al. Annu Rev Biochem, 2009. (Rao, Gomez-
Garcia & Kornberg 2009) 
1.2.1.7 Bio- film formation 
Bio-films are surface-attached, structured communities containing single or 
multiple species of micro- organisms. They are commonly present in a wide range 
of ecosystems, and play a vital role in the (synergistic) growth and survival of most 
bacteria (Hall-Stoodley, Costerton & Stoodley., 2004) , such as protecting them 
against predation by protozoa or white cells (Van Oss., 1978), reduce UV 
penetration  (Elasri & Miller., 1999) and increase their resistance to antibiotics and 
biocides, etc., Studies in Pseudomonas aeruginosa, Porphyromonas gingivalis and 
Bacillus cereus have revealed that the Poly-Pi null cells (achieved by knock-out 
mutation of the PPK1 gene) are deficient in their ability to form biofilms (Rashid 
et al., 2000; Chen, Palmer & Kuramitsu 2002; Shi, Rao & Kornberg, 2004). This 
suggests that Poly-Pi plays an important role in the process of biofilm formation, 
and thereby influences the virulence and the resistance of bacteria. 
1.2.1.8 Cell capsule 
In several Neisseria species, including two important human pathogens, Neisseria 
meningitidis and Neisseria gonorrhoeae, about half of Poly-Pi is found loosely 
attached to the exterior of the cell, and forms part of the capsule (Tinsley, Manjula 
& Gotschlich., 1993). 
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The Poly-Pi capsule is speculated to contribute to the pathogenesis of infections by 
providing an antiphagocytic capsule, by chelating metals needed in complement 
fixation or by complex essential nutrients as iron. 
1.2.1.9 DNA Damage and SOS response 
During the SOS response, which is induced in response to the detection of DNA 
damage, various sets of DNA repair proteins mend the breaks in the chromosome, 
and facilitate the progression of the DNA replication machinery. 
However, in cells with low levels of Poly P (generated by the over-expression of 
the exoployphosphatase Ppx) the expression of rpoS (which encodes the RNA 
polymerase sigma factor, RpoS) and recA (which encodes a DNA-recombinase) are 
reduced (Shiba et al., 1997; Tsutsumi, Munekata & Shiba., 2000). These results 
indicate that Poly -P is involved in the expression of SOS genes.  
 1.2.1.10 Osmotic stress 
Dehydration (water loss) leads to an increase in osmotic pressure, and this usually 
leads to cell death. Many studies have found that osmotic stress can induce cells to 
accumulate large amounts of Poly-Pi, and have speculated that Poly-Pi could 
enhance the ability of cells to survive changes in osmotic pressure (Ault-Riche et 
al, 1998). Recent studies show that cells with low concentrations of Poly-Pi 
(resulting from the deletion of the PPK1 gene) showed lower survival rates towards 
desiccation compared to the wild cells, indicating that Poly-Pi may play an 
important role in resistance to osmotic pressure (Fraley et al., 2007). 
1.2.1.11 Bacterial Motility and Sporulation  
The spore is an important cell form that resists environmental stresses. In Bacillus 
cereus, the ppk, ppx and pap genes were individually ‘knocked-out’ (mutationally-
inactivated) from the genome, and changes in cell properties were evaluated. The 
results showed that only in the ppx mutant, the sporulation efficiency was reduced 
(Shi, Rao & Kornberg., 2004). In the delta-proteobacterium Myxococcus xanthus, 
inactivating the PPK1 gene resulted in delayed fruiting-body formation, fewer 
spores and delayed germination (Zhang, Rao, Shiba, Brown & Kornberg., 2005). 
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Similarly, in the soil-dwelling amoeba Dictyostelium discoideum, the PPK1 mutant 
had smaller fruiting bodies and few spores (Zhang, Gomez-Garcia, and Brown & 
Kornberg., 2005). In addition, the motility of all the above mutants was 
significantly reduced. Thus, Poly -P is regarded as a regulator or mediator of 
sporulation and motility in micro-organisms, but its molecular mechanisms remain 
to be explored. 
1.2.1.12 Regulation of mTOR 
Though Poly-Pi widely exists in tissues and subcellular compartments (Kumble & 
Kornberg., 1995), little information is available about the functions of Poly-Pi in 
animal cells.  
The few known functions mainly include regulation of mTOR (mammalian target 
of rapamycin), modulation of the mitogenic activity of fibroblast growth factors; its 
participation in apoptosis, bone formation and blood coagulation. 
TOR (target of rapamycin), a serine-threonine protein kinase, plays central roles in 
signalling pathways relating to cell growth and proliferation (Schmelzle & Hall., 
2000), and is highly conserved in all eukaryotes analyzed so far (Jacinto & Hall., 
2003). 
 mTOR is composed of two proteins: mTORC1 and mTORC2.in vivo, mTOR can 
respond to the signals from amino acid supply, cellular energy state, various 
hormones (such as insulin) and growth factors.  
Activated by autophosphorylation, mTOR can initiate cascade reactions and 
promote cell growth, and proliferation (Scott et al., 1998). 
 However, in in vitro studies, signals such as insulin or amino acids failed to 
stimulate mTOR as they do in vivo, and surprisingly Poly-Pi was found to be 
capable of strongly activating mTOR (Wang et al., 2003). 
The same result was also seen in vivo with MCF-7, a human carcinoma cell line. 
When the level of Poly-Pi in MCF-7 cells was reduced by supplying the Ppx 
exopolyphosphatase, cells showed low response to insulin and amino acids, and the 
cell growth rate significantly decreased. Based on the above results, Poly-Pi is 
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regarded to be a regulatory factor of mTOR, controlling the growth and 
proliferation of animal cells. 
1.2.1.13 Modulation of mitogenic activity of fibroblast growth factors 
Poly -P plays a role in the proliferation of normal human fibroblast cells.  Cell 
proliferation could be enhanced by adding Poly -P into the culture medium.  
The mechanism might relate to acidic fibroblast growth factor (FGF-1) and basic 
fibroblast growth factor (FGF-2),  the study revealed that (i) their mitogenic 
activities could also be enhanced by Poly-Pi; (ii) a physical interaction was found 
between Poly-Pi and FGF-2; (iii) FGF-2 could be stabilized by Poly -P; (iv) the 
binding of FGF-2 to its cell surface receptors was facilitated by Poly-Pi (Shiba et 
al., 2003).  
 1.2.1.14 Apoptosis 
Apoptosis plays a vital role in various cell activities, e.g. normal cell turnover, cell 
development and chemical-induced cell death. A recent study discovered that Poly 
Pi was related to apoptosis (Hernandez-Ruiz et al., 2006). When adding Poly-Pi to 
human plasma cells (PCs), the secretion of immunoglobulin was inhibited and 
apoptosis was stimulated. Moreover, the Poly-Pi stimulated apoptosis was specific 
for PCs, myeloma (malignant PC) cell lines, primary myeloma cells, and B 
lymphoid cell lines. For normal B cells, T cells, total blood mononuclear cells, and 
non-lymphoid cell lines, no apoptotic effects were detected. The relevance of Poly-
Pi to the humoral immune response makes it an attractive, novel target for the 
therapy of myeloma. 
1.2.1.15 Bone Tissue mineralization and formation 
Poly-Pi has been suggested to be involved in the control of vertebrate skeletal 
mineralization  (Omelon  & Grynpas 2008; Omelon et al., 2009) based on the 
following observations: (i) vertebrate bones contain crystals of apatite, a calcium- 
and phosphate based mineral; (ii) amorphous, electron-dense granules containing 
calcium and phosphate have been identified in skeletal tissue and mitochondria 
(proposed to participate in apatite biomineralization) (Halstead., 1969); (iii) Poly-
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Pi is identified in areas of resorbing bone and calcifying cartilage; (iv) tissue 
nonspecific alkaline phosphatase is able to cleave orthophosphate from 
polyphosphate. The roles of Poly-Pi in the bio-mineralization processes are 
speculated to be in circumstances where the apatite formation is not required (such 
as cartilage tissue or during bone resorption), calcium-Poly-Pi complexes will be 
formed to reduce the concentrations of free orthophosphate and free calcium; 
whereas when the mineralization is required, orthophosphate will be released from 
Poly-Pi catalyzed by tissue-nonspecific alkaline phosphatase, concurrently 
accompanied with the release of calcium previously sequestered by Poly-Pi. 
 1.2.1.16 Poly-Pi role in blood coagulation cascade and Platelets activiation 
Poly -P has been shown to be present in the dense granules of human platelets by 
DAPI staining, NMR and gel electrophoresis (Ruiz et al., 2004). Studies showed 
that Poly-Pi could be released from platelets to accelerate clot formation when 
platelets were activated. While the decrease of Poly-Pi resulting from hydrolysis by 
(the exopolylphosphatase) Ppx led to the inhibition of clotting and the activation of 
fibrinolysis during wound healing (Smith et al., 2006). 
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Figure 1.2–3 A schematic illustration summarizes polyphosphate sources and pivotal 
functions in mammalian cells. 
1.2.2 Intracellular polyphosphate levels and subcellular distribution 
Studies show that polyphosphates are widely distributed and have been found in 
different cellular compartments in prokaryotes, fungi, plants and eukaryotes. 
1.2.2.1 Prokaryotes 
There is difference in the abundance and intracellular distribution of polyphosphate 
in bacteria, as reviewed in (Kornberg, Rao & Ault-Riche, 1999). Some bacteria, 
such as Acinetobacter johnsonii (Van Groenestijn et al., 1989) and Microlunatus 
phosphovorus (Van Groenestijn et al., 1995) isolated from activated sludge, can 
accumulate high levels of Poly-Pi. In A. johnsonii, Poly –P (200mM) accounts for 
up to 30% of the dry biomass (Deinema, Van loosdrecht & Scholten 1985), whereas 
in many other bacteria, Poly-Pi levels are far lower under normal growth conditions. 
For example, E. coli in stationary phase contains about 0.1-50mM of Poly-Pi, 
however it is able to accumulate several hundred-fold more Poly-Pi in response to 
certain nutritional deficiencies and environmental stressed (Kornberg, Rao & Ault-
Riche., 1999). 
Poly-Pi may be found in all compartments of the bacterial cell: cytoplasm, cell 
surface, periplasm and plasma membrane. Poly-Pi appears in the cytoplasm of 
various prokaryotes (Kulaev & Vagabov 1983; Kulaev., 1979) in the form of 
granules, whose size and number depends on the concentration of phosphate in the 
culture medium. Poly-Pi granules are even used as a diagnostic feature of some 
major human pathogens, such as Corynebacterium diphtheriae. But this application 
is not entirely reliable, as Poly-Pi granules have also been identified in some strains 
of non-pathogenic C. glutamicum (Pallerla et al., 2005). Vibrio cholerae (01, 
biotype El Tor) accumulates high level of Poly -P stored as granules under normal 
growth conditions (Ogawa et al., 2000). Pseudomonas aeruginosa is also able to 
accumulate a large amount of Poly-Pi during the stationary phase (Kim, 1998) and 
in response to phosphate and amino acid starvation (Ault-Riche et al., 1998). 
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Poly-Pi is also present in the periplasm (Rao & Torriani 1988; Nesmeyanova, 
Dmitriev & Kulaev, 1974), in the vicinity of the bacterial nucleoid (Kulaev & 
Vagabov, 1983) and on the cell surface (Tinsley, Manjula & Gotschlich 1993; 
Tinsley & Gotschlich., 1995). 
In the plasma membranes of bacteria, Poly-Pi possesses the capacity to form 
complexes with Ca2+ and poly-β-hydroxybutyrate (PHB). These adopt a double 
helix structure, with an outer chain of PHB and an inner chain of Poly-Pi linked 
together by Ca2+ ions (Reusch & Sadoff 1988; Reusch., 1992). The number of 
PHB/calcium/Poly -P complexes is elevated in cells to make it competent for 
transformation (Huang & Reusch., 1995). Also, the high concentration of 
PHB/calcium/Poly-Pi complexes in the membranes can form rigid domains which 
disrupt the liquid bilayer conformation (Castuma et al., 1995). Consequently, it has 
been speculated that these complexes are involved in the process of DNA transport 
into the cell, forming voltage-activated calcium channels (Huang & Reusch., 1996). 
This conserved PHB complex has also been identified in the membranes of a variety 
of fungi, plant tissues, and animal cells (Reusch., 1992). 
1.2.2.2 Fungi 
In simple eukaryotes, Poly-Pi is found in many different cell compartments, 
including cytosol and cell envelope (Kulaev 1979; Kulaev, 1994), vacuoles (Urech 
et al., 1978; Lichko, Okorokov & Kulaev, 1982), nuclei (Kulaev, 1979), 
mitochondria (Beauvoit et al., 1989) and plasma membrane (Pilatus, Mayer & 
Hitdebrandt, 1989). 
The content of Poly-Pi in each compartment is best studied in Saccharomyces 
cerevisiae. The levels of Poly-Pi in the cytosol largely depends on the cell growth 
phase and cultivation conditions; for example, in the cytosol of Saccharomyces 
cerevisiae, the amount of Poly-Pi may vary from 10% (Okorokov, Lichko & Kulaev 
1980) to 70% (Kulaev, Vagabov & Kulakovskaya, 1999) of total intracellular 
Phosphate during different growth phases. 
 In yeast cells, a fraction of the cytosolic Poly-Pi (about 14% of total intracellular 
phosphate) exists in ‘volutin granules’ which act as Pi reserve and cation 
sequestration (Jacobson, Helman & Yariv 1982).Some studies have suggested that 
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the main function of Poly-Pi in the cytosol is phosphate storage (Kulaev 1979; 
Kulaev, Vagabov & Kulakovskaya., 2004).InS. cerevisiae cells, vacuoles may 
contain the major part of Poly-Pi when it is grown in a medium containing arginine 
as the only nitrogen source (Urech et al., 1978). 
Furthermore, the amount of Poly -Pi in the vacuoles increases seven-fold than in 
the cytosol when the cells are cultured with phosphate, glucose and K+, and is ten-
fold in the presence of Mn2+ ions (Lichko, Okorokov & Kulaev., 1982). 
However, under other conditions, the proportion of Poly-Pi in vacuoles is 
significantly lower; less than 15% (of total Poly-Pi) when S. cerevisiae is cultured 
with Rider medium (a phosphate-limited medium) (Reader., 1927).All of these 
studies implicate Poly-Pi in regulatory metabolic processes, either arising as a result 
of alternative metabolic processes during nutrient depletion or, perhaps even 
driving glycolysis under cell stress. 
For example, in the fungus Candida utilis, vacuoles contain 30-50% of the total 
Poly-Pi depending on the growth rate and the nitrogen source in the medium (Nunez 
& Callier., 1989).When other Candidaspp. Were cultured in phosphate-deficient 
medium, no Poly-Pi could be detected in the vacuoles (Bourne., 1991).  
Poly-Pi vacuoles are also found in Neurospora crassa (Cramer & Davis., 1984) and 
Dunaliella salina (Pick & Weiss., 1991). It has been suggested that the main 
function of Poly-Pi in vacuoles is to chelate the cations accumulated inside the 
organelles (Lichko, Okorokov & Kulaev., 1982), but alternative metabolic 
explanations might exist. 
In addition, the levels of Poly-Pi in the cytosol and vacuoles of yeast cells are 
strongly correlated to the phosphate concentration of the growth medium. In a Pi-
deficient medium, the levels of Poly-Pi both in complete cells and in vacuoles are 
sharply decreased. After 7h of Pi starvation, the Poly-Pi level in vacuoles decreases 
by 85%. When cells are transferred from Pi-deficient medium back to Pi-containing 
medium, the intracellular Poly-Pi levels increase considerably (over six-fold), 
compared to those in the initial culture. 
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 This phenomenon is referred to as phosphate overcompensation. It is observed that 
the levels of Poly-Pi in the vacuoles does not respond to the re-supply of phosphate 
in the growth medium (Kulaev, Vagabov & Kulakovskaya 1999). 
Poly-Pi is often localized within the cell envelope. This Poly -P fraction can be 
effectively extracted under weakly alkaline conditions (e.g. at pH 9.0) (Kulaev & 
Vagabov., 1983).  
Short chain Poly-Pi Ca2+. 14 phosphate residues) has also been identified in the 
mitochondria of yeast cells by 31P-NMR, which accounted for ca. 10% of the total 
Poly-Pi. This fraction of intracellular Poly-Pi is speculated to participate in bio 
energetic processes (Beauvoit et al., 1989). Several studies have indicated that Poly 
-Pi can form complexes with nucleic acids present in the nuclei of yeast cells 
(Kulaev & Vagabov 1983; Kulaev., 1979), whose function is thought to be probably 
related to the regulation of gene expression (Kulaev 1979; Kulaev, Vagabov & 
Kulakovskaya., 2004), though much of this remains speculation. 
1.2.2.3 Higher eukaryotes 
Poly-Pi is also present in all higher eukaryotic organisms investigated, but in 
smaller amounts compared to those found in microorganisms (Gabel and Thomas, 
1972). Kumble et al. reported that micromolar levels of long chain Poly-Pi 
(consisting of 50 to 800 phosphate residues) were present within certain 
tissues/organs in rodents (e.g., brain, heart, kidneys, liver, and lungs). This was 
localized within various subcellular compartments such as nuclei, mitochondria, 
plasma membranes, and microsomes (Kumble & Kornberg., 1995). However, there 
is limited understanding of the distributions and functions of Poly-Pi in higher 
organisms including H.sapien. At the time of submission no enzymes of Poly-Pi 
utilization in mammalian organisms have been identified, and the current work is 
therefore the first demonstration of a Poly-Pi dependent enzyme in mammals. 
1.2.3 Main enzymes of polyphosphate metabolism 
As we have seen, polyphosphates are involved in different vital processes and, 
therefore, many enzymes are expected to be involved in their metabolism. 
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Table 1.2–1 Main metabolic enzymes involved in polyphosphate synthesis and 
degradation 
1.2.3.1 Polyphosphate kinase1 (EC 2.7.4.1) 
Polyphosphate kinase 1 (PPK1), also referred to as polyphosphate: ADP 
phosphotransferase, is highly conserved in prokaryotes and is considered to be the 
main synthesizer of Poly-Pi in a majority of bacterial species. Poly-Pi accumulation 
can be understood by in-depth study of all the enzymes involved in it and their 
regulation.  Polyphosphate kinase- PPK, polyphosphate adenosine monophosphate 
phosphotransferase, polyphosphate glucose-6-transferase, exopolyphosphatase and 
adenylate kinase are the main enzymes involved in the metabolism of prokaryotic 
polyphosphate. The first step of Poly-Pi synthesis by PPK1 includes 
autophosphorylation of its histidine residues, and accordingly PPK1 is a histidine 
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kinase (Zhang et al., 2007).Among the growing list of enzymes that make and 
hydrolyze Poly-Pi, polyphosphate kinase 1 (PPK1) is the most widely conserved. 
Poly-Pi PPK1 homologs have been found in more than 100 prokaryotic species, 
including 20 major pathogens, and to date, only in a few eukaryotes. 
The process of polymerization is highly active with no need for oligo- or 
polyphosphate primers, and there are no detectable intermediates (Ahn & 
Kornberg., 1990). The PPK1 protein from E. coli has been crystallized (Zhu et al, 
2005), which provides valuable information about the active site, spatial structure 
and catalytic mechanism of PPK1. 
In addition to its Poly-Pi synthesis activity, PPK1 also exhibits other enzymatic 
activities including nucleotide diphosphate kinase (NDK) activity and guanosine 
5’-tetraphosphate (ppppG) synthesis activity (Kuroda & Kornberg, 1997). The 
reactions catalysed by PPK1 are shown in Table (1.2-1). 
The Poly-Pi and ATP synthesis reactions can be considered as two results of one 
reaction. In general, PPK1 catalysing the forward reaction, that is the Poly-Pi 
synthesis reaction. However, when ADP is present in excess, the reverse reaction 
(ATP synthesis) can be driven to completion. This reaction could be of importance 
in cells that are highly energy depleted, or which undergo sudden increased demand 
for ATP resynthesis. In mammalian muscle cells this reaction is undertaken by the 
transfer of a phosphate from creatine phosphate to ATP during muscle exhaustion. 
The use of Poly-Pi in this circumstance would be highly favourable. 
Among all the enzymes involved in the metabolism of Poly-Pi, PPK1 is the most 
highly conserved enzyme in bacteria and archaea. PPK1 gene homologues are 
present in the genomes of most bacteria sequenced to date, including numerous 
pathogens responsible for major infectious diseases. PPK1 plays an important role 
in the metabolism of Poly-Pi and enables cells to accumulate large amounts of Poly-
Pi in response to unfavourable growth conditions or other environmental stress. 
Studies have shown that PPK1 can serve as a useful gene target for the regulation 
of Poly–P content in cells. Usually, ‘knocking-out’ (i.e. mutationally-inactivating) 
the PPK1 gene leads to a dramatic decrease in the concentration of intracellular 
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Poly-Pi. Therefore, PPK1 has been used for functional studies of Poly-Pi in a 
variety of micro-organisms.  
PPK1-null mutants have been shown to be defective in many notable aspects; such 
as cell motility, quorum sensing, biofilm formation, virulence and predation 
(Rashid et al., 2000). PPK1 genes are present in several species of archaea, 
including Methanosarcina and Haloarcula, but none have been functionally 
characterized to date. Very few PPK1 homologs have been identified within 
eukaryotes. 
Only the DdPPK1 from Dictyostelium discoideum (Zhang et al., 2005), and 
EcPPK1-like enzyme from Candida humicola (McGrath et al., 2005) have been 
characterized. Similar to EcPPK1, DdPPK1 also possesses the conserved residues 
for ATP binding and autophosphorylation, but at the N terminal it has a unique 
extension of 370 amino acids that is necessary for enzyme activity, cellular 
localization and physiological functions. The D. discoideum PPK1-null mutant has 
been shown to have slower rates of cytokinesis and cell division, and is partially 
defective in various aspects of development, sporulation and predation (Zhang et 
al., 2007). 
1.2.3.2 Polyphosphate kinase2 (EC: 2.7.4.1) 
The discovery of Polyphosphate kinase 2 (Ppk2) in Pseudomonas aeruginosa 
PAO1(wild type) was inspired by the finding that the PPK1-null mutant still 
possesses about 20% of the wild-type levels of Poly-Pi (Rashid et al., 2000). 
Although the PPk2 protein from P. aeruginosa also possesses the activity of Poly-
Pi synthesis, it is different from PPK1 in many ways: (i) Whilst PPK1 is mainly 
involved in the synthesis of Poly-Pi, PPk2 favors the synthesis of nucleotide 
triphosphates (GTP/ATP) from nucleotide diphosphates (GDP/ADP), using Poly-
Pi as the phosphate donor. This reaction is 75-fold faster than the synthesis of Poly-
Pi from ATP/GTP. (ii) Ppk2 shows similar selectivity for adenosine and guanosine 
nucleotides; both in Poly-Pi synthesis and in the synthesis of nucleotide 
triphosphates. 
 This is quite different to the PPK1 protein, where the phosphate donor is strictly 
limited to ATP for Poly-Pi synthesis; it also has an 80-fold preference for ADP over 
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GDP in the synthesis of nucleotide triphosphates. (iii) PPk2 prefers Mn+2 over 
Mg2+, whereas PPK1 shows the reverse selectivity for Poly-Pi synthesis. (iv) The 
Poly-Pi synthesis activities of PPk2 are stimulated in the presence of Poly-Pi, while 
for PPK1, no stimulatory effect is detected (Zhang et al., 2002). 
The ppk2 gene is present in many bacterial species. Some species, e.g. P. 
aeruginosa contain multiple ppk2 gene homologues. Some species contain neither 
PPK1 nor ppk2 gene homologues (e.g. S. aureus, T. denticola). Corynebacterium 
diphtheria and several other Corynebacteria species are quite distinct in containing 
two ppk2 homologues, but no identifiable PPK1 gene.  
The ppk2 gene shares significant amino-acid sequence homology to the Fur 
controlled genes, RNA polymerase sigma factor 70 (PvdS), which is involved in 
the biosynthesis of the fluorescent siderophore molecule pyoverdine (Ishige et al., 
2002). 
The PPk2 proteins can be sub-divided into two groups based on the number of 
domains contained in the proteins. By using Poly-Pi as phosphate donor, proteins 
with a single Ppk2 domain are able to catalyse the phosphorylation of ADP to ATP 
(or GDP to GTP), whereas proteins with two fused Ppk2 domains also possess the 
ability to catalyse the phosphorylation of AMP to ADP (or GMP to GDP) (Nocek 
et al, 2008). Consequently, the combination of these two groups of Ppk2 proteins 
allows Poly-Pi to be used as intracellular energy reserve for the regeneration of the 
essential ‘energy’ molecule ATP (and to a lesser extent, GTP).  
The 1-domain Ppk2 protein (SMc02148) from Sinorhizobium meliloti and the 2-
domain Ppk2 protein (PA3455) from Pseudomonas aeruginosa, have been bio-
physically and bio-chemically characterized, and their crystal structures have been 
solved. The single-domain SMc02148 protein, and both the N- and C-terminal 
domains of the PA3455 monomers, are all folded into similar structures: 3-layer 
α/β/α sandwiches with an α-helical lid. In solution, SMc02148 is a tetramer and 
PA3455 is a dimer, suggesting a similar overall quaternary structure (Geourjon et 
al., 2001). 
Alanine replacement mutagenesis has indicated that 9 conserved residues are 
required for the activities of Ppk2 proteins, which are located in Walker A and 
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Walker B motifs [two major conserved motifs required for ATP binding and 
hydrolysis (Geourjon et al., 2001) and in the lid module. 
Poly-Pi is synthesized in D. discoideum using two enzymes namely DdPPK1 and 
DdPPK2. Homology to the bacterial polyphosphate kinase (PPK) sequence 
identified DdPPK1. Biochemical purification of polyphosphate kinase activity was 
performed and then the second protein DdPPK2 was recognized. It was found to 
comprise one actin-related protein and two actin-associated proteins (Zhang et al., 
2005). 
With reference to the functions of Ppk2 in P. aeruginosa, it is thought to play a role 
in the synthesis of alginate, an exopolysaccharide that envelops the bacteria and is 
an important virulence factor. Supporting this hypothesis, the expression of Ppk2 is 
elevated hundreds of times during the stationary growth phase of P. aeruginosa 
which should substantially increase the intracellular concentration of GTP. This 
closely matches the increased demand for GTP for alginate synthesis (Ishige et al., 
2002). Up to now, PPK1 and/or Ppk2 homologues have been found in more than 
500 bacterial species including many major human pathogens.  
Table 2 displays the compositions of PPK1 and Ppk2 homologues in selected 
bacterial species. 
Although there are no identifiable PPK1 or Ppk2 homologues in S. aureus and T. 
denticola, ppnk gene homologues (putatively) encoding Poly-Pi/ATP dependent 
NAD kinases, have been found in the genomes of all these bacteria. It remains to 
be seen whether there are additional unknown enzymes involved in the metabolism 
of Poly-Pi in the bacteria without identifiable PPK1 or Ppk2 homologues.  
1.2.3.3 Polyphosphate: AMP phosphotransferase (EC 2.7.4.B2) 
Polyphosphate:AMP phosphotransferase (PAP) enables Poly-Pi to be used as 
phosphate donor in the phosphorylation of AMP to ADP, which can be further 
catalysed to ATP by PPK1 also using Poly-Pi as phosphate donor.This cyclic 
reaction offers an additional pathway for ATP regeneration using Poly-Pi as energy 
source (Kameda et al., 2001).  
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It was first found in Acinetobacter Strain 210A (Bonting et al., 1991) and exhibits 
its highest activities with Poly-Pi with chain lengths ranging from 18 to 44 
phosphate residues.  
The degradation of Poly-Pi is processive. Pyro-, tri-, and tetraphosphate cannot be 
used by PAP, but serve as competitors to inhibit its activities.  PAP has been 
identified in various bacteria, such as P. aeruginosa (Ishige & Noguchi, 2001), 
Myxococcus xanthus (Zhang et al., 2005) and Bacillus cereus (Shi et al., 2004).  
Further studies have shown that in addition to its Poly-Pi-dependent AMP kinase 
activities, PAP protein from A. johnsonii 210A also has the ability to phosphorylate 
other NMPs and dNMPs (N: nucleotide, G, U, or C). However, compared to the 
reaction for AMP, PAP protein for GMP reacts at a rate 10 times lower, and for the 
pyrimidine nucleotides (UMP and CMP) it is around 1,000 times lower. It can also 
phosphorylate dNMPs, but the reaction rates are ca. 10-fold slower than those of 
the corresponding NMPs (Shiba et al., 2005).  
PAP protein has also been shown to possess Poly-Pi synthesis activity using ADP 
or GDP as phosphate donors, with ADP is preferred over GDP (Itoh & Shiba., 
2004). The activities of the PAP protein from A. johnsonii 210A described above 
are quite similar to those of the 2-domain Ppk2 proteins characterized to data, 
except for the ADP (GDP)-dependent Poly-Pi kinase activity. 
Beyond that, the amino acid sequence of PAP protein cloned from A. johnsonii 
210A is shown to be highly homologous to that of Ppk2 from P. aeruginosa PAO1 
(Itoh & Shiba., 2004). Based on the above two studies, it’s highly possible that PAP 
proteins are actually 2-domain Ppk2 proteins. However, this speculation needs to 
be further verified through the biochemical and biophysical evaluation of additional 
protein homologues. 
1.2.3.4 Exopolyphosphatase (Polyphosphate phosphohydrolase, EC 3.6.1.11) 
Poly-Pi are synthesized by polyphosphate kinase, and hydrolysed by 
exopolyphosphatase and endopolyphosphatases. Exopolyphosphatase (Ppx) 
catalyses the processive hydrolysis of Poly-Pi, progressively releasing phosphate 
monomers (Pi, orthophosphate) from the terminals of the Poly-Pi chain. Based on 
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their protein primary structure (i.e. sequence), Ppx and Gppa/ppx present in E. coli 
and other bacteria and archaea belong to the sugar kinases/actin/hsp70 protein 
superfamily ScPpx and Ppx from fungi and protozoa belong to the superfamily of 
DHH phosphoesterases (Reizer et al., 1993). 
1.2.3.5 Guanosine pentaphosphate phosphohydrolase (EC 3.6.1.40) 
The guanosine pentaphosphate phosphohydrolase protein (denoted by Gppa or 
Gppa/ppx) is similar to Ppx in its structure and functionality. The Gppa/ppx protein 
from Aquifex aeolicus has been characterized by it structure but not by its 
functionality.  
The E. Coli Gppa/ppx protein has been shown to possess exopolyphosphatase 
activity, but its main function within the cell appears to be as a guanosine 
pentaphosphate phosphohydrolase: catalysing the hydrolysis of the 5’-γ-phosphate 
of guanosine pentaphosphate (pppGpp) to form guanosine tetraphosphate (ppGpp). 
The crystal structure of the Gppa/ppx protein from Aquifex aeolicus reveals a 
monomeric protein folding into two domains, with the active site located in the 
interdomain cleft (Kristensen et al., 2004). 
1.2.3.6 Endopolyphosphatase (EC 3.6.1.10) 
Endopolyphosphatase (Ppn) has been discovered in cells from archaea to mammals 
(Kumble & Kornberg., 1996).  
The functional study of Ppn protein from S. cerevisiae reveals that this enzyme is 
able to cleave internal phosphoanhydride bonds within long chains of Poly-Pi to 
produce shorter chains: limited digestion predominantly produces chains containing 
60 and 3 phosphate residues (Sethuraman et al., 2001).  The mature Ppn protein 
from S. cerevisiae is a homotetramer composed of 35-kDa subunits that are 
generated by the proteolytic digestion of a 78-kDa pre-Ppn protein (Shi & 
Kornberg., 2005). 
1.2.3.7 Poly-Pi/ ATP dependent NAD kinase (EC 2.7.1.23) 
Nicotinamide adenine dinucleotide (NAD) and it phosphorlyated form NADP are 
the two factors essential for the proteins that are involved in a variety of cellular 
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metabolic and biosynthetic pathways. NAD kinase is responsible for catalysing the 
phosphorylation of NAD (at the 2’-position) to form NADP.In some bacteria, such 
as M. tuberculosis, Micrococcus flavus, and Bacillus subtilis; NAD kinase can 
utilize both Poly-Pi and ATP as the phosphate donor ((Kawai et al., 2000), and thus 
is denominated as Poly-Pi/ATP dependent NAD kinase. 
However, in other organisms, such as E. coli, S. cerevisiae and the plant 
Arabidopsis, only ATP (and not Poly-Pi) can be used as the phosphate donor for 
this enzyme, which is correspondingly named NAD kinase. 
1.2.3.8 Poly-Pi dependent glucokinase (EC 2.7.1.63) 
Poly-Pi dependent glucokinase catalyses the transfer of the terminal phosphate 
residue of Poly-Pi to glucose, forming glucose 6-phosphate. The Poly-Pi dependent 
glucokinases from M. tuberculosis (Hsieh et al., 1996), C. glutamicum, 
Propionibacterium shermanii (Kowalczyk et al., 1996) and Arthrobacter sp. 
(Mukai et al., 2003) have been functionally characterized. All these enzymes 
optimally use Poly-Pi as the phosphate donor, although ATP can also be utilized. 
However, the glucokinase from Microlunatus phosphovorus, can only use Poly-Pi 
as a substrate (Tanaka et al., 2003). 
Bork and colleagues, established that the three-dimensional structures of actin, 
hexokinase, and Hsp70 protein families included a common ATP binding motifs 
which are the “Phosphate-1” and “Phosphate-2” motifs joining with β- and Ƴ-
phosphates of ATP and the “Connect-1” and “Connect-2” motifs at the interface 
between the subdomains (Bork et al, 1992, Bork et al., 1993). Residues present in 
these motifs which play a role in the interaction of ATP, are highly conserved in 
many glucokinases; these residues are Asp and Gly (in Phosphate-1), Asp (in 
Connect-1), Gly and Thr (in Phosphate-2), and Gly (in Connect-2). Analysis of the 
deduced amino acid sequences of the ppgk gene demonestrated that this enzyme 
involves regions that are homologous to Phosphate-1 and Phosphate-2 regions of 
yeast glucokinase. Moreover, sequence alignment studies on other prokaryotic 
glucokinases sequences also revealed the exsistance of phosphate binding motifs. 
These phosphate binding sites are conserved from eukaryotic hexokinases to 
prokaryotic glucokinases. 
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The recognition of sequences participating in polyphosphate binding is not clear 
yet. Previously, Bork and co-workers showed that tryptophans in the peptide, 
KNDWTYPKWAKQ, of Poly -P-glucokinase from H37 Ra strain were found to be 
particularly oxidized by N-bromosuccinimide with associated loss of enzymatic 
activity (Hsieh et al, 1993). Tetrapolyphosphate or long chain polyphosphate 
substrate sustains protection toward this oxidation and the loss of activity. Residues 
177-216 of the Poly-Pi-glucokinase sequence from H37 Rv encode a closely related 
sequence, RKDWSYARWSEE. Therfore this region might be a binding site for 
polyphosphate, in addition to Phosphate 1 and 2, which specifically enables the 
Poly-Pi-glucokinase to utilize polyphosphates. Several charged groups around this 
region as Lys188, Glu189, Lys190, Asp192, Lys197, and Lys200 may play a crucial role 
in Poly-Pi binding mechanism (Bork et al., 1993). 
Poly-Pin+D-glucose→Poly-Pin-1+D-glucose 6-phosphate. 
This enzymatic activity was first observed in Mycobacterium phlei (Szymona, 
1957), and then in numerous bacteria (Szymona et al., 1962; Szymona and 
Ostrowsky., 1964), including other Mycobacteria (Szymona and Szymona, 1978), 
Corynebacterium diphtheriae (Szymona and Szymona., 1961) and Nocardia 
minima (Szymona and Szymona., 1979). 
The screening for polyphosphate glucokinase activities in different organisms 
showed its presence in the phylogenetically ancient bacteria belonging to the 
Actinomycetales (Szymona et al, 1967, 1969, 1977; Kulaev and Vagabov., 1983). 
The enzyme activity was not found in eukaryotes. The discovery of this enzyme 
was of the greatest significance to understand the role of Poly-Pi: it provided the 
first evidence of the possible function of Poly-Pis as a phosphate and energy donor 
without the nucleoside phosphate system. 
There have been numerous reports on the occurrence of various isoenzymes of 
polyphosphate glucokinase in different microorganisms and on differences in the 
molecular weights of the enzyme in the same organism (Szymona et al., 1977; 
Kowalska et al., 1979; Pastuszak and Szymona., 1980). Szymona et al, 1977 found 
that the molecular mass of native enzyme from M. tuberculosis when using 
Sephacryl-200 size exclusion gel, was 118 kDa, while Pastuszak and Szymona 
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(1980) found a larger form of the enzyme. The enzyme from M. phlei was found to 
be a protein of 113 kDa (Szymona and Ostrowski., 1964) or 275–280 kDa (Girbal 
et al., 1989). The native enzyme from P. shermanii was reported to have a molecular 
mass of 31 kDa (Clark., 1990). The purified enzymes from P. shermanii (Phillips 
et al., 1993) and M. tuberculosis (Hsieh et al., 1993b) also showed multiple proteins 
by HPLC gel filtration, native PAGE and isoelectric focusing (lEF)–PAGE, 
although a single band was observed by SDS–PAGE. 
 One explanation for the existence of varying molecular masses of these 
glucokinase, is variable chain lengths of strongly bound Poly-Pis (Phillips et al., 
1999), showed the enzymes from P. shermanii, M. tuberculosis and 
Propionibacterium arabinosum were all homodimers of 30 kDa sub units, 
variability in molecular mass being ascribed to binding of Poly-Pi of varying chain 
length: this remains speculative but plausible. 
Poly-Pi glucokinase have been shown to contain a polyphosphate glucokinase 
activity and an ATP- dependent activity. Stable co-purification of these activities 
suggested that both of them can be catalysed by a single enzyme (Szymona et al, 
1977; Pepin and Wood., 1986). 
A detailed characterization of enzyme preparations unequivocally revealed that a 
single enzyme from these sources catalyses both Poly-Pi and ATP-dependent 
glucokinase activities (Hsieh et al., 1993a, Phillips et al., 1993, Kowalczyk et al., 
Phillips et al., 1999). 
The most convincing evidence was cloning the gene from M. tuberculosis (Hsieh 
et al, 1996a). It was shown that the recombinant protein, expressed and purified 
from E. coli, contained both activities. The ability to utilize both inorganic (Poly-
Pi) and organic (ATP) phosphoryl donors in glucose phosphorylation shows that 
the fundamental differences in the structures of the two phosphate donors brings 
differences in the residues involved in their binding also :Horn et al., (1991), 
Phillips et al, (1993a), and Hsieh et al., (1993a) provided evidence of separate 
binding sites for the substrates. 
Despite the lack of similarities in sequence between eukaryotic hexokinases and 
prokaryotic glucokinases in the putative adenosine site, Hsieh (1996) found some 
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structural similarities between the adenosine site in polyphosphate glucokinase and 
the proposed adenosine site in yeast hexokinase.  
Comparison of the kinetic features of Poly-Pi and ATP-dependent reactions for the 
enzymes from different sources supports the hypothesis that glucokinase in the 
earliest organisms may have predominantly been dependent on Poly-Pi rather than 
ATP (Phillips et al., 1999). There is a progressive decrease in the efficiency of Poly-
Pi utilization by glucokinases, from older to newer organisms. The polyphosphate 
glucokinase from Microlunatus phosphovorus was closely related to the 
polyphosphate/ATP–glucokinase of Mycobacterium tuberculosis, but it could not 
phosphorylate glucose with ATP (Tanaka et al., 2003). 
The catalytic sites are shared for Poly-Pi-dependent phosphorylation and ATP-
dependent phosphorylation of the enzyme, and the Poly-Pi-utilizing mechanism of 
the enzyme was shown to be non-processive (Mukai et al., 2003).  
The deduced amino acid sequence of the polypeptide exhibited homology to the 
amino acid sequences of the Poly-Pi/ATP–glucokinase of M. tuberculosis (level of 
homology, 45 %), ATP-dependent glucokinases of Corynebacterium glutamicum 
(45 %), Renibacterium salmoninarum (45 %) and Bacillus subtilis (35 %) (Mukai 
et al., 2003). 
All of these observations show that Poly-Pi was a precursor of ATP in bioenergetics 
processes at the earliest stage of evolution (Kulaev, 1971, 1974). There might have 
been a gradual transition from Poly-Pi to ATP as the phosphoryl donor in glucose 
phosphorylation (Phillips et al., 1999). 
1.2.4 Applications of polyphosphate 
1.2.4.1 Removal of phosphate in the environment 
Traditionally, metal salts (such as lime, alum or ferric chloride) are used to 
precipitate and remove phosphate (Pi) from waste water. This stimulates the ‘algal 
blooms’ that are unfavourable to the river water and estuarine ecosystems.  
This is especially important for water contaminated by the agricultural waste 
containing fertilizers, or various discharges from industrial sources. However, this 
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method has limited application because of its high cost and the need for extra 
operations to remove the toxic metal from water.  
These disadvantages can be eliminated by the use of enhanced biological phosphate 
removal processes, which utilize a group of polyphosphate accumulating organisms 
(PAOs) to accumulate a large amount of phosphate in the form of Poly-Pi in cells. 
Subsequently, the accumulated Poly-Pi can be efficiently removed along with the 
bacteria as sludge (McGrath & Quinn., 2003).  
To further develop this process, genetically engineered bacteria may be used for 
their increased ability in taking up Pi and converting it to Poly-Pi.  
Currently, there are numerous studies aimed at modifying microbial populations in 
‘activated sludge’ to make the Poly-Pi accumulation process more efficient. 
1.2.4.2 Chelation of mercury, Copper and Uranium 
When the synthesis of Poly-Pi is induced or up-regulated in bacteria, they have 
enhanced abilities to take-up and chelate heavy metals from the growth medium. 
The high chelating efficiencies of Poly-Pi towards mercury, copper and uranium 
have been reported in several studies (Pan-Hou et al., 2002-Renninge et al., 2004).  
This approach may be used to remove these toxic elements from the environment. 
1.2.4.3 Antibacterial actions and use as a food additive 
Short-chain Poly-Pi (oligomers containing 3-10 phosphate units) is used as a food 
additive because of the following properties that are desired: (i) it is a safe, 
biodegradable polymer; (ii) it can inhibit microbial growth, especially for 
grampositive bacteria (Loessner et al, 1997, Maier et al, 1999); (iii) it is able to 
enhance the water binding, emulsification and colour retention of food, as well as 
retard oxidative rancidity. 
The above effects are thought to be mainly due to the metal chelating activities of 
Poly-Pi (Jen &Shelef 1986, Denny et al., 2003). The characterization of two D. 
discoideum enzymes DdPPK1 and DdPPK2 in synthesizing Poly-Pi in vitro 
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suggested that both enzymes might contribute to the synthesis of Poly-Pi in vivo. 
The ability of Poly-Pi to chelate is considered to be responsible for the inhibitory 
effects.  It is observed that certain Poly-Pi macromolecules bind to the cell wall, 
remain bound, and chelate structurally essential metals, which then destabilize the 
cell wall. 
1.2.4.4 Regeneration of ATP and other nucleotide triphosphates 
Generally, acetylphosphate, creatine phosphate and phosphoenolpyruvate are used 
as substrates for the enzymatic formation or regeneration of ATP.However, this 
method is exorbitantly expensive to be performed on an industrial scale. Poly-Pi is 
an inexpensive chemical that can be easily synthesized by heating NaH2PO4 at 
700°C. Several studies have showed that Poly-Pi and its associated enzymes (such 
as Ppk and PAP) can be employed to regenerate ATP, which should be significantly 
cheaper than existing methods if scale-up is feasible (Kameda et al., 2001, Butler 
1977-Haeusler et al., 1992). Moreover, when combined with the NDK (nucleotide 
diphosphate kinase) activities of PPK1, Poly-Pi can also be used as a substitute for 
phosphoenolpyruvate in the regeneration of uridine triphosphate, for the production 
of oligosaccharides (Noguchi & Shiba., 1998). 
1.2.4.5 Insulating fibres 
Poly-Pi can also be used to synthesize calcium polyphosphate fibres that have 
properties similar to asbestos. These fibres can be used to form insulating materials 
for possible use in a variety of household and industrial applications (Griffith, 
1992). However, products containing asbestos release tiny fibres in to the air which 
cause a lot of health issues.  This application is not currently being pursued because 
of these health related issues. 
1.2.4.6 Medical applications of polyphosphate 
As discussed above, Poly-Pi plays a number of roles essential for bacterial growth 
during the stationary-phase and during times of environmental stress. 
Cells with low levels of Poly-Pi exhibit a wide range of deficiencies in their 
resistance to various challenges from an infected host organisms or harmful agents, 
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e.g. antibodies, lysozyme, antibiotics, etc. The intimate relationship between Poly-
Pi levels and cell survival offers new clues and possible targets for future 
antimicrobial therapies. 
In microbial cells, low Poly-Pi levels can be induced and maintained by inactivating 
the PPK1 (ppk) gene, which encodes the main protein responsible for Poly-Pi 
synthesis. This gene is present in the majority of bacterial species sequenced to date, 
including many important pathogens, e.g. Mycobacteriumtuberculosis, B. 
anthracis, Clostridium difficile, Neisseria meningitidis and P. aeruginosa (Zhang 
et al., 2002).  
Results of a number of studies conducted in this field shows that the deletion of the 
PPK1 gene results in a variety of deleterious effects on bacterial metabolism, and 
remarkably decreases their persistence and virulence (Chen et al., 2002, Chouayekh 
& Virolle., 2002 and Sureka et al., 2007).  
PPK1 gene homologues appear to be absent in all higher eukaryotes, which 
suggests that this protein, or polyphosphate metabolism in general, may be a 
possible target for future antibiotic therapies. 
1.2.5 Various forms of Polyphosphate in cells  
Poly-Pis may be present in living cells both in the free and bound states. Modern 
methods like 31P NMR spectroscopy, give some evidence of this theory. Since the 
classic work of MacFarlane (1936), it has been considered that acid-soluble low-
molecular-mass Poly-Pis are present in cells in the free -state. However, the 
question of the state of polymeric Poly-Pis within a cell cannot yet be considered 
as having been finally resolved. 
1.2.5.1 Polyphosphate–Cation Complexes 
Being polyanions, Poly-Pis can form complexes with different cations including 
biologically important Ca2+ and Mg2+ (Van Wazer and Campanella., 1950; Van 
Wazer, 1958; Corbridge, 1980; Bonting et al., 1993a; Cini et al., 2000). The 
dissociation constants for Mg2+– and Ca2+–polyphosphate complexes were 9.3 × 
10−2 Mand 1.5 × 10−2 M, respectively (Bonting et al., 1993a). 
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Analysis with electron microscopy and energy disperse X-ray showed that Poly-Pi 
granules of cyanobacteria contain Mg2+, Ca2+, Mn+2 and other cations (Baxter and 
Jensen, 1980a, b; Jensen et al, 1982). Large Poly-Pi granules of Acinetobacter 
contain Mg2+, Ca2+ and K+ in a ratio which depends on the extracellular 
concentrations of the above cations (Bonting et al., 1993a). In bacteria, Poly-Pi 
complexes with heavy metals were observed: with Sr2+ and Ba+2 in Plectonema 
boryanum (Baxter and Jensen., 1980 a,b), with Ni2+ in Staphylococcus aureus 
(Gonzales and Jensen., 1998), and with Cd+2 in Anacystis nidulans (Keyhani et al, 
1996) and Escherichia coli (Keasling and Hupf, 1996; Keasling, 1997; Keasling et 
al., 2000). 
Poly-Pis can form complexes with arginine, spermidine, lysine, Mg2+, Ca2+ and 
Mn2+ in vacuoles of yeast (Wiemken andD¨urr, 1974; D¨urr et al., 1979; Okorokov 
et al, 1980; Lichko et al., 1982; Westenberg et al, 1989; D¨unn et al., 1994) and 
Neurospora crassa (Cramer and Davis, 1984). The cells of protozoa (Docampo and 
Moreno., 2001; Rodrigues et al., 2002a,b) and some algae (Ruiz et al., 2001b) 
possess an acidic organelle, acidocalcisome which contain pyrophosphate and Poly-
Pis bound with Ca2+, Mg2+, Zn2+ and other cations. In these organelles, low-
molecular-weight Poly-Pis, including the alkali soluble Poly-Pi3, is present in the 
bound state. 
1.2.5.2 Polyphosphate–Ca2+–Polyhydroxybutyrate Complexes 
Specific complexes containing polyhydroxybutyrate (PHB) and Poly-Pis have been 
found in, membranes of many organisms (Reusch and Sadoff., 1988; Reusch, 1992, 
1999a, 2000). When such components of E. coli membranes were isolated and 
analysed, Ca2+ was found to be the predominant neutralizing cation (Reusch and 
Sadoff, 1988). Non-aqueous size-exclusion. Chromatography showed that the 
polymer length was 130–150 residues for PHB (∼ 12 kD), (Seebach et al, 1994a), 
and 55–70 residues for Poly-Pi (∼ 5 kD), as determined by SDS-PAGE 
electrophoresis (Castuma et al., 1995). Non-aqueous size-exclusion 
chromatography results estimated the molecular weight of the complex as 17 (± 4) 
kDa (Reusch et al., 1995).  
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1.2.5.3 Complexes of Polyphosphates with Nucleic Acids 
Poly-Pi–ribonucleic acid complexes have been extracted from different organisms 
(Belozersky, 1955, 1958, 1959a; Chayen et al, 1955; Chaloupka and Babicky, 1957, 
1958). The central cylinder represents the Poly-Pi helix with binding sites for Ca2+, 
with the Ca2+–PolyP complex being surrounded by the PHB helix (Reusch and 
Sadoff, 1988; Das et al., 1997). 
 
Figure 1.2–4 Model of the PolyP–PHB channel structure as proposed by Reusch and 
co-workers (from Reusch, 1999a). 
Kulaev and Belozersky., 1957, 1958; Ebel et al., 1958c, 1962, 1963; Langen and 
Liss., 1958; Stahl and Ebel., 1963; Wang and Manchini., 1966). 
These studies did not address the question if RNA was combined with the Poly-Pi 
or it was co-precipitated during extraction and separation from the cells because of 
the chemical and physio-chemical properties that are similar to them: It was found 
impossible to separate these compounds completely by precipitation and re-
precipitation in the presence of Ba2+, Mg2+, Ca2+ and other metal ions. The use of 
different conditions for RNA separation (by sodium dodecyl sulphate (SDS) or 
phenol, or by a combination of the two) from yeast cells, which contained large 
amounts of Poly-Pis, failed to yield RNA fractions free from Poly-Pis. It proved 
especially difficult to separate Poly-Pis from such RNA fractions when they 
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contained relatively small amounts of Poly-Pis. For example, the RNA–PolyP 
complex obtained from Aspergillus niger could not be separated by electrophoresis 
in a Tiselius apparatus (Kulaev and Belozersky., 1958). Similar results were 
observed when paper chromatography was used in an attempt to separate the 
PolyP–RNA complex from yeast, in which RNA predominated (Chayen et al., 
1955). 
However, it was found possible to separate the latter from the RNA either by 
electrophoresis (Chayen et al., 1955; Ebel et al., 1962; Dirheimer et al., 1963) or by 
paper chromatography (Ebel et al., 1962; Dirheimer and Ebel., 1964a). 
Belozersky and Kulaev (1970) and Stahl and Ebel (1963) showed that Ca2+ and 
Mg+2 ions were responsible for the formation of very stable and ‘difficult-to-
separate’ PolyP/RNA complexes. Investigations into the possible existence of 
covalent or hydrogen bonds in these complexes have shown that both forms of 
bonding are absent, while electrostatic interactions mediated by Ca2+, Mg2+ and 
other metal ions are possibly present (Ebel et al., 1962; Belozersky and Kulaev., 
1964, 1970).  
There might be some similarity between RNA–Poly-Pi and PHB–Poly-Pi, at least, 
participation of divalent cations in the linkage of the two polymers. It is probable 
that the complexing with Poly-Pi enhances the RNA stability. Some evidence has 
been obtained that in E. coli, Poly-Pis inhibits RNA degradation by degradosome 
(Blum et al., 1997). 
The possibility of Poly-Pi interaction with DNA is now confirmed by evidences of 
data showing its participation in gene activity control (Kornberg., 1999; Kornberg 
et al., 1999). Earlier, Poly-Pi60 was found in DNA preparations from filamentous 
fungal species of Colleotrichum (Rodriguez., 1993). 
1.2.5.4 Binding of Polyphosphates with Proteins 
 Liss and Langen (1960 a,b) showed that the most highly polymerized yeast Poly-
Pi fraction, extractable only with strong alkali (0.05 M) or when incubated  for a 
long period with diluted CaCl2 solution, is apparently firmly bound to some cell 
components other than RNA. The removal of RNA by RNAase had no effect on the 
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extraction rate of this Poly-Pi fraction. It was considered that in this case Poly-Pi 
was bound to protein. 
Numerous PolyP-binding proteins were detected in crude cell extracts from 
different organisms, including yeast and animals, using a filter-binding technique 
or affinity chromatography on PolyP–zirconia (Lorenz et al., 1994a). 
Poly-Pi complexes with proteins play an important role in cell regulatory processes. 
It is observed that RNA polymerase isolated from the stationary-phase cells of E. 
coli was closely bound with Poly-Pi (Kusano and Ishihama., 1997). Poly-Pi 
competes with the DNA for the DNA binding sites at histones while Poly-Pis can 
interact with non-histone proteins in the nucleus. It is observed that Poly-Pis and 
PHB (polyhydroxybutyrate) are related to the ion-conducting proteins such as the 
human erythrocyte Ca2+- ATPase pump.  
Cellular Poly-Pihosphate has the ability to bind with other compounds, including 
polysaccharides, such as polyhexamines and chitin. Poly-Pis was shown to form 
complexes with polysaccharides of the cell wall of N. crassa, in vitro (Harold and 
Miller., 1961). The complex-forming reaction depended on both pH and the Poly-
Pi chain length.The complexing ability of Poly-Pi is one of the major properties of 
this negatively charged biopolymer, it determines its regulatory function in living 
cells to a significant extent. 
 Such metabolically active molecules as Poly-Pis do not exist in cells in the free 
form in large amounts (Kulaev et al., 1999). They are compartmentalized and 
combined in the cell, either permanently or temporarily, with other compounds 
through the chelate bridges. As described above, Poly-Pis can form complexes with 
such biologically active cations as Ca2+, Mg2+, K+, etc., with polyhydroxybutyrate 
and it is of great importance with nucleic acids and proteins. Probably, the 
interactions of Poly-Pis with other biopolymers are mediated in some cases by Ca2+. 
 However, this has only been established with certainty for PolyP–
polyhydroxybutyrate–Ca2+ complexes. The ability of Poly-Pis to form complexes 
with different components of living cells allows them to perform many specific 
functions in such cells. 
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1.2.5.5 ATP-dependent protease 
Lon formed a complex with Poly-Pis under degradation of ribosomal proteins at 
amino acids starvation (Kuroda et al., 2001). Poly-Pi is able to compete with DNA 
for the DNA binding sites at histones (Schr¨oder et al., 1999), while Poly-Pis can 
interact with non-histone proteins in the nucleus (Offenbacher and Kline., 1984). 
Poly-Pis and PHB have been found to be associated with ion-conducting proteins 
such as the human erythrocyte Ca2+–ATPase pump (Reush et al, 1997) and the 
Streptomyces lividans potassium channel (Reusch., 1999b). Some enzymes of Poly-
Pi metabolism, such as polyphosphate glucokinase (Phillips et al., 1999) and yeast 
high-molecular-weight exopolyphosphatase can contain tightly bound Poly-Pi 
(Andreeva et al., 2001, 2004). 
 Aims of research 
The aim of this thesis is the biochemical characterization and study of PPGKm, a 
new discovered enzyme in ovine liver, its possible physiological functions and 
distribution in other tissues. 
 Specific objectives 
1 - Kinetics studies and biochemical characterization of the novel enzyme. 
2 - Purification, sequencing and recombinant expression of the enzyme. 
3 - Investigate the cellular and subcellular distribution in different tissues using cell 
fractionation. 
4 - Aim to establish possible physiological function(s) of the enzyme using a variety 
of biochemical strategies and bioinformatics where possible. 
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Chapter 2 
Materials and Methods 
All chemicals and reagents used for enzyme assays, buffers and NMR reagents were 
purchased from Sigma Aldrich, UK, Dorset, unless stated otherwise. All ovine 
tissues (liver, kidney, heart, skeletal muscle, bone marrow, lung and lymph node) 
and Porcine liver tissues were obtained from a local market. 
 Preparation of buffers 
1.4.1 Homogenization buffer 
HEPES buffers were made up in a concentrated form (4 x concentrations) and 
frozen. When diluted ready for the assay procedure the concentrations of the 
components were as follows:  
7.5 mM MgCl2, 2.5 mM DTE (1, 4-Dithioerythritol) or DTT (Dithiothreitol), 100 
mM KCl 50mM Na HEPES (4-(2-Hydroxyethyl) piperazine-1-ethanesulfonic acid 
sodium salt, N-(2-Hydroxyethyl) piperazine-N′-(2-ethanesulfonic acid) sodium 
salt. 
Appropriate amounts were weighed and dissolved in deionized water and frozen or 
refrigerated daily until required. Final assay buffers were completed by the addition 
of fresh substrates and linking enzymes and adjusted to the correct pH with 
NaOH/HCl as described below.  
1.4.2 Assay buffer 
Assay buffer (A) was prepared by the addition NAD, ATP or ADP to achieve 0.5 
mM NAD and 5mM ATP or ADP in the final homogenization buffer, 
hexamathaphosphate (glass sodium salts), sodium tripolyphosphate salts, 
diadenosine tetra or penta phosphates, UTP, CTP and GTP were used as phosphoryl 
donor substrates at a concentration of 5mM, and then the pH was adjusted to 7.6 at 
22 °C (pH = 7.4 at 38°C (see Appendix III for the optimum assay temperature). 
Blank assay buffer (buffer B) was prepared in the same way without adding any 
phosphoryl donor. 
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Approximately 200 IUof G6PDH was added per 50ml of assay buffer from a stock 
solution containing 958 IU per mg protein (40k IU per ml) to each of the buffer 
solutions.(One unit will oxidize 1.0 mmole of D-glucose 6-phosphate to 6-phospho-
D-gluconate per minute in the presence of NAD at pH 7.4 at 30 °C). 
 Homogenization procedure 
For the preparation of the homogenate, 1 gram of liver (fresh liver samples or frozen 
liver samples at -80oC) were weighed and homogenized in 9ml of ice-cold 
homogenization buffer (producing a 10% homogenate) using a pestle and mortar 
for 10 minutes. All tissues (kidney, heart, muscle, lymph node, adipose tissue, Lung 
and bone marrow) were homogenised on ice. The homogenates were centrifuged 
using a Beckman coulter ultra-centrifuge for 60 minutes at 40,000rpm (100,000 g) 
at (4˚C). The 50,2Ti Rotor was used. The supernatant was collected and kept on ice 
to be used the same day or frozen for use on subsequent days. 
 Spectrophotometric determination of a novel PPGK activity in Ovine liver 
Spectrophotometric coupling assays were conducted using a micro-plate reader 
spectrophotometer-Nano (BioTek ) model number S/N 601-0029, at 38˚C 
Absorption readings were taken every minute at 340nm on each well over a period 
of  30 minutes following addition of homogenate to start the reaction. The assay 
being equivalent to the continuous method used in previous studies (Davidson 
&Arion 1986). 
 All assays were carried out in duplicate or triplicate (see relevant section for 
details) using a 96 well plate .The homogenate was assayed using ATP, ADP, AMP, 
UTP, UDP, CTP, AP4A, AP5A, long chain inorganic polyphosphate (P700), sodium 
tripolyphosphate salts, Hexamethaphosphate (glass sodium salts), and a blank 
buffer (which contains the HEPES buffer with NAD and G6PDH) i.e. none of the 
phosphoryl donors were added to the blank buffer. The principle of this reaction is 
to measure the activity of hexokinases in an NAD-coupled reaction system, by 
measuring the accumulation of NADH causing an increase in absorbance at 340nm; 
this requires that G6PDH is in excess.  
The appearance of NADH is then directly linked to the rate of formation of G6P, 
which gives the activity of the hexokinase enzymes. 
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Figure 2.3–1 Glucose phosphorylation in the coupled enzyme reaction 
Using high and low concentrations of glucose (0.5 or 100 mM) allows for the 
discrimination between low Km hexokinases and the glucokinases. This is because 
of the specific kinetics of the hexokinase isoenzymes in mammalian systems, which 
have either very high affinity for glucose (low Km=0.05-0.2 mM glucose) or very 
low affinity for glucose (Km or S0.5 =8-20 mM glucose). 
The final volume in each well was 300µl of which: 
 20µl homogenate or enzyme. 
 250µl reaction buffer (containing substrates or blanks). 
 30µl (1M or 5mM Glucose stock solution) which is diluted 10- fold in the 
well to 100mM and 0.5mM respectively. 
 Optimization of enzyme assay temperature 
The hexokinase enzyme assay was conducted at a range of temperature from 25°C 
to39°C in the spectrophotometer. Experiments were made in triplicate, and the 
results recorded in Appendix III .The optimum temperature for the PPGK was 
found to be 38.5°C, and all subsequent enzyme assays conducted at this 
temperature. The optimum temperature for the other HKs was similar (Appendix 
III). 
 
        ATP or  NAD 
       ADP  
NADH 
Glucose        G-6-P                Gluconate 
        G6PDH 
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 Thermostability of the novel enzyme   
Ovine liver homogenate prepared as described in (section 2.2 above) was incubated 
at a range of temperature in pre-heated water bath at the following temperatures 
(40°C, 45°C, 50°C, 55°C, and 60°C) in 1ml aliquots for10 and 30 mins at each 
temperature, and then returned to ice for 20 mins until assayed, prior to assay 
samples were micro-fuged for 5 minutes at 1000g using microcentrifuge to remove 
any precipitated protein.The clear supernatant assayed for hexokinase and novel 
kinase activity using ATP and hexamethaphosphate as phosphoryl donors. 
 Calculations of PPGKm Activity  
To calculate HK activity, the blank values (at0.5mM glucose) were subtracted from 
the results in response to 0.5mM glucose concentration with 5mM ATP, as 
previously described (Arion and Davidson). 
GK activity was calculated by the subtraction of ‘blank’ values (activity in response 
to5mM ATP without glucose).HK activity (activity with 0.5mM glucose and 5mM 
ATP) was then substracted to give the high Km PPGK activity (in the presence of 
2mM hexamethaphosphate ,HMP) free from the non-specific reduction of the 
sample blank and any low Km hexokinases 
Present. This works well as PPGK has a very low affinity for glucose and is all, but 
inactive at 0.5mM glucose (see results section 4). 
The enzymatic activity (IU) was calculated using Microsoft Excel. One IU is 
equivalent to 1µmole G6P formed per min per g liver (or mg of enzyme). 
The calculation takes into account the change in absorbance per minute in the linear 
(continuous assay) range (see below) and converts this to µmoles NADH formed 
per min by accounting for the well volume and then conversion to IU by taking 
account of the amount of homogenate or enzyme added to the well.The assay has 
stoichiometric equivalence for NADH formation and G6P production ,because 
G6PDH is in excess (see above):this was assessed by adding more G6PDH to the 
wells with highest activity and checking that the rate does not increase. 
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 Determination of kinetic parameters (Km, Vmax, Kcat) 
A range of glucose concentration was prepared from a stock solution of 1M glucose 
(9 grams glucose in 50 ml dH2O). Different glucose concentrations prepared: 
0.5mM, 10mM, 20mM, 30mM, 40mM, 50mM, 60mM, and 100mM.  Then they 
were assayed with ovine liver homogenate to investigate the Km of the novel 
enzyme using fixed hexamethaphosphate (HMP) concentrations (1mM or 2mM). 
  PPGKm activity dependence on HMP concentration  
Eight Ovine livers were screened for the activity of the novel kinase with and 
without phosphoryl donors. The liver sample with lowest activity of the novel 
kinase (PPGK) in the absence of any phosphoryl donor was assayed with increasing 
concentrations of hexamethaphosphate (HMP) to examine the response of the 
enzyme toward the substrate. 
 Assessment of PPGKm inherent substrate  
1.4.3 Screening for the novel enzyme activity and Hexokinase in different Ovine 
tissues & in different species  
A variety of Ovine tissues collected, homogenized and ultra-centrifuged were then 
assayed for the presence of hexokinase and PPGKm activities using different 
phosphoryl donors (ATP, ADP, AMP, and Hexamethaphosphate). 
Ovine tissues used for this purpose were: Kidney, skeletal muscle, cardiac muscle, 
liver, lymph node, bone marrow, lung and adipose tissue. Also liver samples from 
rat, pig and cow have been assayed for hexokinase and novel kinase activities using 
a variety of phosphoryl donors.  
 Temporal stability and Longevity of the enzyme  
This experiment has been done to assess the stability and longevity of the novel 
enzyme compared to hexokinase .The ovine liver homogenate prepared and 
aliquots,  some of the aliquots were left at room temperature (about 20°C) , others 
were left at (4°C and -20°C) all samples were checked daily for the enzymes activity 
, the samples left at room temperature were checked for 5 days then the activity 
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disappeared while the other samples at (4°C and -20°C) were checked for two 
weeks .  
Hexokinase and PPGKm enzyme activity in ovine liver homogenates was 
monitored at room temperature and at 4oC at set points for 5 days. This experiment 
was designed to assess the stability and longevity of the novel enzyme compared to 
Hexokinase.  
  Substrate specificity of PPGKm  
The efficacy of a variety of phosphoryl donors on the novel kinase was studied, by 
assaying the homogenate using different phosphoryl donors, such as (ATP, ADP, 
AMP, Diadenosine tertaphosphate (AP4A), Diadenosine pentaphosphate (AP5A), 
hexamethaphosphate (HMP), sodium trimethaphosphate (Tri-P), UTP, CTP, GTP, 
and long chain inorganic polyphosphate (P700) then PPGK activity was calculated 
as previously described. 
  Metal ions dependency assay  
Sheep liver homogenate was assayed using 3 metal ions Zn2+, Cu2+, and Mn2+ at 2.5 
and 7.5 mM, to check the activity of the sheep PPGK. This was carried out by 
replacing the Mg2+ in the assay buffers. In a different assay a range of Mg2+ 
concentrations (2mM, 4mM, 6mM, 7.5mM, 15mM, 20mM, 30mM, 40mM,  and 
50mM) were used to check the dependency of PPGK on Mg2+. 
 Partial separation (purification) of Glucokinase, Hexokinase and Novel Enzyme 
Using Gel Filtration (sephacryl S-200 Gel) 
Ovine, rat and porcine liver tissue were homogenized and centrifuged as described 
in section 2.1.3.The gel was prepared by mixing 3 volumes of sephacryl S-200 to 
1volume of homogenization buffer. The supernatant of sheep, rat and pig liver 
homogenates were collected and transferred into centricon(Spin-X® UF 
concentrator MW cut off 50,000kDa) then centrifuged to be concentrated using a 
bench top centrifuge (BeckMan AllEGRA,X15-R, Refrigerated bench top 
centrifuge SX4750 rotor) at 5000 RPM for 30 minutes for Ovine liver sample and 
50min for Porcine  liver sample. Then 1 ml of each sample loaded on the top of the 
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gel column, the buffer was added and 1 mL fractions were collected, and kept on 
ice. 
The fractions were assayed for enzymatic activity using the coupling enzyme assay 
previously described with high and low glucose as well as with ATP and 
Hexamethaphosphate. 
 Sub cellular fractionation and enzyme markers assay for the localization of the 
novel kinase enzyme  
Ovine liver (50g) was weighed then washed 3 times for 5 minutes by immersing in 
cold PBS (15 ml for each wash). To minimize the rupture of cell organelles all 
homogenizers and solutions were kept on ice during the whole procedure of 
subcellular fractionation. 
1.4.4 Homogenisation Buffers 
 Buffer I (0.25M sucrose):  0.25M Sucrose .5mM Tris HCL. 
5mM Mgcl2, 1mM DTT all components were dissolved in 250 mL of distilled 
water.  The pH of the buffers adjusted to 7.4. 
 Buffer II (2M sucrose): 2 M sucrose, 5mM Tris HCL. 
5mM Mgcl2, 1mM DTT all components were dissolved in 250 mL of distilled 
water, with stirring on hot plate to dissolve the sucrose.  The pH of the buffers 
adjusted to 7.4. 
 Buffer III 7.5: mM Mgcl2. 2.5 mM DTT. 100 mM Kcl. 50mM Na HEPES 
1.4.5  Methods 
Ovine liver (10g) was homogenized by adding 50ml of homogenisation buffer (I) 
using Pestle & Mortar for 10 minutes on ice. The suspension was filtered through 
two layers of muslin cloth in order to remove any tissue debris, and then 3 x 1ml 
eppendorfs (original homogenate) were stored at -80, the remaining homogenate 
transferred to a 50ml centrifuge tube, and spun at 600g (2760 rpm) for 10 
minutes.The supernatant retained (cytoplasmic fraction) and the pellet resuspended 
(nuclear fraction) in 6ml of homogenisation buffer II. To increase the yield of 
 59 
 
nuclear fraction, the cytoplasm fraction was spun for another 10 minutes at 600g 
(2760 rpm), then the pellet (nuclear) resuspended in 6 ml buffer II. 
The supernatant (cytoplasmic) was retained on ice, and the nuclear fraction 
centrifuged at 800g (Beckman coulter Avanti J-26XPI centrifuge S/N JXT08C02) 
for 15 minutes. The supernatant was discarded and the nuclear pellet resuspended 
in buffer I, and kept on ice for further steps.  The supernatant from the first spin 
spun in the high speed centrifuge at 8000g (10,000 rpm) using (Beckman coulter 
Avanti J-26XPI centrifuge S/N JXT08C02), for 10 mins, the supernatant was saved  
and the pellet resuspended (mitochondrial fraction) in 3ml of homogenisation 
buffer I. To improve the mitochondrial fraction yield the previous step repeated. 
The remaining supernatant was then centrifuged at 15,000g (13,800rpm) (Beckman 
coulter Avanti J-26XPI centrifuge S/N JXT08C02) for 10 min, the pellet (lysosomal 
fraction) was resuspended in 6ml of homogenisation buffer III, and 1ml aliquots 
kept at -80°C, the final supernatant and the nuclear pellet were centrifuged at 
100,000g (40,000 rpm) for 1hour using (Beckman coulter optima L-look ultra-
centrifuge 52, Ti rotor S/N colo8E23).  
 After this last spin, 3 x 1ml aliquots of particle free supernatant were collected 
carefully avoiding the upper fatty layer and stored at-80°C and the pellet was 
resuspended (microsomal fraction) in 3ml of homogenisation buffer III, then 3 x 
1ml aliquots. The nuclear pellet resuspended in 6ml of buffer III. (Cox&Emili 
2006). 
The nuclear and the mitochondrial fractions were sonicated on ice for 20 seconds, 
at the highest speed with 5 sec interval to rupture the nuclear and mitochondrial 
membranes and release the soluble proteins. Then, both fractions were centrifuged 
for 30 minutes at 9,000 g (Beckman coulter Avanti J-26XPI centrifuge S/N 
JXT08C02) to get rid of membranes debris. The supernatants were collected and 
aliquot in 1 ml eppendorfs, and stored at -80 the pellets were discarded.    
All aliquots were examined for the PPGKm and hexokinase activity, using ATP, 
HMP, and without any phosphoryl donor. 
All subcellular fractions were assayed for enzyme markers to check their purity as 
previously described (Lee & Chung., 2010). 
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The marker enzymes were used to identify the specific subcellular fractions as 
follows: 
Mitochondria:  Glutamate dehydrogenase.  
 Lysosomes:  Acid phosphatase. 
Microsomes:  Glucose-6-phosphatase.  
 Particle free supernatant:  Lactate dehydrogenase 
Errors can arise where the fractions are cross-contaminated, and also where 
organelles are damaged due to improper homogenization and handling.  This 
particularly applies to the acid phosphatase of lysosomes, which are released into 
the supernatant if the particles are ruptured by adverse physical or chemical 
conditions.  The marker enzymes therefore provide an assessment of separation 
technique and relative success. 
1.4.6  Determination of protein concentration (Lowry method) 
A standard curve was constructed using the following concentrations of BSA: 20, 
40, 80,120&160µg. The kit used was the modified Lowry protein assay kit from 
Thermo scientific the protocol was followed as breifly described below: 
Preparation:  1ml of modified Lowry reagent reagent was added to each tube of 
standard and unknown protein sample, vortexed briefly, and then allowed to stand 
at room temperature for 10 minutes to allow any precipitated protein to re-dissolve.
  
A 100l of 1X Folin Ciocalteu reagent added to each tube of standards and 
unknown protein, then incubated at room temperature for 30 minutes to allow the 
colour to develop.  
To each tube, 2ml of distilled water was added and the absorbance acquired at 
750nm against the control blank containing no protein.  
 The calibration curve was plotted, and the protein concentration determined in each 
fraction (including the original homogenate) the values were expressed in mg 
protein/ml of each sub-cellular fraction. 
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1.4.7  Enzyme marker assays 
1. Glucose-6-Phosphatase assay 
Principal: Glucose-6-phosphatase catalyses the hydrolysis of glucose-6-phosphate 
to glucose and phosphate.  The Phosphate is measured following a simple inorganic 
reaction with ammonium molybdate producing a coloured product which can be 
monitored using a spectrophotometer. 
Preparation:  
Buffers and solutions were prepared as showen below: 
A. Citrate Buffer, Citric acid (2.101g/100ml water), Adjust to pH 6.5 with NaOH. 
B. Glucose-6-phosphate, 80mM Glucose-6-phosphate (243.3mg/10ml water). (Pre 
warmed to 37 °C prior to analysis) 10% TCA 
C. 0.5% Ammonium Molybdate, Ammonium Molybdate 2.5g/500ml water, Add 
14ml conc H2SO4 to 200ml water. Diluted acid poured into molybdate solution 
and adjusted up to 1litre. 
D. Reducing agent:  5.7g metabisulphite & 0.2g sodium sulphite (Na2SO4) were 
dissolved in 50ml water, then 0.1g of 1-Aminonapthol-4-sulphonic acid (4 
Amino-3-hydoxynapthalene-1-sulphonic acid) dissolved in the above mixture 
and diluted to 100ml with distilled water.(stored in dark bottle and used within 
10 days .) 
E. Phosphate standard: Pottasium dihydrogen phosphate 438mg/100ml (stored at 
4 °C). 
Methods 
A. First step: For each fraction a 100l aliquot was added into a test tube (a 
negative control tube containing 100l of citrate buffer pH 6.5 was prepared). 
All samples Incubated in a preheated water bath at 37°C for 5 minutes.  
100l of pre-warmed (80mM) glucose-6-phosphate was added to each sample.  
(The exact time of addition for each tube addition was the same). All tubes were 
incubated the exactly15 minutes at 37°C, and then 2ml of 10% TCA (w/v) 
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added to stop the reaction.  Each tube centrifuged for 5 minutes at 2300 rpm, 
and the clear supernatant saved for the later stages of the assay.  
B. Second step: For each fraction1ml of the previous supernatant pipette into a test 
tube together with 5ml of 0.5% Ammonium molybdate.  (In addition, a standard 
tube was prepared containing 100g of phosphorous i.e. 100l of standard into 
1ml of distilled water.) When all the tubes were prepared, 1ml of reducing agent 
was added and the time noted.  The absorbance measured at 660nm after exactly 
the same time for each fraction.  The timing is not critical in itself but (15min – 
60 min) time should be the same for all samples. The calculation was made to 
estimate the amount in g of phosphate produced i.e. Absorbance sample / 
Absorbance standard x 100 x 2.2.  
Given that 1g of Phosphate = 0.032moles of glucose-6-phosphate:   the 
enzyme activity calculated as moles of glucose-6-phosphate used/min/mg 
protein for each subcellular fraction and of the original homogenate. 
2.  Acid Phosphatase assay 
Principle: Both Alkaline and acid phosphatase will catalyse general phosphatase 
reactions.  The standard method of assaying is by incubating the phosphatase 
enzyme with a colourless substrate (p-nitro phenyl phosphate). Following catalysis, 
the products are p-nitro phenol and phosphate.  
 Conveniently, for assaying alkaline phosphatase, the reaction can be monitored 
continuously as the p-nitro phenol is coloured under alkaline conditions.  Under 
acidic conditions however, p-nitro phenol is colourless, therefore assaying acid 
phosphatase is a little more difficult.  As the reaction proceeds, no obvious changes 
can be seen, however, after a given period, the reaction is terminated by the addition 
of an alkaline buffer. The p-nitrophenol becomes coloured and can be determined 
spectrophotometrically 
 
Preparation:  
A. Acetate Buffer pH 4.5, 0.2M Sodium acetate trihydrate, 0.2M Acetic acid 
(11.5ml/l glacial acetic acid). 
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B. P-Nitro phenyl phosphate , P-Nitrophenyl phosphate (di-Tris salt) (0.369g/l) 
C. Alkali-Tris buffer pH9, 1M Tris HCl, adjusted to pH7 containing 1M Na2CO3 
and 0.4M K2HPO4. (Addition of Na2CO3 & K2HPO4 will raise pH to required 
9). 
D. P-Nitro phenol standard , 5mM p-Nitro phenol (0.06956g/l/100ml Alkali Tris), 
(final concentration was50µM), 10% Triton x-100 
Method:  
Each sub cellular fraction diluted (10 fold in 0.2M acetate buffer pH 4.5) and 200l 
of each fraction was added to a separate test tubes, together with 1.2ml of acetate 
buffer and 100l of Triton X-100 (10% v/v)  a negative controls were included in 
which the fractions were replaced with buffer.    
0.5ml of substrate (8mM p-nitro phenyl phosphate) was added, the contents of each 
tube mixed thoroughly, and incubated for 10 min at room temperature.  
The reaction was stopped by adding 2ml of alkaline tris buffer (pH9.0). The 
precipitate was spun down in the bench centrifuge for one minute at top speed and 
the absorbance determined at 405nm for each sample.  
As with the Lowry determination, a calibration curve will be necessary to determine 
the enzyme activity.  Therefore a standard curve of p-nitro phenol was constructed. 
3.  Glutamate Dehydrogenase assay 
Principle: Glutamate dehydrogenase catalyses the reversible oxidative deamination 
of glutamate to -ketoglutarate.  NADH is required as a coenzyme so the reaction 
can be readily measured following the change in absorbance at 340nm.  EDTA is 
present in the reaction mixture to remove heavy metal ions which might otherwise 
inactivate the enzyme.  As indicated earlier, glutamate dehydrogenase is a 
mitochondrial enzyme; therefore, in order to measure the enzyme activity, the 
mitochondria must be disrupted.  This is achieved by addition of the detergent 
Triton X-100. 
Preparation: 
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A. 0.1M potassium phosphate buffer pH7.4 was prepared. 
B. 0.15M Sodium-2-Oxoglutarate, Prepared by adding 0.5475g α-Ketoglutaric 
acid, in 25ml phosphate buffer PH7.4. 
C. 0.75M Ammonium acetate, 1.44g Ammonium Acetate, in 25ml phosphate 
buffer. 
D. 30mM EDTA, 0.2192g EDTA, in25ml phosphate buffer. 
E. NADH, 2.5mg NADH /ml in phosphate buffer.  
F. 10% Triton  
Method:  
 Each sub cellular fraction diluted  (10 fold in 0.1M phosphate  buffer pH 7.4) and 
200l of each fraction was added to a separate test tube, together with 2.1ml of 
phosphate buffer, 0.1ml of NADH (2.5mg/ml), 0.2ml of Ammonium acetate 
(750mM), 0.2ml of 30mM EDTA and 0.1ml of Triton X-100 (10%w/v) then mixed 
thoroughly.  
 The reaction was terminated by addition of 100l of -ketoglutarate (0.15M), the 
tubes were mixed, and the contents transferred into a cuvette, the absorbance 
monitored at 340nm for each fraction separately.  
Provided that the Molar Absorptivity Coefficient of NADH at 340nm is 6220, the 
enzyme activity calculated as moles of NADH oxidised /min/mg protein for each 
sub-cellular fraction and as well as  the original homogenate. 
4.  Lactate Dehydrogenase assay 
Principle: The principle of this assay is that the coenzyme NADH is required for 
the enzymatic catalysis of pyruvate to lactate.  As the reaction proceeds, the NADH 
will be oxidised to NAD and this form of the coenzyme no longer absorbs light at 
340nm.  Thus, the rate of change of OD at 340nm is a measure of the activity of the 
lactate dehydrogenase. 
Preparation:  
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A. 0.1M Potassium phosphate Buffer PH7.4. 
B. 2.5mM NADH   
C. 50mM Na-Pyruvate   
All above components were added to a 1.5ml cuvette the assay for each fraction 
was measured one at a time.  Each sub cellular fraction diluted (10 fold in 100mM 
phosphate buffer pH 7.4) and 50l was added to a 1.5ml cuvette, together with 
600l of 100mM phosphate buffer (pH 7.4), 230l of distilled water and 60l of 
2.5mMNADH.  
 Contents of the cuvette were mixed thoroughly, and then 60l of Na-Pyruvate 
(50mM) was added, mixed again and immediately the cuvette placed in a 
spectrophotometer and the absorbance measured at 340nm.  
Readings were taken every 10 seconds and the reaction monitored until a linear rate 
of NADH oxidisation was observed.  
Given that NADH has a molar absorptive coefficient of 6220, the absorbance/min 
and enzyme activity as moles NADH oxidised per minute/mg protein were 
calculated for each sub cellular fraction and of the original homogenate. 
5.  Protein Identification by LC-MS/MS  
Analysis was performed by LC-MS/MS post in-gel digestion with trypsin. Peptides 
were eluted over a 20 min gradient using a Waters nanoAcquity UPLC interfaced 
to a Bruker maXis HD mass spectrometer.  Peptide identification was achieved by 
searching tandem mass spectra against the expected protein database using the 
Mascot search program.  Matches were filtered to accept only peptides with expect 
scores of 0.005 or better. Protein inferences required a minimum of two unique 
peptide sequences. 
A. In-gel Digestion: In-gel digestion with trypsin performed after reduction with 
DTE and S-carbamidomethylation with iodoacetamide. Gel pieces were washed 
two times with 50% (v/v) aqueous acetonitrile containing aqueous 25 mM 
ammonium bicarbonate, then once with acetonitrile before drying in a vacuum 
concentrator for 20 min.  A 0.2 g aliquot of sequencing grade modified porcine 
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trypsin (Promega) was added in 10 L aqueous 25 mM ammonium bicarbonate 
prior to incubation overnight at 37oC.  
B. LC-MS/MS: Peptide mixtures were loaded onto a nanoAcquity UPLC system 
(Waters) equipped with a nanoAcquity Symmetry C18, 5 µm trap (180 µm x 20 
mm Waters) and a nanoAcquity HSS T3 1.8 µm C18 capillary column (75 m x 
250 mm, Waters). The trap wash solvent was 0.1% (v/v) aqueous formic acid 
and the trapping flow rate was 10 µl/min. The trap was washed for 5 min before 
switching flow to the capillary column.  Separation used a gradient elution of 
two solvents (solvent A: aqueous 0.1% (v/v) formic acid; solvent B: acetonitrile 
containing 0.1% (v/v) formic acid). The capillary column flow rate was 350 
nl/min and the column temperature was 60°C. The gradient profile was linear 
2-35% B over 20 mins. All runs then proceeded to wash with 95% solvent B for 
2.5 min. The column was returned to initial conditions and re-equilibrated for 
25 min before subsequent injections. The nanoLC system was interfaced with a 
maXis HD LC-MS/MS system (Bruker Daltonics) with CaptiveSpray ionisation 
source (Bruker Daltonics). Positive ESI-MS and MS/MS spectra were acquired 
using AutoMSMS mode. Instrument control, data acquisition and processing 
were performed using Compass 1.7 software (microTOF control, Hystar and 
DataAnalysis, Bruker Daltonics). Instrument settings were: ion spray voltage: 
1,450 V, dry gas: 3 L/min, dry gas temperature 150°C, ion acquisition range: 
m/z 150-2,000, MS spectra rate: 2 Hz, MS/MS spectra rate: 1 Hz at 2,500 cts to 
10 Hz at 250,000 cts, cycle time: 3 s, quadrupole low mass: 300 m/z, collision 
RF: 1,400 Vpp, transfer time 120 ms. The collision energy and isolation width 
settings were automatically calculated using the AutoMSMS fragmentation 
table, absolute threshold 200 counts, preferred charge states: 2 – 4, singly 
charged ions excluded. A single MS/MS spectrum was acquired for each 
precursor and former target ions were excluded for 0.8 min unless the precursor 
intensity increased fourfold. 
C. Database Searching: Tandem mass spectra were searched against the Ovis 
subset of the NCBI database (147,277 sequences; 77,737,218 residues) using a 
locally-running copy of the Mascot program (Matrix Science Ltd., version 
2.5.1), through the Bruker ProteinScape interface (version 2.1).  Search criteria 
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specified: Enzyme, trypsin; Fixed modifications, Carbamidomethyl (C); 
Variable modifications, Oxidation (M), Deamidation (N, Q); Peptide tolerance, 
10 ppm; MS/MS tolerance, 0.1 Da; Instrument, ESI-QUAD-TOF.  Results were 
filtered to accept only peptides with an expect score of 0.005 or lower. Protein 
inferences required a minimum of two unique peptide sequences. 
6.  NMR Assay 
Standard solutions of the following were prepared: 
1ml of each component ATP, ADP, AMP, NAD, NADH was prepared at 10mM 
concentration. Dissolved in homogenization buffer, pH adjusted to 7.4 +10% D2O. 
A. NMR standards preparation  
A number of standards for different metabolites (G6P, F6P, G1P, 
Hexamethaphosphate, 6 phosphogluconic acid barium salts, ATP, ADP, NAD and 
NADH) were prepared.The mixture for each standard was made as following: 
 300µl of 20% D2O, 210µl of 100mM TSP (in D2O), 264µl of 1M MDP, 50mM of 
each metabolite. The total volume was 3ml; the final volume was made up by 
adding homogenisation buffer (described in section 2.1.3). The pH of each sample 
adjusted to 7.4 at 22 °C. All standards were freshly prepared the same day of the 
experiment. 
For each standard 600µl was added to the NMR tube (Aldrich color -spec NMR 
tubes, tube diameter L5mmx7in, thrift color coded yellow, limit 400MHZ 
frequency). 31P,13 C, and 1H NMR spectra were acquired for each standard at 
500MHz. Spectra were acquired using 300 pulses and long relaxation times (at least 
3 times the T1 so that spectra were fully relaxed and could be used for quantitation. 
1H NMR spectra were obtained with H2O saturation using a standard Bruker 
presaturation protocol (Bruker PRESAT). 32K spectra were collected with a 20ppm 
sweep width. 31P NR spectra were obtained with 1H-decoupling with a 50ppm 
sweep width. 13C NMR spectra were obtained 1H –decoupled using a 400ppm 
sweep width. All spectra were recorded on a Bruker AMX500 NMR sepctrometer. 
NMR assay for Ovine liver PGK  
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Ovine liver homogenate freshly prepared and concentrated using the MWC 50kDa 
(section 2.1.4). 
Three samples were prepared for NMR experiment as following: 
 
Table 2.14–1 Samples for NMR experiment 
Components of each sample were mixed and pH adjusted to 7.4 at 22̊C. 600 µl of 
each sample was pipette into the NMR tubes (Aldrich color -spec NMR tubes, tube 
diameter L5mmx7in, thrift, color coded yellow, limit 400MHZ frequency), then 
phosphorus, carbon and proton spectra were acquired at 25˚C. 
The reactions were monitored over couple of hours (see results section). In other 
experiments the reaction carried out and monitored for 24hours. Spectra were 
recorded with a variety of acquisition parameters according to the requirements of 
each experimental condition (see above for more details on NMR parameters. 
Briefly, spectra were accumulated with 90+% relaxation, using a recycling time of 
at least 3xRT, so that spectra could be used quantitatively. Sweep wifth was not 
altered to achieve this but an additional delay following the acquisition time was 
added where required. 
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7.  SDS gel electrophoresis and silver staining of partially purified PPGK  
A.  Samples preparation: A few fractions obtained from different chromatography 
procedures were analyzed using denaturing SDS gel, and then stained using silver 
staining. In this experiment, total Ovine liver homogenate prepared as described in 
(section 1.4), then the homogenate ran through size exclusion gel filtration using 
sephacryl 200-gel (as described in section 2.1.15) the fractions contained the 
PPGKm activity were pulled together , also the nuclear fraction obtained from sub-
cellular fractionation experiment (as described in section 2.1.16) used in this 
experiment , some of the nuclear fraction ran through the size exclusion gel 
filtration, and the fractions that showed PPGKm activity were used in this 
experiment.  
Additional fractions were used from an experiment applying different 
chromatography methods including size exclusion, ion exchange and overnight 
depletion assay, in which a mixture of Ovine liver homogenate, glucose, NAD and 
G6PDH were incubated for 24 hrs at 37 ˚C to exhaust the inherent substrate, and 
then the mixture ran through the size exclusion gel filtration.The fractions that 
showed activity with HMP and was also used as a partially purified PPGKm. 
 16% precise- mini Tris-Glycine gel (10x8cm) was purchased from Thermo 
scientific, all samples described above were used in this experiment.  
 2µl of each sample was mixed with2.5µl of4X LDS sample buffer (from 
Thermo scientific), and 5.5µl ultrapure water (total volume 10µl). 
 Samples heated for 2 minutes at 85 C̊ to be denatured. 
 The running buffer prepared by adding 50mL of 10X Tris-Glycine-SDS running 
buffer to 450mL ultrapure water. 
 The gel rinsed with ultrapure water, then placed in gel electrophoresis unit 
(Xcell sureLock mini-cell invitrogen). 
 200mL of running buffer was added to the inner (cathode) chamber and 300mL 
of running buffer to the outer (anode) chamber. 
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 5 µl of the molecular weight marker and protein samples were loaded on the 
gel, the gel ran at 185V for 40 minutes. 
B. Silver staining: Silver Xpress staining kit was purchased from invitrogen. 
 Fixing:  Using 90mL ultrapure water, 100mL Methanol and 20mL (200mL total 
volume) the gel was immersed for 10 minutes. 
 Sensitizing: By adding 105 mL ultrapure water, 100mL Methanol and 5mL of 
the sensitizer (total volume 200mL). The gel immersed in 100mL for 30 
minutes, then poured and the other 100mL added and the gel incubated for 
30minutes. 
 Washing: The gel washed twice using 200mL ultrapure water for 5 minutes 
each. 
 Staining: 5mL from each of stainer A and stainer B (from the kit) were mixed 
with 90mL ultrapure water, and then the gel incubated in it for 15 minutes at 
room temperature. 
 Washing: The gel washed twice with 200mL ultrapure water 5 minutes each. 
 Developing: 5mL of the developer mixed with 95mL ultrapure water, the gel 
placed in it and incubated at room temperature for 10 minutes. 
 Stopping: 5mL of the stopper was added directly to the developing solution. 
 Washing: The gel washed 3 times with 200mL ultrapure water for 10 minutes 
each. 
Gel was photographed and the desired bands were cut, and placed in clean 
eppendorfs. Samples were sent to be sequenced to York University (proteomic 
facility) Biology department, the method used was mass-spectrometry, and liquid 
chromatography mass-spectrometry (LC-MS/MS). 
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 Statistical analysis of results 
All experiments were conducted in triplicate as a minimum standard and ‘n’ for 
each experiment is shown in the legends to individual figures.  
Significance of mean differences was analysed using ANOVA (one-way ANOVA), 
and P-values reported where significant differences were found, and are detailed in 
the legend to figures, accordingly. The results are shown plotted as the mean ± sem, 
and the full data for each plot is shown in the relevant section of Appendix IV. 
Values with P < 0.05 were considered statistically significant. The statistics were 
performed using Minitab statistical software (Minitab17). 
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Chapter 3 
PPGKm phosphoryl donor substrate specificity for glucose 
phosphorylation in Ovine liver 3.1 Introduction 
Glucose metabolism in Ovine species differs in a number of aspects from that in 
humans and other non-ruminants species. Apart from the observations that small 
amounts of glucose is actually absorbed from the gut (Lindsay., 1978), and also 
ovine are less sensitive to insulin compared to non-ruminants species (Brockman, 
1983), one of the most significant differences from a metabolic point of view is that 
Ovine do not have a specific GK enzyme, according to Ballard (Ballard., 1965) or, 
multiple factors in the assay can significantly affect underestimation of glucokinase 
activity in liver homogenate (Davidson & Arion., 1986). 
The observations of Davidson & Arion highlighted the fact that glucokinase activity 
may be inhibited in vivo by specific binding with other cellular proteins. 
Thus in ovine liver we observed certain phosphorylation activity of the glucose at 
high concentrations in the absence of any common known phosphate donor, the 
first of our aims was to study PPGKm specificity for possible phosphate donors, 
including nucleoside phosphate as well as inorganic phosphate. 
In order to determine the Km for the phosphate donor, we will study the PPGKm 
activity with inherent substrate and, the concentration that show the lowest PPGKm 
activity (low inherent substrate) will be used to further investigate the response of 
PPGKm to the increased concentrations of HMP, and to estimate the Km for 
phosphate donor. 
 Results and discussion 
1.4.8 Phosphate donor specificity of PPGKm  using different substrates. 
To determine the specificity of our enzyme, PPGKm, for the phosphate donor ovine 
liver homogenate was prepared as described in methodology section 2.2, and 
assayed with different phosphate donors. 
Figure 3.1-1 below shows the specificity for possible -and most common- 
phosphate donors in Nature, inorganic and nucleosides phosphates, although none 
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of them showed increase in the activity of PPGKm when compared to the activity 
with inherent substrate (0.44 IU). As it is seen in the graph, the activity of the 
enzyme was even decreased when trinucleoside phosphates, were used in the assay 
buffer. 
 
Figure 3.1–1 Glucose phosphorylating activity of PPGKm using different phosphate 
donors in the presence of either 100mM or 0.5mM glucose. Values are Mean ±SEM. 
(n=3 for each substrate). P-values when ˂ 0.05 are represented by (*), or (**) when 
the p-value is ≤ 0.01. One IU of enzyme converts one µmole of glucose to glucose 6-
phosphate per min per g of liver. 
Glucose phosphorylating activity of ovine liver homogenate in the presence of 
5mM phosphoryl donors (or blank – inherent substrate only) and either 100mM or 
0.5mM glucose. Values are Mean ±SEM. (n=3 for each substrate).  
 However, the activity of the enzyme is higher for inorganic phosphate donors (P700 
and Tri-P) 0.64 and 0.61 IU respectively, and becomes maximum when it is used 
HMP (1.3 IU), to compare the effect of each substrate on PPGKm activity and the 
accuracy of our results, I used one-way ANOVA Test (Table 3.1-1). The P-value 
of the activity when using the different nucleosides, compared with the inherent 
substrate, was as follows: ATP P-value =0.113(non significant).P-value when using 
ADP was 0.083, AMP P-value was 0.097 , AP4A P-value was 0.177, AP5A was 
0.981, GTP was 0.587, non of the substrate tested showed significant increase in 
PPGKm activity compared to the activity with inherent substrate, PPGKm activity 
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with UTP was dramatically decreased  when compared with inherent substrate and  
showed a P- value of  0.002  this may indicate an inhibitory effect of the substrate . 
The results obtained until now demostrate the presence of an enzyme, PPGKm, in 
sheep liver extracts, shown for the first time to utilize inorganic polyphosphate as a 
substrate to phosphorylate glucose at high concentrations, being the first report of 
an enzyme involved in polyphosphate metabolism identified in mammals (Pavlov 
et al., 2010). 
 
Table 3.1–1 Shows the P-value when the activities (*IU) with the inherent substrate 
and each of the examined phosphate donors where compared, using one- way ANOVA 
(Analysis of variance). *IU (in which the activity is expressed as µmol.G-6-P produced 
/ min / gram of liver). ‘Activity (IU)’ is the mean activity obtained from 3 expts per 
substrate (n=3). 
1.4.9 Statistical significance of the inherent substrate as a phosphate donor 
To evaluate the significance of that hexamethaphosphate being used as phosphate 
donor, twenty Ovine livers were checked for the new PPGKm enzyme activity with 
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ATP, hexamethaphosphate as phosphate donors, and with no substrate (inherent 
substrate). 
ANOVA test (one-way ANOVA): 
The results were calculated as the mean ± standard deviation (SD) for the number 
of experiments (3 times). Statistical significance between samples group were 
compared by one-way ANOVA. Values with P < 0.05 were considered statistically 
significant.  
The p- value for PPGKm activity with inherent substrate vs. activity with 
hexamethaphosphate was 0.0320, which considered to be statistically significant 
The P-value was 0.0241 when the PPGKm activities with 5mM ATP and2 mM 
HMP were compared, these results showed the preference of PPGKm to use HMP 
over ATP as phosphate donor in all twenty liver samples assayed, this was clear 
specially when PPGKm activity with inherent substrate was low.Table 3.1-2. below 
summarizes the statistical results. 
 
Table 3.1–2  Summary of statistical analysis used to investigate the significance of 
HMP as phosphate dono 
1.4.10 PPGKm Km for HMP  
Because it is difficult to determine the substrate Km for an enzyme in native 
homogenate, this was one of the major problems in this study to purify the protein 
and investigate the relevant biochemical characteristics. In this section an 
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experiment was carried out to roughly estimate the Km regarding HMP substrate, 
therefore as mentioned in section 3.2.2,  liver homogenate was obtained from the 
previous screening experiment, sample number 7 which showed the lowest activity 
with the inherent substrate used, and assayed with incresed concentrations of 
hexamethaphosphate as phosphate donor to phosphorylate glucose, as shown in the 
Figure3.1-2 the enzyme activity increased with increased HMP concentration at 
high glucose concentration (100mM) compared to the activity with inherent 
substrate. 
 
Figure 3.1–2 Assaying Liver sample7 (has lower inherent substrate activity) with 
increased HMP concentrations (0-3 mM) using either 0.5 mM or 100mM glucose, 
values were Mean±SEM, n=3. 
The results obtained from this experiment suggest that PPGKm is polyphosphate 
dependent enzyme; the activity increases with the concentration. Follows 
Michaelis-Menten kinetic being possible to determine Km, it can be observed from 
the saturation curve that the Vmax (maximum reaction rate) of the enzyme is roughly 
estimated as 0.4 µmol.min.g-1. Half maximal velosity is estimated fromthe curve at 
HMP concentration (S0.5) to be close to 0.58µm. 
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Table 3.1–3 shows PPGKm activity in Ovine liver homogenate obtained from 
previous experiment section 3.2.2 sample 7 assayed with increased HMP 
concentrations and 100mM glucose. ‘Activity (IU)’ is the mean activity obtained from 
3 expts per substrate (n=3). 
 
As shown in the table above, optimum PPGKm is obtained at 2.5mM HMP 
concentration. 
A HMP -saturation curve was produced from these results and is shown in Figure 
3.2.3.a double reciprocal plot of the same data is shown in Figure 3.2.4 
From the double reciprocal plot we can use Lineweaver and Burk equation to 
calculate the Km: 1/v= (Km/Vmax) 1/[S] +1/Vmax. 
Intercept is 1/Vmax =1/2.62=0.381 
Gradient =Km/Vmax.  1.44=Km/0.381 = Km=1.44*0.381 = 0.549 mM. 
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Figure 3.1–3 Double reciprocal plot of the responce of PPGKm to increased 
concentrations of HMP. 
1.4.11 Screening different liver samples for the inherent substrate  
To determine the incidence of phosphorylation activity of the glucose at high 
concentrations in the absence of any common known phosphate donor in ovine 
liver, twenty different ovine liver samples were assayed for (PPGKm) activity, as 
described in Section 2.3, Materials and Methods, with 5mM ATP or 2mM 
Hexamethaphosphate (HMP) as a phosphate donor, and without any phosphate 
donor (blank –inherent substrate), at high and low glucose concentrations. 
The sample that showed the lowest PPGKm activity with inherent substrate (sample 
number 7), was used to further investigate the response of PPGKm to the increased 
concentrations of HMP, and roughly estimate the Km for phosphate donor. 
Our results showed a variable activity of the PPGKm in all the samples tested, when 
using high concentration of glucose (100mM) (figure 3.1-4) in opposition to what 
happens at low glucose concentrations (0.5mM), where no observable significant 
enzymatic activity was detected (figure 3.1-5), except for hexokinase under 5mM 
ATP  and 0.5mM glucose conditions. 
When adding HMP 2mM; the PPGKm activity increases at both sugar 
concentrations although is very small at low levels and remarkably increased at high 
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glucose concentrations, especially when the activity with the inherent substrate is 
low (figures 3.1-4 and 3.1-5) that indicates  the higher affinity or certain specificity 
of the PPGKm for the inorganic donor, HMP. 
 As shown in the results (figure 3.1-4), the activity of PPGKm with different 
nucleoside phosphates, and other phosphate donors revealed that the PPGKm 
activity increased dramatically when HMP used as a phosphate donor compared to 
the activity of the enzyme with inherent substrate (no phosphate donor added to the 
assay buffer). Further experiments were performed to elucidate the nature of the 
enzyme: e.g.coupling the assay in the presence and absence of either glucose or 
G6PDH and these results are shown in appendix I.To date no previous studies have 
established the presence of enzymes responsible for polyphosphate synthesis or 
utilization in mammals. However, many studies investigated the presence of 
polyphosphate in mammalian cells and its importance and diverse roles in mammals 
such as cancer cell proliferation (Wang et al, 2003) and protein stabilization by 
physical interaction with e.g.fibroblast growth factor (FGF-2) (Shiba et al., 2003). 
The great variability in activity of PPGKm seen with inherent substrate, could 
explain the hypothesis that polyphosphate already bound to the enzyme in the native 
state, the chain lenght of bound polyphosphate then influencing inherent activity as 
measured in vitro.  
Furthermore, no previous information available regarding the nutritional status, 
age, sex, and breed of the animal, since all samples were obtained from local 
butchers. 
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Figure 3.1–4 PPGKm activity assayed in 20 Ovine livers with 2mM HMP, 5mM ATP 
and inherent substrate with 100mM glucose.(Data represents the Mean ± SEM) n=3. 
The increase in activity when adding 2mM HMP compared with  inherent substrate 
in the absence of ATP was highly significant in each liver studied (*indicates P- ˂ 0.05). 
 
Figure 3.1–5 PPGKm activity assayed in 20 Ovine livers with 2mM HMP, 5mM ATP 
and inherent substrate with 0.5mM glucose.(Data represents the mean ± SE) n=3. 
Neither HMP nor inherent, native substrate was capable of significant glucose 
phosphorylation at 5mM glucose (p<0.001 in all cases). 
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 Chapter summary 
1. Our results clearly show that in ovine liver tissues, there is a constant enzymatic 
activity at high glucose concentrations (100mM) that varies with the samples It is 
concluded that the residual activity, observed by other authors (Ballard., 1965 ) in 
the high concentrated glucose blanks in from sheep liver extracts, is due to the 
presence of an enzyme. Due to its biochemical characteristics shown as result of 
our experiences, we have named this enzyme polyphosphate glucose kinase or 
PPGKm. 
2. The ability of the ovine liver extracts to phosphorylate glucose at high glucose 
concentration in the absence of added phosphate donors, led to the hypothesis that 
the phosphate donor is inherent in the liver homogenate. There is a large variability 
of PPGKm when it is assayed in different liver samples without the addition of 
exogenous phosphorylating substrate. This variability decreased when HMP is 
added and much higher activity is returned. A simple explanation for this finding is 
that the liver sample genuinely contains a variable amount of polyphosphate 
substrate and that the PPGKm enzyme binds its polyphosphate substrate tightly. 
Before addition of HMP, livers with plentiful polyphosphate return high enzyme 
activities and those with lower substrate concentration return lower values of 
activity.  
3. PPGKm activity was highest when HMP was used as a substrate versus other 
phosphate donors - 1.3 IU with HMP, a less significant activity of 0.6 IU for P700 
and Tri-Pi, and under 0.4 IU for AMP, ADP, ATP and the nucleosids, GTP and 
CTP, being undetectable for UTP.  
4. Maximum glucokinase activity in the presence of an inorganic polyphosphate 
donor has not previously been described in mammals but is commonly in bacteria. 
5. The results obtained from the saturation curve with glucose and HMP suggest 
that PPGKm is a polyphosphate dependent enzyme, its Vmax (maximum reaction 
rate) = 1.3 µmol.min.g-1 and Km for HMP of 0.58mM. 
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Chapter 4 
Kinetics and Biochemical characterisation of PPGKm 
 Introduction 
In this chapter a preliminery investigations were carried out to biochemically 
chracterize PPGKm in Ovine liver, in previous section characterised to be a 
polyphosphate dependent glucokinase in mammals. 
These investigations included Km studies for glucose dependency assay, 
thermostability of the enzyme, temporal stability, Mg2+ concentraions dependency 
and different metal ions dependency. 
 Results and discussion 
1.4.12 Metal ions dependency of PPGKm 
Ovine liver homogenate assayed using different divalent metal ions substrates at 
concentration of 5mM for each substrate the PPGKm activity investigated using 
high and low glucose concentrations (0.5mM and 100mM). 
The results showed that hexokinase (enzyme activity with 5mM ATP and 0.5mM 
glucose) was Mg2+ dependent (figure 4.2-1 B). All values calculated were Mean 
±SE, the P-value for hexokinase activity with Mg2+ compared to the other metal 
ions was 0.001 using ANOVA one-way test which indicates that hexokinase 
activity (0.5mM glucose and 5mM ATP) is dependent on Mg2+ . 
On the other hand PPGKm showed activity with Mg2+ as well as other metal ions 
at 100mM glucose as shown in figure 4.2-1.A.This result is similar to the findings 
by Tanaka and coworkers, 2003  which indicated the requirement of strictly 
polyphosphate -dependent glucokinase in Microlunatus phosphorus,to 1-10 mM of 
Mg2+ ,Mn2+, Co2+ and Zn2+ (Tanaka et al., 2003).This indicate that PPGKm and 
hexokinase might be different in their binding sites for substrates , and allosteric 
effect of different molecules. 
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Figure 4.2–1 PPGKm activity assayed with different divalent metal 
(Mg2+,Zn2+,Cu2+,and Mn+2 ions ) in the presence of 2mM HMP,  5mM ATP or inherent 
substrate with high and low glucose concentrations (0.5mM or 100mM glucose). The 
data represents Mean±SEM, n=3. At 0.5mM glucose only Mg2+ was capable of glucose 
phosphorylation (p<0.001 in all cases). At 100mM glucose, Mg2+ could be replaced by 
another maetal ion except Zn (P<0.001 for both postulates).  
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Figure 4.2–2 PPGKm activity assayed with increased Mg2+ concentrations with 2mM 
HMP, 5mM ATP or Inherent substrate at 100mM (figure 4.2-1 A) or 0.5 mM glucose 
(figure 4.2-1B). The figure plotted from Mean ± SEM (n=3). At 100mM glucose only 
large changes in Mg2+ concentration resulting in significant changes in glucose 
phosphorylation (* indicates P<0.05 compared to 15mM Mg2+ or less). At 5mM 
glucose the effect of Mg2+ on glucose phosphorylation is apparent at lower  Mg2+ 
concentration (** indicates significant changes (P<0.01) to the concentration 
preceding – e.g. 6mM Mg2+compared with 4mM Mg2+). 
PPGKm activity was investigated using 2mM HMP and  variable Mg2+ 
concentrations, between(2-50 mM) as shown in the figures above with low and high 
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glucose  (0.5 and 100 mM).The results showed an increase in  PPGKm activity with 
Mg2+ concentrations at 20,30,40 and 50 mM compared to lower 
concentrations(2,4,6,16 mM) when 2mM HMP was used as phosphate donor with 
100mM glucose. PPGKm activity when assayed with inherent substrate and 
100mM glucose was the same with all Mg2+ concentrations tested, on the other hand 
activity with 5mM ATP and 100mM glucose showed the highest activity with 4mM 
Mg2+ with no observable increase with other concentrations, as shown in figure 4.2-
2 A. 
Figure 4.2-2 B shows the result of the same experiment, but with 0.5mM glucose it 
can be noted slightly increase of the activity with 5mM ATP,and 20,30,40 and 
50mM Mg2+, compared to the activity with lower concentrations ,surprisingly there 
was an increase in the activity of PPGKm with 2mM HMP, and with inherent 
substrate with higher Mg2+ concentrations, the activity of PPGKm always being  
detected with 100mM glucose, this result demonestrated the presence of PPGKm 
activity at 0.5mM glucose with either inherent substrate or when 2mM HMP used 
as phosphate donor, the possible explanation is that Mg2+ might have an allosteric 
effect on the PPGKm that enhances its affinity for glucose. 
1.4.13 Glucose concentration dependency assay 
 
Figure 4.2–3 Glucose saturation curve of PPGKm in Ovine liver 
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The kinetics parameters for PPGKm regarding glucose were measured in this 
experiment, by assaying ovine liver homogenate with increased concentrations of 
glucose (0.5-100mM) as shown in figure 4.2-3. The assay buffer also contained 
2mM HMP as phosphate donor. The values were Mean±SE. The experiment carried 
out in triplicate (n=3). 
The graph was plotted and Vmax and Km were estimated .The Km is the substrate 
concentration at 1/2 Vmax (as shown from the glucose saturation curve above), the 
Vmax (maximum reaction rate) of the enzyme is estimated from the saturation curve 
as 0.5 µmol.min.g-1. Half maximal velocity is estimated from the curve at glucose 
concentration (S0.5) Km estimated to be 15mM. 
1.4.14  Thermo stability of PPGK 
To study the thermostability of PPGKm, Ovine liver homogenate was prepared as 
described in section 2.2, and assayed before incubation at different temperatures as 
described previously in section 2.6. The samples were assayed 
spectrophotometrically, the activity was calculated for each sample the data 
obtained plotted as shown in figure 4.2-5(A) which represents the set of samples 
incubated for 10 minutes and assayed with 100 mM glucose, figure 4.2-5(B) 
represents set of samples incubated also for 10 minutes, but assayed with 0.5mM 
glucose. The residual activities were calculated as (%) from the activity values 
before and after incubation  as shown in Tables 4.2-1, 4.2-2, 4.2-3, 4.2-4 in p in 
pages 99 -100. There was no activity with inherent substrate and 2mM HMP when 
assayed with 0.5mM glucose, therfore no residual activities for these samples were 
shown in the tables. 
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Figure 4.2–4 (A) and (B) shows the effect of heating at different temperatures for 10 
minutes, with high and low glucose (0.5 and 100Mm) on the activity of PPGKm, data 
plotted from the Mean±SEM, n=3. (* indicates p<0.05 and** indicates significant 
changes (P<0.01) to the adjacent lower temperature). 
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Figure 4.2–5 (C) and (D) shows the effect of heating at different temperatures for 30 
minutes, with high and low glucose (0.5 and 100mM) on the activity of PPGKm, data 
plotted from the Mean±SEM, n=3. (* indicates p<0.05 to the adjacent lower 
temperature). 
 PPGKm gradually lost its activity when subjected to elevated temperature. This 
occurred more rapidly the longer period of incubation. Compared to hexokinase, 
PPGKm was more heat sensitive as it rapidly losts its activity. The presence of HMP 
appeared to make little difference to the enzyme heat stability. 
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Table 4.2–1 showing the residual activity (%) of thermostability experiment with 
5mM ATP and 0.5mM glucose (samples heated for 10 mins). 
 
Table 4.2–2 showing the residual activity (%) of thermostability experiment with 
100mM glucose (samples heated for 10 mins) 
 
Table 4.2–3 showing the residual activity (%) of thermostability experiment with 
0.5mM glucose (samples heated for 30 mins) 
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Table 4.2–4 showing the residual activity (%) of thermostability experiment with 
100mM glucose (samples heated for 30 mins) 
1.4.15 Temporal stability of PPGKm 
To assess the temporal stability of PPGKm, Ovine liver homogenate was aliqouted, 
and then some were kept at -20°C, 4°C and at room temperature (22°C).  
Figure 4.6.1 represents the data obtained from the follow up enzyme assay through 
a period of 4 months with 100mM glucose, 5mM ATP or 2mM HMP, samples here 
were kept at (-20°C). Figure 4.6.2 shows the results of the same experiment, but 
with 0.5mM glucose. 
The temporal stability of PPGKm was longer compared to hexokinase, since the 
highest activity for hexokinase lasts for about 10 days then declined, while PPGKm 
activity lasts for a couple of months before any observable decrease in the activity 
can be observed. 
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Figure 4.2–6 Temporal stability of PPGKm(inherent substrate or 2mM HMP)  and 
hexokinase (5mM ATP) stored at -20˚C, and assayed with 100mM glucose (n=1). 
 
Figure 4.2–7 Temporal stability of PPGKm(inherent substrate or 2mM HMP) and 
hexokinase (5mM ATP) stored at -20˚C, and assayed with 0.5 mM glucose, (n=1). 
Figure 4.2-7 represents the data obtained from the follow up enzyme assay through 
a period of 5 days with 100mM glucose, 5mM ATP or 2mM HMP, samples here 
were kept on the bench at room teperature (22°C). Figure 4.2-8 shows the results of 
the same experiment, but with 0.5mM glucose. 
Activity of hexokinase (5mM ATP) declined dramatically at day 2, compared to the 
activity of PPGKm (2mM HMP) as well as with inherent substrate, which showed 
a longer life span at 22˚C, since its activity declined at day 3 and disappeared at day 
4. 
 
Figure 4.2–8 Temporal stability of PPGKm(inherent substrate or 2mM HMP) and 
hexokinase(5mM ATP) incubated at 22˚C and assayed with 100 mM glucose, (n=1). 
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Figure 4.2–9 Temporal stability of PPGKm(inherent substrate or 2mM HMP) and 
hexokinase (5mM ATP) incubated at 22˚C and assayed with 0.5 mM glucose, (n=1). 
Figure 4.2-9 represents the data obtained from the follow up enzyme assay through 
a period of 10 days with 100mM glucose, 5mM ATP or 2mM HMP, samples here 
were kept at 4°C in the fridge. Figure 4.2-10 shows the results of the same 
experiment, but with 0.5mM glucose. 
The results demonestrated that PPGKm was more stable than hexokinase at 4˚C, 
since PPGKm activity with both inherent substrate and 2mM HMP remained up to 
day 8 on the other hand hexokinase activity (5mM ATP) disappeared at day6. 
PPGKm is more stable than hexokinase when stored at -20°C with high activity 
lasting for 60 days, similar study by Tinsley and colleagues 1993, who reported that 
PPK purified from N.meningitidis stored at -20˚C for up to 4 months with no 
significant loss of activity. 
Hexokinase is clearly quite labile under the conditions of the liver homogenate even 
when frozen, but it is more resistant to heating for short periods of time. These 
results suggest that HK and PPGKm undergo quite different mechanisms of activity 
loss, and suggest they have distinct structural differences or that these differences 
are due to association with Poly-Pi. 
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Figure 4.2–10 Temporal stability of PPGKm(inherent substrate or 2mM HMP) and 
hexokinase(5mM ATP) incubated at 4˚C, and assayed with 100 mM glucose over a 
period of 10 days, (n=1). 
 
Figure 4.2–11 Temporal stability of PPGKm(inherent or 2mM HMP) and 
hexokinase(5mM ATP) incubated at 4˚C, and assayed with 0.5 mM glucose over a 
period of 10 days, (n=1). 
 Chapter summary 
1-PPGKm in Ovine liver has a high Km for glucose, defining it was estimated to 
be 10mM, no sufficient studies were performed on sheep GK (hepatic GK or 
pancreatic GK) since it was previously (erroneously) reported by (Ballard., 1965) 
that sheep lack GK. 
2-Ruminant do not absorb significant amounts of glucose from the gut because 
ruminal microflora will breakdown the glucose present in the diet and sheep rely 
almost entirely on glucneogenesis to maintain constant blood glucose. 
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3- At this time it is unclear how this new enzyme is integrated in to liver metabolism 
or what its role (if any) is in regulating glycemia. However, it is clear from the 
studies in this section that the enxyme is a stable hexokinase with a high Km for 
glucose and a practical Km for HMP, as this substrate is present in some cellular 
compartments at this concentration in ovine and other mammalian tissues (Kumble 
& Kornberg., 1995). 
4-The high Km (S0.5) isoform, ATP-dependent glucokinase, has a specific role in 
omnivores in both controlling insulin secretion and hepatic glucose uptake and 
output (Murphy H.C. et al., 2003). ATP-GK achieves this because its half-
saturation is in the physiological range such that as blood glucose concentration 
rises from a fast, more G6P is made in tissues expressing GLUT2 transporters 
(pancreas and liver) – this signals insulin secretion and hepatic glycogen synthesis 
which both lower blood glucose in a concerted way back to fasting levels.  
5-The Km of the ovine PPGKm is even higher than S0.5 of glucokinase (EC2.1.7.2) 
in humans and rats (about 6mM in human) (Iynedjian., 2009), suggesting its role is 
sensing glucose concentration above that value. One possibility is that it is part of 
the gluconeogenic mechnaism and physically proximal to this important ovine 
biochemical pathway, such that the local glucose concentration is higher than that 
measured in the blood or liver as a whole. Pregnancy toxemia is a metabolic 
disorder occurring in pregnant small ruminants (ewe), and it is similar to diabetes 
mellitus in humans. The main cause of this disorder is abnormal carbohydrate and 
fat metabolism which affects pregnant ewes toward the end of gestaion period, and 
particulary if multiparous (Edmondson et al., 2012), PPGKm might be part of the 
abnormal glucose sensing in such conditions as ATP-dependent GK is absent in this 
species. Further biocehmical characterization, including intracellular location of the 
enzyme was undertaken (see below) to begin to address some of these questions. 
The PPGKm activity was shown to be dependent on divalent metal ions, and it is 
possible Poly-Pi is bound to the enzyme and it is negatively charged, divalent metal 
ions may play a crucial role in this binding. 
6-PPGKm was more stable over time than than hexokinase, but HK had much better 
short term stability at high temperatures. These results suggest that inactivation of 
the enzymes occurs in different ways, and further structural studies will help to 
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elucidate these intersting features once the gene for the enzyme has been identified 
such that a pure form of the enzyme can be synthesised recombinantly for X-
crystallograpic and NMR studies. 
  
 96 
 
Chapter 5 
Screening of different Ovine tissues and different species for the 
activity of PPGKm 
 Introduction 
As the role of the PPGK enzyme was completely unknown, studies were undertaken 
to characterize the enzyme further. Both tissue wide and subcellular location of GK 
and HK in mammalian tissues are an important features of both the biochemical 
functioning of these enzymes in health and disease, but also how they are used to 
physiologically integrate glucose metabolism across the organs and maintain 
glycemia. The fundamental principles of glycemic control by GK are given in the 
introduction (1.7.2). The purpose of these studies was to investigate the tissue and 
organ-wide distribution of the enzyme in ovine tissues but also in other species. The 
Ovine tissues investigated include: liver, kidney, Lung, Lymph node, bone marrow, 
cardiac muscle, skeletal muscle, and adipose tissue. Parallel investigation for the 
presence of PPGKm activity in different animal species was done by comparing 
liver tissues homogenate from sheep, cow, pig, rat, rabbit and chicken. Since this is 
the first description of this enzyme’s cell, tissue, organ and species distribution to 
my knowledge, no similar studies are available for comparison, although much is 
known about the distribution of other hexokiase enzymes.  
 Results and discussion 
1.4.16 PPGKm Enzyme assay for various Ovine tissues 
 The tissues homogenate were prepared as described in methodology section 2.2. 
The homogenates were assayed using 2mM HMP, 5mM ATP and with no substrate 
(inherent substrate) at high and low glucose concentrations as shown below in the 
graphs. The results were Mean±SE. (n=3) 
PPGKm was shown to be dominant in liver samples, very little activity was detected 
in cardiac muscle, skeletal muscle and lung other tissues examined (adipose tissue, 
bone marrow and kidney) showed no PPGKm activity. 
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Once the gene for PPGKm is identified, an antibody can be generated and 
immunohistochemistry and molecular studies could be applied to investigate the 
espression profile of PPGKm in various tissues and subcellular compartments, a 
cDNA library could also be generated from cellular mRNA. 
PPGKm might be expressed in all tissues, but the presence of certain inhibitors 
doesn’t allow the detection of its activity. Future research can investigate the 
presence of such inhibitors and their co-localisation, and if they are absent in liver 
tissue, this will justify the fact that PPGKm has the predominat high activity in 
Ovine liver. 
 
Figure 5.2–1 Different Ovine tissues screened for PPGKm activity with 5mM ATP, 
2mM HMP at high glucose concentraion (100mM), data represent Mean±SEM, (n=3). 
Liver 3 clearly had the highest PPGKm activity measured with either inherent or 
substrate or HMP (P<0.01) 
As shown in figure 5.2-1, no PPGKm activity was detected in inherent substrate or 
2mM HMP when assayed with 0.5mM glucose, only hexokinase activity was 
present (5mM ATP+ 0.5mM glucose). 
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Figure 5.2–2 Different Ovine tissues screened for PPGKm activity with low glucose 
concentraion (0.5mM), data represent Mean±SEM, (n=3). HK activity was hgighly 
variable as expected in diffrent tissues types (see Appenndix IV). 
1.4.17 PPGKm activity in livers of different species  
Livers from different species homogenized as described previously in section 2.2, 
then assayed with 5mM ATP, 2mM HMP and with no phosphate donor at high and 
low glucose (0.5mM and 100mM glucose). 
Figure 5.2-3 shows the activity of PPGKm with 100mM glucose in livers from 
different species, it can be observed that the highest PPGKm present in sheep, pig 
and cow respectively, however there was very little activity in chicken, rabbit and 
rat. 
The possible explanation for this low activity is that the amount of protein expressed 
in these species is low, due to the presence of certain factors that affect PPGKm 
transcription and expression in these species, or the protein might be expressed but 
some inhibitors interfer with its activity and could be investigated in future research. 
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Figure 5.2–3 Screening different species liver tissue for the presence of PPGKm with 
5mM ATP, 2mM HMP at high glucose concentration (100mM), data plotted from 
Mean±SEM, (n=3). Sheep had the highest PPGKm activity (with HMP) compared 
with other species (** indicated P<0.01), porcine activity was higher than bovine 
(*<0.05). 
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Figure 5.2–4 Screening different species liver tissue for the presence of PPGKm with 
low glucose concentration (0.5mM)), data plotted from Mean±SEM, (n=3). 
Figure 5.2-4 shows the data from assaying different species livers assayed with 
5mM ATP, 2mM HMP or inherent substrate and  0.5 mM glucose .The data showed 
no activity in inherent substrate and 2mM HMP,only activity with 5mM ATP was 
detected. 
 Chapter summary 
1-PPGKm activity is present at very high activity in Ovine liver, comparable to the 
ATP depdendent glucokinase activity found in man and rats that is capable of 
synthesisng 100g of glycogen following a meal in a few hours (Murphy et al., 2003) 
In the other ovine tissues investigated activity is present at lower amounts (e.g. 
muscle) or activity appears absent. 
2- One of the limitations of this project is that no information regarding nutritional 
status of the animal, age and sex, breed etc was available and this may provide 
further understanding in future studies. However, it can be interpreted that tissues 
that are involved in glucose metabolism appear to express the enyzyme (Liver, 
muscle, heart). It was not possible to obtain pancreatic tissue from sheep and this 
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would be an obvious tissue to study in future because of the role of high Km GKs 
in insulin secretion.  
3-Data from the liver of different species showed the presence of high PPGKm 
activity at 100mM glucose, in sheep, pig and cow. Low PPGKm activity was 
detected in chicken rabbit and rat, and although the activity is low (about 5% of 
ATP-GK) this enzyme may be an important point of study since much is known 
about liver glucose metabolism with respect to high Km GKs. 
4-The absence of PPGKm activity does not completely rule out its presence in these 
tissues: ATP-GK is bound and inactivated in the hepatcoyte nucleus during 
starvation and it is possible that such inhibitory processes may occur for PPGKm 
in these tissues. Once the gene for PPGKm is identified, an antibody can be 
generated and immunohistochemistry and molecular studies could be applied to 
investigate the espression profile of PPGKm in various tissues and subcellular 
compartments, a cDNA library could also be generated from cellular mRNA. 
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Chapter 6 
Sub- cellular activity of PPGKm 
 Introduction 
Because HKs and GKs are bound in discreet cellular locations which is helping to elucidate 
why cells need 5 or more enzymes to phosphorylate glucose, it was considered a 
potentially valuable investigation to study the sub-cellular distribution of PPGKm. 
Subcellular fractionation techniques are well established and routine well-described 
methodology methods was followed.  
 Results and discussion 
Figure 6.2-1 shows different fractions obtained from subcellular fractionation experiment, 
assayed with 100mM glucose, 5mM ATP or 2mM HMP and inherent substrate. No 
PPGKm activity was observed with 0.5mM glucose as seen in figure 6.2-1 
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Figure 6.2–1 Subcellular activity of PPGKm in Ovine liver (fractions assayed with 100mM 
glucose) data plotted from the average of 3 independent experiments, Mean ± SEM (n=3). 
PPGKm was highly localized to the nucleus (** indicates P<0.01 compared with other 
fractions). (*PF = particle free supernatant). 
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Figure 6.2–2 Subcellular activity of PPGKm in Ovine liver (fractions assayed with 0.5 mM 
glucose) data plotted from the average of 3 independent experiments, Mean ± SEM (n=3). 
(*PF= particle free supernatant). 
 Chapter summary 
It was clearly observed that nuclear fraction has the highest PPGKm activity; however 
other cellular organelles contained some PPGKm activity, this is not necessarily that 
PPGKm is already present in these organelles, but it might be a contamination during the 
separation processe. 
 This might be overcome by using commercially available kit to separate the intact cellular 
organells, for more efficient identification and study of protein of interest. 
Presence of specific antibody represents a useful tool to precisely detect the cellular 
localisation of PPGKm; uses of flourecent dyes in immunohistochemistry can provide a 
conclusive answer.DAPI stain can also be used to stain polyphosphate, and in this case it 
could be used together with a specific flourecent antibody for PPGKm, once it becomes 
available to show if the enzyme and substrate are bound. 
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Chapter 7 
Partial purification and SDS gel electrophoresis of PPGKm 
 Introduction 
Gel filtration chromatography is a technique that allows protein separation on the basis of 
size (size exclusion). 
In this chapter the molecular weight of PPGKm was roughly estimated from native liver 
homogenate as well as the nuclear fraction obtained from the subcellular fractionation, by 
using size exclusion chromatography (sephacryl -200 gel). 
 Results and discussion 
In figure 7.2-1 showing Fig. 7 shows the size exclusion chromatography on 1mL of Ovine 
liver homogenate: fractions were eluted using homogenisation buffer described in section 
2.1.1. Fractions were then collected in 0.5ml eppendorf tubes. All fractions were assayed 
using 5mM ATP or 2mM HMP and without phosphate donor (blank), the data obtained 
from the spectrophotometric measurement of the coupled enzyme assay was plotted as 
shown in figure 7.2-1 below. 
Size exclusion chromatography allows estimation of protein size, repeated gel filtration 
experiments using 200-Sephacryl gel have clearly shown that PPGKm enzyme is slightly 
larger than Hk1, which has a known weight at 100 kDa. The PPGKm was 115 kDa at a 
rough estimation (bovine albumin and vitamin B12 were used as standard). Unusually large 
Hk1 enzymes have been reported, Naked rat mole Hk1: G5B184, along with the two others 
described by (Rajesh et al., 1996) and (Kalab et al., 1994) were both seen to be around the 
115 kDa estimated weight.  
It is obvious that PPGKm enzyme eluted few fractions before hexokinase, which 
confirmed previous unpublished data showing it had a higher Mw than ATP-HK (probably 
mostly HK1). 
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Figure 7.2–1 Fractions from Size exclusion chromatography of Ovine liver homogenate 
assayed for PPGKm, and hexokinase activities. Data plotted from the average of 3 
independent experiments (mean ± SEM) n=3. 
Figure 7.2-1 demonstrate the results obtained from size exclusion chromatography 
experiment, in which the nuclear fraction from subcellular fractionation was loaded on 
200-Sephacryl gel, and eluted using homogenization buffer the fractions were collected in 
0.5mL eppendorf tubes, and then assayed for PPGKm activity. 
As shown in the figure below it is clear that only PPGKm was present, no hexokinase 
activity was detected (5mM ATP+ 0.5mM glucose), which also confirms that PPGKm is 
totally different from hexokinase, it is also clear that ATP has an inhibitory effect on 
PPGKm, as we can see from figure 7.2-1 the activity with 5mM ATP+ 100mM glucose is 
lowered compared to the activity with inherent substrate and 100mM glucose. On the other 
hand the same figure shows that HMP has been used as phosphate donor since the activity 
with 2mM HMP is much higher than inherent substrate or 5mM ATP. 
PPGKm appears to be a nuclear enzyme and hexokinase known to be a cyosolic enzyme, 
cellular localisation of proteins provides a useful tool to address their function/s in the cell. 
The exact function/s of PPGKm is yet to be identified; extensive research is needed to map 
the metabolic pathways in which the enzyme is involved in.  
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Figure 7.2–2 Fractions from Size exclusion chromatography and cell fractionation 
experiment, (nuclear fraction) assayed for PPGKm activity. Data plotted from the average 
of 3 independent experiments (mean ± SEM) n=3. 
 
Figure 7.2–3 Silver stained SDS-PAGE of different fractions containing PPGKm obtained 
from previous chromatography experiments. 
Lane (A) is the molecular weight marker; the size is shown on the left in kDa. 
Lane (B) Recombinant sheep glucokinase isoform 1, Lane (C) Recombinant sheep 
glucokinase isoform 2, Lane (D) nuclear fraction obtained from sub cellular fractionation 
assay, Lanes (E, F and G) samples from previous anion exchange/ size exclusion 
chromatography, Lanes (H, I) samples from size exclusion/ anion exchange followed by 
inherent substrate depletion for 24 hrs (these samples were obtained from previous student 
project). 
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The amount loaded for all samples was 10µL, on 16% SDS-PAGE. 
Samples B, C, D, and H were cut, and used for MS/MS and finger printing, the first trial 
to identify these bands only was succssful to identify recombinant sheep glucokinases but 
not other bands, the possible explanation for this the band contains a complex of proteins 
/ the Poly-Pi bound to the protein, therefore they didn’t show any match when compared 
against data base. To overcome this problem an alternative strategy to investigate the 
fingerprinting, was suggested by protein service team at York University.  
The result obtained by LC-MS/MS is shown in appendix II, and no match has been found 
to any of polyphosphate kinases. One protein identified, that might be important for future 
investigation is the HSP70 (Heat shock protein70), which also called molecular chaperon 
it has a common ATPase binding domain with hexokinase family. HSP70 is an important 
protein involved cellular protection against stress, and has a role in protein folding. 
 This experiment needs to be repeated in the future research using affinity 
chromatography columns (Poly-Pi Zirconia beads columns)  as described by Lorenz et 
al; 1994a to purify bacterial polyphosphate dependent glucokinase.  The fractions that 
show PPGKm activity could be loaded on SDS-PAGE, the band/bands then can be 
further analysed using LC-MS/MS, and finger printting. Because of time limittation 
this approach could not been attempt. 
 Chapter summary 
1- Size- exclusion chromatography revealed that PPGKm has a slightly bigger size 115 
kDa compared to Hk1 which is 100kDa, this was established from a nmuber of 
experiments, in which  both activities were consistently detected in a different fractions: 
PPGKm activity appeared few fractions before HK1, Variable size polyphosphate 
dependent glucokinase was previously reported by Szymona et al., 1964, in M.pheli, as 
well as it was mentioned in the literature (section 2.5.4) that polyphosphate was able to 
form complexes with many different proteins (discussed in chapter 9.1.4). 
2- Analysis was performed by LC-MS/MS post in-gel digestion with trypsin, this was an 
alternative approach to MS/MS, since the later does not show any match against expected 
protein database the Ovis subset of the NCBI database. The explanation for this is that our 
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protein of interest is forming a complex with polyphosphate, and accordingly it is difficult 
to show any similarity with other proteins in the data base. Therefore LC-MS/MS provided 
the advantage of physical separation by liquid chromatography, as well as, the capability 
of mass analysis by mass spectrometry, it is commonly used technique to identify a 
complexed mixtures. 
Peptides obtained by LC-MS/MS, were identification by searching tandem mass spectra 
against the expected protein database the Ovis subset of the NCBI database (147,277 
sequences; 77,737,218 residues, using the Mascot search program.  Matches were filtered 
to accept only peptides with expect scores of 0.005 or better. Protein inferences required a 
minimum of two unique peptide sequences. LC-MS/MS results does not show any match 
with the known polyphosphate metabolising enzymes (results shown in appandix II). 
However one interesting finiding was the presence of HSP70 (heat shock protein70), this 
protein has a structural similarity with actin and hexokinase family of enzymes.  Three-
dimensional structures of actin, hexokinase, and HSP70 protein families included a 
common ATP binding motifs which are the “Phosphate-1” and “Phosphate-2” motifs 
joining with β- and Ƴ-phosphates of ATP and the “Connect-1” and “Connect-2” motifs at 
the interface between the subdomains(Bork et al, 1992, Bork et al, 1993). Residues present 
in these motifs which play a role in the interaction of ATP, are highly conserved in many 
glucokinases; these residues are Asp and Gly (in Phosphate-1), Asp (in Connect-1), Gly 
and Thr (in Phosphate-2), and Gly (in Connect-2) (discussed in chapter 9.1.4). This would 
provide an idea for future research and investigation. 
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Chapter 8 
NMR studies of PPGKm 
 Introduction to (NMR) 31P Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy has been used extensively to study 
metabolism (Glonek et al., 1971; Salhany et al., 1975; Burt et al., 1977; Ugurbil et al, 1978; 
Navon et al, 1977a, b, 1979; Ferguson et al, 1978; Ostrovsky et al, 1980; Gadian, 1982; 
Sianoudis et al, 1986; Roberts, 1987; Shanks and Bailey, 1988; Chen., 1999). 
In vivo and in vtiro 31P NMR spectroscopy, referred to as MRS and NMR repectively are 
powerful methodologies which are quantitative for many phosphorylated metabolites and 
causes no disruption to cellular or tissue functions when used in vivo (Gadian., 1982; 
Roberts, 1987; Chen, 1999). 
The basic principle of the nuclear magnetic resonance (NMR) spectroscopic technique 
involves measurement of the radio frequency of the energy absorbed by magnetic nuclei 
(Roberts, 1987; Chen., 1999). Phosphorus compounds of living cells include phosphates, 
phosphonates and various esters of phosphates and phosphonates. The chemical shift of 
31P atoms in these compounds can span over a 30ppm range, making 31P-NMR 
spectroscopy an attractive tool for examining phosphorus metabolites in microorganisms, 
plants and animal tissues (Burns S.P. et al., 1997) The singular weakness of 31P NMR or 
MRS is sensitivity, and can only measure in the mM range (Burns S.P. et al., 2000). 
31P NMR spectrum of living cells or cell extracts is fairly simple with about 10 peaks from 
relatively the ‘mobile’ compounds. Insoluble or immobilized compounds, including 
membrane phospholipids, may give broad signals that are partly ‘NMR-invisible’ or 
appear as broad humps underlying the narrow metabolite signals, especially but not only 
in vivo (Burns S.P. et al., 1996). It is possible that some of the Poly-Pi bound to enzymes 
or protein systems are bound and partially invisible. 
NMR spectroscopy can sometimes provide information on cellular compartmentalization 
of metabolites, for example the signal for Pi in yeast is split in two probably as a 
consequence of pH difference between cell compartments (Navon et al., 1979; Gillies et 
al, 1981; Nicolay et al., 1982, 1983). This is caused because of the pKa of Pi in the 
 111 
 
physiological range (pKa =6.8) and undergoes pH-induced shifts of the peak – e.g. in 
mitochondrial matrix – high pH and cytoplasm of muscle cell (low pH). This was elegantly 
demonstrated in a study of live cell heterogenity, with some hepatocytes working at pH 
7.8 and others at pH 7.2 (Burns S.P. et al., 2001). 
NMR can be used to study the structure of phosphate compounds and their metabolism in 
biological samples. Poly-Pi NMR spectra have been widely investigated (Glonek et al., 
1971; Salhany et al., 1975; Burt et al., 1977, Navon et al, 1977a, b; Ugurbil et al., 1978; 
Ferguson et al., 1978; Ostrovsky et al., 1980; Tijssen and Van Steveninck., 1984; Roberts., 
1987; Chen., 1999). Poly-Pi has three principle peaks: terminal P, at about −6.62 to −7 
ppm; penultimate P at about −20.17 to −21.7 ppm; middle P at about −22.37 to −22.5 ppm. 
at −5.39 ppm assigned to the γ -phosphate groups of nucleoside triphosphate and the β-
phosphate groups of nucleoside diphosphate, at −10.05 ppm to the α-phosphate groups of 
nucleoside phosphates, and at −18.90 ppm to the β-phosphate groups of nucleoside 
triphosphate, respectively. The peak at −10.66 ppm includes both NADP and NADP (H). 
The peak at (−6.62 ppm) is the sum of PPi and the terminal phosphate groups of Poly-Pi. 
The peaks at (−18.00 ppm) and (−20.17 ppm represent) are penultimate phosphates from 
Poly-Pi, while peaks at (−22.37 ppm) represents the middle phosphate from longer Poly-
Pis.  
The concentration or chain length of the linear Poly-Pis can be calculated using the peak 
area, provided the Poly-Pi is not bound to proteins, which is unlikely to be completely 
accurate in biological samples. The quantitative determination of Poly-Pis by using the 
NMR shows some anomalies, (Krupyanko et al., 1998) with the total area of the core 
phosphate groups proportional to the concentration of each individual Poly-Pi with a 
defined chain length, but no proportional correlation between Poly-Pis with a small 
number of phosphate groups and Poly-Pis with a large number of these groups. Poly-Pi 
which can be detected by NMR spectroscopy are called ‘NMR-visible’, and represent a 
more mobile fraction of the total Poly-Pi content. Lack of an ‘NMR-visible’ Poly-Pi signal 
does not indicate the absence of Poly-Pis in a sample. In addition the peak positions are 
influenced by the divalent cations concentration in the sample further complicating clear 
interpretation (Pilatus et al., 1989). The detection of a Poly-Pi signal indicates their 
presence in the sample, but their absence cannot be concluded with NMR as described in 
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experiments using Chlorella fusca (Sianoudis et al., 1986). NMR spectroscopy therefore 
provides a unique but sometimes incomplete picture of Poly-Pi metabolism in biologcal 
samples.  
13C NMR spectroscopy has also been used widely in biosicence studies but is greatly 
limited by the very low natural abundance (c. 1.1%) of 13C in living systems (Murphy H.C. 
et al., 2003). 12C does not produce an NMR signal and so the total observed signal arises 
from the presence of 13C. However, this gives the opportunity to add a labelled 13C 
compound to a biological system and to obseve which metabolites and structures it enters 
(Murphy H.C. et al., 2003). In the present work 13C1 labelled glucose was used in ezyme 
assays conducted inside the NMR spectrometer to look at the evolution of the label from 
the C1 of glucose. It was anticipated that following the action of G6PDH on 
13C1-G6P 
made by PPGK a new NMR signal would appear in the NMR sepctrum at the position of 
6-phosphogluconate (6PG) the product of G6PDH action on glucose-6-phosphate (G6P). 
This would only occur if PPGK was converting glcuose to G6P and in the absence of 
G6PDH, the G6P would accumulate. G6PDH conducts a dehydrogenation reaction of G6P 
converting its C1 to a carbonyl causing a shift from 99 and 97ppm for G6P (not visible 
because the very large glucose peaks in a very similar position) to 178ppm because of the 
chemical shift exerted by the new carbonyl group at C1. This would provide definitive and 
unequivocal evidence that in the absence of ATP that PPGK was using Poly-Pi to convert 
glucose to G6P – i.e. defining it as a high Km Polyphosphate dependent glucokinase in 
mammalian tissue. 
 Results and discussion 
Phosphorus NMR spectra of Ovine liver homogenate assayed with 2mM HMP, and 
100mM glucose, spectra A, B and C in which the sample ran for 3hrs with no G6PDH was 
added to the assay mixture, the experiment stopped by taking the NMR tube out of the 
NMR machine, and 10µL of G6PDH was added and sample ran again for one hour, spectra 
D shows the disappearance of G6P after addition of G6PDH enzyme, and the increased 
appearance of 6-phosphogluconate 
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Figure 8.2–1 Shows the 31P NMR spectra obtained from ovine liver homogenate assayed for 
PPGKm activity over a period of 3hrs without G6PDH (A=from 0-1h, B=1-2h and C=2-3h), 
spectra (D) ran for 1hr after the addition of G6PDH. The first panel (A1-D1) represents the 
experiment where HMP was added, showing the appearance of G6P (glucose 6-phosphate), 
and 6PG (6phosphogluconate), the second panel (A2-D2) shows results but intnhe absence of 
HMP: G6P and 6PG were not detected.  
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Figure 8.2–2 Shows the 13C spectra obtained from liver homogenate assayed for 
PPGKmactivity over period of 3hrs without G6PDH,  (E=from 0-1h, F=1-2h and G=2-3h), 
Spectrum H1 is the sample from G1 run in the presence of G6PDH for 1h. The first Panel 
(E1-H1) represents the experiment where HMP was added, and the second panel was an 
indenitcal experiment in the absence of HMP. 
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Carbon spectra of the same experiment explained above (E, F, and G) before addition of 
G6PDH, (H) after adding G6PDH. 
The sudden appearance of the signal for 6-phosphogluconate (6PG) occurs because the 
13C1 glucose which has been steadily converted to glucose 6-phosphate by PPGK is 
rapidly converted to 6PG by the addition of exogenous G6PDH. The data provide definitve 
and supporting evidence that PPGK is synthesising G6P from glucose and is a high Km 
ATP independent and Poly-Pi dependent glucokinase in mammalian tissues. 
 Chapter summary 
It is clear from the NMR data that the novel Poly-Pi dependent GK converts glucose to 
G6P in the absence of ATP. The appearance of G6P in the 31P NMR spectrum when 
G6PDH is not present and then its conversion to 6-phosphogluconate provides definitive 
evidence for the action of the novel enzyme as a high Km Polyphosphate dependent 
glucokinase in mammalian tissue. This data is reinforeced by the use of 13C1 glucose in 
this assay because only in the presence of G6PDH does a new peak coincident with 6-
phosphogluconate appear in the 13C NMR spectrum (confirmed with a standard sample of 
6PG). This 6PG is synthesised from G6P made by the PPGK in the homogenate. The only 
ATP that could have been present in the NMR experiment run in the absence of ATP would 
have arisen from the original tissue sample and estimated to be less than 100µM following 
homogenization and dilution. This absence of ATP powerfully supports the hypothesis 
that the PPGK synthessies G6P from glucose in the reaction using the Poly-Pi substrate.  
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Chapter 9 
Concluding discussion 
 Major findings and contributions 
1.4.18 PPGKm substrate specificity 
It is proposed a novel kinase that is present in Ovine liver but also in other mammal tissues. 
This novel enzyme is able to phosphorylate glucose using polyphosphate as donor, which 
I proposed to be HMP, and shows a very high activity at high glucose concentration in 
comparison to the ATP dependent glucokinase activity found in man and rats. The high 
Km of the enzyme regarding glucose, suggesting its role is sensing glucose concentration 
above normal values, however the enzyme showed a very low activity at low glucose 
concentrations. Therefore, I proposed for this enzyme the name, PolyPhosphate-
Glucokinase (mammalian) or PPGKm.  
PPGKm activity was determined in ovine liver homogenate in response to increased HMP 
concentrations with 100mM glucose. The results obtained from the saturation curve 
suggest that PPGKm is a polyphosphate dependent enzyme, being its Vmax (maximum 
reaction rate)= 0.4 µmol.min.g-1 and Half maximal velocity at HMP concentration (S0.5) 
of 0.58mM (in this experiment liver sample number 7, that showed the lowest inherent 
activity was used in this assay see section 3.2.4). These data suggest a possible role in the 
mechanism of glucose-regulation in a similar way to the ATP-dependent glucokinase 
(Murphy H.C. et al, 2003). Whether this enzyme is involved in insulin secretion awaits 
investigation of its presence in pancreas which will need a molecular probe for mRNA or 
protein, this in return needs the DNA sequence to be established. 
PPGKm activity with different phosphate donors shows a maximum activity (1.3 IU) with 
2mM HMP, a lower activity (0.6 IU) with long phosphate chains, P700 and Tri-P and 
under 0.4 (IU) for AMP, ADP, ATP and the nucleoside, GTP and CTP, being undetectable 
for UTP.  
Polyphosphate glucokinase being discovered and studied only in bacterial species 
(Szymona.,1957, Szymona et al., 1962), in some bacteria polyphosphate -dependent 
glucokinase in M.tuberculosis was demonstrated to use both ATP and polyphosphate to 
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phosphorylate glucose (Hsieh et al., 1996), however a strictly polyphosphate-dependent 
glucokinase was found in Microlunatus phosphovorus, which was reported to use 
polyphosphate of long chain and short chain the Km for both polyphosphates was 0.06µM, 
and 3.8µM respectively (Tanaka et al, 2003),it could be observed that the affinity to 
ployphosphate depends on chain length: the enzyme has a high affinity to polyphosphate 
with long chains, await research would investigate the affinity of PPGKm to variable Poly-
Pi chains, in the recent project only long chains Poly-Pi were investigated since no short 
chain Poly-Pi were available to purchase. 
The results of the recent project showed that both ADP and AMP when used as phosphoryl 
donors the activity of PPGKm was decreased, which suggest that they have an inhibitory 
effect on the enzyme, this in agreement with the findings of Hsieh and colleagues 1996, in 
which they demonstrated the inhibitory effect of both, AMP and ADP, on bacterial 
polyphosphate dependent glucokinase.  
Twenty ovine livers were screened for PPGKm activity with inherent substrate to see if 
there is a variability, all livers examined they showed variable degree of activity with 
inherent substrate, however when the homogenates were assayed with 2mM HMP the 
activity dramatically increased, this could be justified by the amount of inherent substrate 
present in the native state could be different according to the nutritional status of the 
animal, age and sex, all these, variables needs to be clarified in future research.   
1.4.19 PPGKm activity in different ovine tissues and various species 
As I am aware this is the first study to describe a mammalian polyphosphate dependent 
enzyme, no similar enzymes were studied or found in animals, although polyphosphate 
was found to be distributed in some  animals (Imsiecke et al., 1996), the relation between 
Poly-Pi and RNA synthesis was studied in the embryos of frog (Shiokawa and Yamana., 
1965), different mammalian tissues were shown to contain Poly-Pi, but in a concentrations 
less than those found in microorganisms (Kumble and Kornberg, 1995; Kornberg, 
1999;and Schröder et al., 2000). 
These findings demonstrate the wide spread of polyphosphate in many living organisms 
at different stages of evolution, depending on growth conditions, type of tissue or cellular 
compartment being studied. 
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The sub-cellular fractionation results demonstrated the presence of PPGKm in the nuclear 
fraction of liver tissue homogenate, the enzyme in the nuclear fraction showed high 
activity with inherent substrate compared to the activity with inherent substrate when total 
liver homogenate  was used, this clearly shows that the inherent substrate (polyphosphate) 
abundantly present in the nucleus, this is supported by the findings of Kornberg., 1999 in 
which he demonstrated the presence of high concentrations of polyphosphate in the 
nucleus of rat liver  (89µM) compared to the cytosol containing (12µM) (Kornberg., 1999).  
The screening of liver of different species revealed the presence of high PPGKm activity 
at 100mM glucose in sheep, pig and cow livers whereas low activity (about 5% of ATP-
GK) was detected in chicken, rabbit and rat, constituting an important point of study to 
understand liver glucose metabolism with respect to high Km GKs. 
In ruminants glucose metabolism is different from monogastric animals, in this regard 
dietary carbohydrates are fermented by ruminal micro-flora to short chain fatty acids, 
therefore only little glucose, if any, absorbed from small intestine (Bergman et al., 1974), 
in contrast monogastric animals they absorb glucose directly from small intestine. Thus in 
ruminants blood glucose has to be generated nearly exclusively from gluconeogenesis 
(Elmahdi et al., 1997), this explain the markedly lower blood glucose level in most 
ruminants (2.5-3.5 mM/l) compared to monogastric animals (3.5-5.0 mM/l), with the 
exception of camel that has a higher blood glucose level (7.0 mM/l) (Elmahdi et al., 1997).  
According to the unique glucose metabolism in ruminants, PPGKm may play a distinctive 
role in this regard specially in glucose sensing to avoid hypoglycaemia. Liver lobules have 
a unique structure, the periportal hepatocytes, are specialised to perform gluconeogenesis, 
on the other hand perivenous hepatocytes has the key enzymes for glycolysis (Keppens 
and Wulf., 1988). The intra lobular distribution of PPGKm would provide an important 
area of research in future investigations. 
The screening of different ovine tissues showed PPGKm to be dominant in liver samples,  
However, activity was detected in cardiac muscle, skeletal muscle and lung. Other tissues 
examined (adipose tissue, bone marrow and kidney) showed undetectable PPGKm 
activity. This absence of PPGKm activity does not completely rule out its presence in these 
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tissues, and future experiments will need to investigate these when molecualr probes 
become available.  
1.4.20 Biochemical properties of PPGKm 
The results of this study confirmed that PPGKm has high Km for glucose, estimated to be 
20mM, as high activity rates of the enzyme shown with increased glucose concentrations. 
On the other hand, no detectable activity was observed with low glucose concentrations. 
The Km of HMP was estimated to be 0.6µM. These findings demonstrate that PPGKm has 
low affinity to glucose, but its affinity to HMP is high, this might highlight that PPGKm 
has a role in glucose sensing in the nucleus, and generally in hepatic energy metabolism. 
As described previously ruminants depends on continuous gluconeogenesis to maintain 
constant blood glucose this sustained process needs a highly controlled mechanism as well 
as a ceaseless source of energy, the presence of high km glucokinase dependent on 
polyphosphate might provide these requirements. The binding of polyphosphate to the 
enzyme may play a role in its regulation, since it was demonstrated that sheep lack a 
glucokinase regulatory protein due to mutation in the gene, but no mutations being 
identified in their glucokinase gene (Irwin and Huanran, 2014). Recombinant sheep 
glucokinase 1 and isoform 2 where purchased and assayed for activity, both demonstrated 
activity with high glucose and 5mM ATP, but no activity was observed with 2mM HMP 
(data not shown), this proves the presence of functional high km glucokinase in sheep.The 
sequences were obtained from the ovis aries protein sequence at NCBI data base, as it was 
mentioned in the data base the sequences belong to sheep pancreatic glucokinase isoform, 
this  suggest that PPGKm is the hepatic glucokinase isoform and accordingly it is different 
in its biochemical properties and function, this would be investigated in the future studies.  
The PPGKm activity has shown to be dependent on divalent metal ions, suggesting 
possible Poly-Pi binding to the enzyme, since Poly-Pi is negatively charged this allows the 
interaction with divalent metal ions. 
On the other hand hexokinase showed highest activity only with 5mM ATP, and 4mM 
Mg2+, the positively charged Mg2+ interacts with negatively charged phosphate oxygen 
atoms of ATP, providing charge compensation and allows the favorable conformation of 
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ATP at hexokinase active site. This demonstrates that PPGKm has adiscriminated 
substrate binding sites compared to hexokinase. 
It was demonstrated by Belozersky and Kulaev, 1970 that Poly-Pi and RNA they were 
tightly bound and difficult to separate due to the interaction with Ca2+ and Mg2+ ions, this 
was further investigated to see if there is any presence of covalent or hydrogen bonds 
associated with Poly-Pi and RNA complex, but it was confirmed that both types of bonding 
were absent and the only explanation for this tight binding is the presence of electrostatic 
interaction mediated by divalent cations (Belozersky and Kulaev., 1970). 
The results also showed an interesting observation in which there was PPGKm activity 
with increasing Mg2+ concentrations, at low glucose concentration (0.5mM) with both 
inherent and 2mM HMP. PPGKm activities were persistently reported throughout the 
study with high glucose concentrations, this might be explained by that Mg2+ might have 
an allosteric effect on PPGKm to enhance its affinity to glucose.  
Thermostability assays suggest that PPGKm is more stable over time than hexokinase, but 
higher short term heat lability. These results suggest that inactivation of the enzymes 
occurs in different ways, and further structural studies will help to elucidate my findings. 
The recognition of sequences participating in polyphosphate binding is not clear yet. 
Previously, Bork and co-workers (1992), showed that amino acid tryptophans residues in 
the peptide, KNDWTYPKWAKQ, of Poly -P-glucokinase from H37 Ra strain 
(M.tuberculosis) were found to be particularly oxidized by N-bromosuccinimide with 
associated loss of enzymatic activity (Hsieh et al., 1993). Tetrapolyphosphate or long chain 
polyphosphate substrate sustains protection against this oxidation and the loss of activity. 
Residues 177-216 of the Poly-Pi-glucokinase sequence from H37 Rv encode a closely 
related sequence, RKDWSYARWSEE. Therfore this region might be a binding site for 
polyphosphate, in addition to Phosphate 1 and 2, which specifically enables the Poly-Pi-
glucokinase to utilize polyphosphates. Several charged groups around this region as 
Lys188, Glu189, Lys190, Asp192, Lys197, and Lys200 may play a crucial role in Poly-Pi binding 
mechanism (Bork et al, 1993). Therefore I would suggest looking for the homology of 
these residues in mammalin glucokinase in general, and ovine in specific. 
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1.4.21 PPGKm size estimation and partial purification 
Size exclusion chromatography revealed that PPGKm has a slightly bigger size than 
hexokinase, this could be interpreter by the binding of polyphosphate with the enzyme, the 
ability of Poly-Pi to bind with other proteins demonstrated in many studies.  (Szymona et 
al, 1964; Lorenz et al, 1994a; Kusano and Ishihama, 1997; Andreeva et al., 2001, 2004). 
There have been numerous reports on the occurrence of various isoenzymes of 
polyphosphate glucokinase in different microorganisms and on differences in the 
molecular weights of the enzyme in the same organism (Szymona et al, 1977; Kowalska 
et al, 1979; Pastuszak and Szymona., 1980). Szymona et al., (1977) found that the 
molecular mass of native enzyme from M. tuberculosis was 118 kDa using sephacryl-200 
size exclusion chromatography, while Pastuszak and Szymona (1980) found a larger form 
of the enzyme. The enzyme from M. phlei was found to be a protein of 113 kDa (Szymona 
and Ostrowski, 1964) or 275–280 kDa (Girbal et al., 1989). The native enzyme from P. 
shermanii was reported to have a molecular mass of 31 kDa (Clark., 1990). The purified 
enzymes from P. shermanii (Phillips et al., 1993) and M. tuberculosis (Hsieh et al., 1993b) 
also showed multiple proteins by HPLC gel filtration, native PAGE and isoelectric 
focusing (lEF)–PAGE, although a single band was observed by SDS–PAGE.One 
explanation for the existence of varying molecular masses of these glucokinases, is 
variable chain lengths of strongly bound Poly-Pis (Phillips et al., 1999). Although this 
remains speculative while plausible, is strongly supported by the evidence presented in 
this thesis. An obvious outstanding question is how the enzyme might go about using 
bound Poly-Pi, and also whether the chain length influences factors like strength of 
binding, or maximum enzyme activity. 
Size exclusion gel filtration of the nuclear fraction showed no hexokinase activity, which 
confirms that the PPGKm is not the same protein, furthermore the size exclusion of total 
liver homogenate revealed both hexokinase activity and PPGKm activity, and they were 
eluted in a different fractions. The nuclear localization of the enzyme together with its 
substrate, polyphosphate, could assist in the future studies to highlight the possible 
functions of PPGKm like apoptosis, gene transcription, and DNA repair. As it was 
mentioned previously in the literature the vital roles of polyphosphate in mammalian 
system when it form complexes with proteins important in cell regulatory processes, like 
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RNA polymerase isolated from the stationary -phase cells of E.coli (Kusano and 
Ishihama., 1997), also the ATP-dependent protease Lon forming a complex with Poly-Pi 
under degradation of ribosomal proteins during amino acid starvation (Kuroda et al., 
2001), furthermore Poly-Pi was shown to compete with DNA at its histones binding sites 
(Schröder et al, 1999). Poly-Pi also can bind with non-histone proteins in the nucleus 
(Offenbacher and Kline., 1984).   
LC-MS/MS of the silver stained protein band obtained from nuclear fraction (cell 
fractionation experiment), and from chromatography protein purification (anion exchange 
and depletion assay), didn’t exclusively confirm the presence of any protein that might 
share any homology to the known bacterial enzyme involved in Poly-Pi metabolism. The 
only observation that might be interesting is the presence of HSP70 a molecular chaperon, 
recombinant HSP70 was assayed with 2mM HMP and 5mM ATP at high and low glucose 
concentration, the protein was also incubated with 2mM HMP for 24 hours, but no activity 
was detected (data not shown) 
It was established by Bork and colleagues (1993), that the three-dimensional structures of 
actin, hexokinase, and Hsp70 protein families included a common ATP binding motifs 
which are the “Phosphate-1” and “Phosphate-2” motifs joining with β- and Ƴ-phosphates 
of ATP and the “Connect-1” and “Connect-2” motifs at the interface between the 
subdomains(Bork et al., 1992, Bork et al., 1993). Residues present in these motifs which 
play a role in the interaction of ATP, are highly conserved in many glucokinases; these 
residues are Asp and Gly (in Phosphate-1), Asp (in Connect-1), Gly and Thr (in Phosphate-
2), and Gly (in Connect-2). Analysis of the deduced amino acid sequences of 
the ppgk gene demonestrated that this enzyme involves regions that are homologous to 
Phosphate-1 and Phosphate-2 regions of yeast glucokinase. Moreover, sequence alignment 
studies on other prokaryotic glucokinases sequences also revealed the exsistance of 
phosphate binding motifs. These phosphate binding sites found to be conserved from 
eukaryotic hexokinases to prokaryotic glucokinases. 
I tried also to predict and assay some other proteins throughout my research, in addition to 
ovine heat shock protein, a recombinant human HKDC1 (hexokinase containing domain 
1) was also assayed with high and low glucose in the presence of 2mM HMP or 5mM 
ATP, it was incubated over night with the substrate, but no activity was detected (data not 
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shown), HKDC1 its amino acid sequence contains all of the known functional active 
residues as hexokinase (Irwin and Huanran., 2014).  
13C NMR studies confirmed the formation of 6-phosphogluconate in the presence of high 
glucose concentration (100mM), 2mM HMP and NAD, and this provides powerful 
evidence for PPGKm.  It is concluded that the novel enzyme is a high Km Polyphosphate 
dependent glucokinase, uses HMP to phosphorylate glucose producing G6P. These data 
confirm the presence of this type of enzyme for the first time in mammalian tissues. 
 Future directions 
In this section I suggest some methods that would assists in future studies and 
investigations. Also a number of factors have to be considered also such as:  nutritional 
status of the animal, age and sex variations .Tissues that are involved in glucose 
metabolism, such as liver, muscle, heart, or pancreas, must have more focus of attention, 
specially pancreas this obvious tissue to study in future because of the role of high Km 
GKs in insulin secretion. 
PPGKm is a novel enzyme and its role in cellular functions and metabolism as general has 
yet to be elucidated. Therfore it opens up a wide area for future research.Investigation of 
phosphate donor specificity in vitro revealed the preference of PPGKm to HMP, P700 and 
Tri-P but the inherent native substrate needs to be further investigated using for example 
4’, 6-diamidino-2-phenylindole (DAPI) which is a fluorescent dye that is widely used to 
stain DNA (or RNA), e.g. for the in vivo visualization of cell nuclei or bacterial nucleoids. 
DAPI has also been shown to bind to Poly-Pi (Tijssen et al., 1982).  The excitation and 
emission wavelength of Poly-Pi-DAPI complexes (ex. 415nm, em. 550nm) are different 
from those of DNA-DAPI complexes (ex. 358nm, em. 461nm) and RNA-DAPI complexes 
(ex. 358nm, em. 500nm), which allow the discrimination of Poly-Pi signals from DNA 
and RNA signals (Tanious et al; 1992, Kubista et al., 1987).Its high sensitivity and 
specificity make DAPI an attractive reagent for the staining of Poly-Pi in cells, in solution 
and on polyacrylamide gels (Smith &Morrissey, 2007, Aschar-Sobbi et al., 2008). 
The sub-cellular fractionation results showed the highest PPGKm activity in the nuclear 
fraction, however other cellular organelles like mitochondria and particles free contained 
some PPGKm activity, in order to elucidate this point, we propose more efficient cellular 
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fractionation by using commercially available kit for the separation of each cellular 
organelles to minimize cross-contamination.   
The gene for PPGKm was not identified yet, therefore approaches as Native gel 
electrophoresis and in -situ enzyme assay would be usefulthis method was described by 
Szymona et al, 1977,in which the protein sample loaded in 12.5% native SDS- PAGE, and 
subject to electrophoresis , the gel then will be stained for enzyme activity using activity 
stainig.The activity staining contains the same components of HMP enzyme assay mixture 
in addition to p-nitro blue tetrazolium (0.35 mg/ml, final concentration), and phenazine 
methosulphate (0.035 mg /ml, final concentration). Band that show activity could be 
further analyzed for sequence identification. 
Protein purification using affinity chromatography is another technique that would provide 
good opportunity for future studies to sucssesfuly purify PPGKmAs described in section 
2.5.5, many Poly-Pi binding proteins were detected in crude cell extracts from different 
organisms, including yeast and animals, by using filter-binding technique or affinity 
chromatography on Poly-Pi Zirconia beads (Lorenz et al., 1994a). 
PPGKm was shown to be in liver tissue, more specifically it is a nuclear protein For future 
research directions when the gene for PPGKm is identified, a specific antibody can be 
generated and produce to be applied in a various immunohistochemical approaches for 
further quantitative and qualitative studies, this will allow to design more studies to 
understand the mechanism by which the protein expression is up or down regulated or if 
there is any post translational modifications that may differ in various tissues and species. 
Tissue and cell culture techniques would provide a suitable tool in this regard. 
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Appendix I: PPGKm enzyme assay in the presence and absence 
of G6PDH/ glucose. 
 
 
 
\  
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In this experiment the assay ran for 15 minutes, no G6PDH was added to the assay buffers, then 
the spectrophotometer paused, 1µl of G6PDH was added to each well, and the absorbance 
measured again. The assay performed with high and low glucose concentrations (0.5mM and 
100mM glucose) as showen above in figures A,B,C and D.Another assay carried out with NO 
glucose, but with G6PDH added to each assay buffers the absorbance measured  for 15 minutes 
then paused, then100mM glucose added to each well, and absorbance measured again ( Figures E 
and F) below. 
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Appendix II: Summary of LC/MS results for nuclear fraction. 
 
NO Accession number Description 
1 gi|514388105 glutamate dehydrogenase 1, mitochondrial [Ovis aries] 
2 gi|426242361 PREDICTED: liver carboxylesterase-like isoform X1 [Ovis aries] 
3 gi|4501885 actin, cytoplasmic 1 [Homo sapiens] 
4 gi|426238347 PREDICTED: protein disulfide-isomerase isoform X1 [Ovis aries] 
5 gi|426245288 PREDICTED: catalase isoform X1 [Ovis aries] 
6 gi|426239663 
PREDICTED: dimethylaniline monooxygenase [N-oxide-forming] 
1 [Ovis aries] 
7 gi|251823897 protein disulfide-isomerase A3 precursor [Ovis aries] 
8 gi|426239655 
PREDICTED: dimethylaniline monooxygenase [N-oxide-forming] 
3 [Ovis aries] 
9 gi|426239774 PREDICTED: alpha-enolase isoform X3 [Ovis aries] 
10 gi|803289802 
PREDICTED: carbamoyl-phosphate synthase [ammonia], 
mitochondrial isoform X2 [Ovis aries musimon] 
11 gi|426224929 
PREDICTED: ATP synthase subunit beta, mitochondrial [Ovis 
aries] 
12 gi|392583892 heat shock 70 kDa protein 1A/1B [Ovis aries] 
13 gi|426221286 
PREDICTED: 60 kDa heat shock protein, mitochondrial [Ovis 
aries] 
14 gi|426228900 PREDICTED: calreticulin [Ovis aries] 
15 gi|426247368 PREDICTED: aldehyde dehydrogenase, mitochondrial [Ovis aries] 
16 gi|57164373 serum albumin precursor [Ovis aries] 
17 gi|350535721 cytochrome P450 2D6 [Ovis aries] 
18 gi|57164387 corticosteroid 11-beta-dehydrogenase isozyme 1 [Ovis aries] 
19 gi|426256884 
PREDICTED: amine oxidase [flavin-containing] B isoform X1 
[Ovis aries] 
20 gi|548484074 
PREDICTED: methylmalonate-semialdehyde dehydrogenase 
[acylating], mitochondrial [Capra hircus] 
21 gi|803112201 
PREDICTED: propionyl-CoA carboxylase alpha chain, 
mitochondrial isoform X1 [Ovis aries] 
22 gi|803277851 
PREDICTED: protein disulfide-isomerase A4 isoform X2 [Ovis 
aries musimon] 
23 gi|326937428 UDP-glucuronosyltransferase 2B7 precursor [Ovis aries] 
24 gi|426218256 
PREDICTED: propionyl-CoA carboxylase beta chain, 
mitochondrial [Ovis aries] 
25 gi|326937422 UDP-glucuronosyltransferase 1-3 precursor [Ovis aries] 
26 gi|426239537 PREDICTED: epoxide hydrolase 1 [Ovis aries] 
27 gi|426253779 
PREDICTED: ATP synthase subunit alpha, mitochondrial [Ovis 
aries] 
28 gi|164414449 myoglobin [Ovis aries] 
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Appendix III: Optimization of enzyme assay temperature 
 
To investigate the optimum temperature for the PPGKm activity, enzyme assay ran at different 
temperatures (25˚C, 37˚C, 38˚C and 39˚C) with high and low glucose concentrations (0.5 mM and 
100mM) in the presence of 5mM ATP or 2mM HMP and blank (inherent substrate). 
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glucose)
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 149 
 
Appendix IV (Raw numerical data) 
Variable HMP concentrations 
 
 
Different glucose concentrations 
Ovine liver with different HMP concentrations
substrate Activity Average sem
0 0.02010 0.01980 0.01960 0.01983 0.00015
0.3µM 0.13641 0.14310 0.13460 0.13804 0.00259
0.58µM 0.18080 0.17900 0.18400 0.18127 0.00146
0.83µM 0.22785 0.23500 0.22500 0.22928 0.00297
1mM 0.26555 0.24600 0.25100 0.25418 0.00586
1.4mM 0.28382 0.29000 0.28400 0.28594 0.00203
1.6mM 0.28750 0.29100 0.29000 0.28950 0.00104
2mM 0.29806 0.29700 0.29600 0.29702 0.00060
2.5mM 0.30610 0.30300 0.30100 0.30337 0.00148
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PPGKm glucose Km
Glucose concentration AVERAGE stdev SEM
0 0.0001 0.0001 0.0001 0.0001 0.0000 0.0000
20 0.1714 0.1684 0.1710 0.1703 0.0016 0.0009
30 0.5555 0.5631 0.5573 0.5586 0.0040 0.0023
40 0.7270 0.7321 0.7151 0.7247 0.0087 0.0050
50 0.9044 0.8961 0.9044 0.9016 0.0048 0.0028
60 0.9080 0.9065 0.9076 0.9074 0.0008 0.0004
70 0.9095 0.9103 0.9087 0.9095 0.0008 0.0005
80 0.9166 0.9175 0.9165 0.9169 0.0006 0.0003
100 0.9532 0.9531 0.9487 0.9517 0.0026 0.0015
120 0.9525 0.9497 0.9510 0.9511 0.0014 0.0008
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Different phosphoryl donors 
 
 
 
 
 
Activity of PPGKm with 100mM glucose and different phosphoryl donors
inherent substrate ATP ADP AMP CTP GTP HMP AP4A AP5A P700 Tri-p UTP
0.4566 0.2000 0.2200 0.1700 0.3100 0.2740 1.3023 0.5100 0.4700 0.6400 0.6300 0.0033
0.3950 0.2300 0.1770 0.1910 0.2930 0.3210 1.2000 0.4870 0.4530 0.5900 0.6500 0.0030
0.4100 0.2200 0.2010 0.2110 0.3010 0.2890 1.3000 0.5200 0.4310 0.6200 0.5400 0.0031
AVERAGE 0.4205 0.2167 0.1993 0.1907 0.3013 0.2947 1.2674 0.5057 0.4513 0.6167 0.6067 0.0031
STDEV 0.0321 0.0153 0.0215 0.0205 0.0085 0.0240 0.0584 0.0169 0.0196 0.0252 0.0586 0.0001
SEM 0.0186 0.0088 0.0124 0.0118 0.0049 0.0139 0.0337 0.0098 0.0113 0.0145 0.0338 0.0000
Activity of PPGKm with 0.5mM glucose and different phosphoryl donors
inherent substrate ATP ADP AMP HMP AP4A AP5A UTP CTP GTP P700 Tri-p
0.0009 0.1120 0.0346 0.0036 0.0219 0.0008 0.0143 0.0024 0.0025 0.0050 0.0010 0.0005
0.0009 0.1014 0.0269 0.0027 0.0173 0.0008 0.0110 0.0002 0.0003 0.0030 0.0013 0.0004
0.0007 0.1200 0.0326 0.0034 0.0141 0.0009 0.0127 0.0099 0.0027 0.0037 0.0020 0.0005
AVERAGE 0.0008 0.1111 0.0314 0.0032 0.0178 0.0008 0.0127 0.0041 0.0018 0.0039 0.0014 0.0005
STDEV 0.0001 0.0093 0.0040 0.0005 0.0039 0.0001 0.0017 0.0051 0.0013 0.0010 0.0005 0.0001
SEM 0.0001 0.0054 0.0023 0.0003 0.0023 0.0000 0.0010 0.0029 0.0008 0.0006 0.0003 0.0000
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Different ovine tissues 
 
 
Different ovine tissues assayed for PPGKm activity
0.5mM Glucose
 Liver 1 Liver 2  liver3  Heart  Lymph Node  Muscle  Lung adipose tissue bone marrow kidney
ATP 0.2010 0.2250 0.3340 0.6400 0.4630 0.3780 0.5690 0.0078 0.1630 0.1910
0.2250 0.2610 0.3410 0.6310 0.4460 0.3760 0.5680 0.0076 0.1720 0.1920
0.2410 0.2370 0.3300 0.6350 0.4570 0.3810 0.5590 0.0070 0.1640 0.1870
Average 0.2223 0.2410 0.3350 0.6353 0.4553 0.3783 0.5653 0.0075 0.1663 0.1900
STDEV 0.0201 0.0183 0.0056 0.0045 0.0086 0.0025 0.0055 0.0004 0.0049 0.0026
SEM 0.0116 0.0106 0.0032 0.0026 0.0050 0.0015 0.0032 0.0002 0.0028 0.0015
Inherent substrate 0.0012 0.0019 0.0021 0.0019 0.0026 0.0001 0.0022 0.0018 0.0012 0.0010
0.0010 0.0016 0.0018 0.0015 0.0015 0.0013 0.0131 0.0016 0.0013 0.0010
0.0008 0.0017 0.0018 0.0012 0.0013 0.0011 0.0014 0.0018 0.0011 0.0010
Average 0.0010 0.0017 0.0019 0.0015 0.0018 0.0008 0.0056 0.0017 0.0012 0.0010
STDEV 0.0002 0.0002 0.0002 0.0003 0.0007 0.0006 0.0065 0.0001 0.0001 0.0000
SEM 0.0001 0.0001 0.0001 0.0002 0.0004 0.0004 0.0038 0.0001 0.0001 0.0000
HMP 0.0011 0.0016 0.0014 0.0026 0.0011 0.0020 0.0012 0.0138 0.0038 0.0010
0.0014 0.0017 0.0012 0.0025 0.0014 0.0020 0.0011 0.0143 0.0034 0.0016
0.0017 0.0019 0.0014 0.0025 0.0012 0.0019 0.0014 0.0135 0.0029 0.0014
Average 0.0014 0.0017 0.0013 0.0026 0.0012 0.0020 0.0012 0.0139 0.0034 0.0013
STDEV 0.0003 0.0002 0.0001 0.0001 0.0002 0.0001 0.0002 0.0004 0.0005 0.0003
SEM 0.0002 0.0001 0.0001 0.0000 0.0001 0.0001 0.0001 0.0002 0.0003 0.0002
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100mM Glucose
 Liver 1  Liver 2  liver3  Heart  Lymph Node  Muscle  Lung adipose tissue bone marrow kidney
0.0400 0.0408 0.0910 0.0310 -0.0630 -0.0080 -0.0820 0.0380 0.2800 -0.0182
ATP 0.0380 0.0590 0.1310 0.0220 -0.0430 -0.0050 -0.0540 0.0380 0.2910 -0.0070
0.0330 0.0510 0.1210 0.0490 -0.0730 -0.0070 -0.0900 0.0322 0.2710 -0.0050
Average 0.0370 0.0503 0.1143 0.0340 -0.0597 -0.0067 -0.0753 0.0361 0.2807 -0.0101
stdev 0.0036 0.0091 0.0208 0.0137 0.0153 0.0015 0.0189 0.0033 0.0100 0.0071
SEM 0.0021 0.0053 0.0120 0.0079 0.0088 0.0009 0.0109 0.0019 0.0058 0.0041
inherent substrate 0.2270 0.2560 0.3310 0.0260 -0.0340 0.0220 0.0250 0.0064 -0.0073 0.0031
0.2310 0.2710 0.3420 0.0241 -0.0330 0.0220 0.0240 0.0059 -0.0071 0.0028
0.2290 0.2630 0.3400 0.0243 -0.0340 0.0220 0.0240 0.0063 -0.0068 0.0026
Average 0.2290 0.2633 0.3377 0.0248 -0.0337 0.0220 0.0243 0.0062 -0.0071 0.0028
stdev 0.0020 0.0075 0.0059 0.0010 0.0006 0.0000 0.0006 0.0003 0.0003 0.0003
SEM 0.0012 0.0043 0.0034 0.0006 0.0003 0.0000 0.0003 0.0002 0.0001 0.0001
HMP 0.3126 0.3752 0.7531 0.0380 0.0043 0.0350 0.0167 0.0059 0.0070 0.0052
0.3527 0.4261 0.6891 0.0410 0.0039 0.0324 0.0186 0.0068 0.0068 0.0054
0.3471 0.4223 0.7131 0.0391 0.0040 0.0330 0.0168 0.0071 0.0051 0.0051
Average 0.3375 0.4079 0.7184 0.0394 0.0041 0.0335 0.0174 0.0066 0.0063 0.0052
stdev 0.0217 0.0284 0.0323 0.0015 0.0002 0.0014 0.0011 0.0006 0.0010 0.0002
SEM 0.0125 0.0164 0.0187 0.0009 0.0001 0.0008 0.0006 0.0004 0.0006 0.0001
 154 
 
PPGKm activity in different species 
 
 
 
 
100mM glucose
sheep pig cow Rat Rabbit chicken
ATP 0.0002 0.1481 0.0287 0.4345 0.0726 0.0331
0.0001 0.1521 0.3124 0.4581 0.0763 0.0371
0.0003 0.1542 0.3341 0.4451 0.0735 0.0321
stdev 0.0001 0.0031 0.1698 0.0118 0.0019 0.0026
SEM 0.0001 0.0018 0.0980 0.0068 0.0011 0.0015
Average 0.0002 0.1515 0.2251 0.4459 0.0741 0.0341
inherent substrate 0.3940 0.2140 0.0950 0.0029 0.0283 0.0203
0.4010 0.2310 0.1100 0.0032 0.0352 0.0212
0.3980 0.2530 0.1210 0.0034 0.0299 0.0204
stdev 0.0032 0.0195 0.0130 0.0002 0.0036 0.0005
SEM 0.0019 0.0112 0.0075 0.0001 0.0021 0.0003
Average 0.3977 0.2327 0.1087 0.0032 0.0311 0.0206
HMP 0.6681 0.3460 0.1224 0.0106 0.0391 0.0154
0.7012 0.3541 0.1421 0.0110 0.0413 0.0162
0.6981 0.3724 0.1243 0.0112 0.0401 0.0157
Average 0.6891 0.3575 0.1296 0.0109 0.0402 0.0158
stdev 0.0180 0.0135 0.0109 0.0003 0.0011 0.0004
SEM 0.0104 0.0078 0.0063 0.0002 0.0006 0.0002
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0.5mM glucose
sheep pig cow Rat Rabbit chicken
ATP 0.1772 0.4072 0.0880 0.2943 0.1550 0.3156
0.1802 0.3985 0.0921 0.3102 0.1632 0.3201
0.1783 0.4171 0.0901 0.3251 0.1586 0.3172
Average 0.1786 0.4076 0.0901 0.3099 0.1589 0.3176
Stdev 0.0015 0.0093 0.0021 0.0154 0.0041 0.0023
SEM 0.0009 0.0054 0.0012 0.0089 0.0024 0.0013
inherent substrate 0.0015 0.0015 0.0030 0.0002 0.0002 0.0010
0.0013 0.0015 0.0028 0.0001 0.0001 0.0011
0.0012 0.0014 0.0026 0.0001 0.0002 0.0009
Average 0.0013 0.0015 0.0028 0.0001 0.0002 0.0010
Stdev 0.0002 0.0001 0.0002 0.0000 0.0000 0.0001
SEM 0.0001 0.0000 0.0001 0.0000 0.0000 0.0001
HMP 0.0001 0.0020 0.0039 0.0002 0.0002 0.0039
0.0002 0.0018 0.0028 0.0002 0.0002 0.0041
0.0001 0.0019 0.0026 0.0002 0.0003 0.0035
Average 0.0001 0.0019 0.0031 0.0002 0.0002 0.0038
Stdev 0.0000 0.0001 0.0007 0.0000 0.0001 0.0003
SEM 0.0000 0.0001 0.0004 0.0000 0.0000 0.0002
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Metal ions dependency assay 
 
 
100mM glucose
ATP Inherent substrate HMP
Mg 0.0423 0.2279 0.3752
0.0441 0.2418 0.4310
0.0436 0.2357 0.3981
Average 0.0433 0.2351 0.4014
Stdev 0.0009 0.0070 0.0280
SEM 0.0005 0.0040 0.0162
Zn 0.0987 0.1616 0.0000
0.1103 0.1521 0.0000
0.1212 0.1571 0.0000
Average 0.1101 0.1569 0.0000
Stdev 0.0113 0.0048 0.0000
SEM 0.0065 0.0027 0.0000
Cu 0.1498 0.2905 0.3984
0.1512 0.3011 0.4121
0.1469 0.3211 0.3991
Average 0.1493 0.3042 0.4032
Stdev 0.0022 0.0155 0.0077
SEM 0.0013 0.0090 0.0045
Mn 0.1072 0.3463 0.3184
0.1102 0.3732 0.3210
0.1089 0.3510 0.3012
Average 0.1088 0.3568 0.3136
Stdev 0.0015 0.0144 0.0108
SEM 0.0009 0.0083 0.0062
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Assay with 0.5mM glucose
ATP Inherent substrate HMP
Mg 0.2011 0.0010 0.0001
0.1984 0.0010 0.0001
0.2010 0.0010 0.0001
Average 0.2002 0.0010 0.0001
Stdev 0.0015 0.0000 0.0000
SEM 0.0009 0.0000 0.0000
Zn 0.0002 0.0002 0.0001
0.0002 0.0002 0.0001
0.0002 0.0002 0.0001
Average 0.0000 0.0002 0.0001
Stdev 0.0000 0.0000 0.0000
SEM 0.0000 0.0000 0.0000
Cu 0.0000 0.0012 0.0010
0.0000 0.0012 0.0014
0.0000 0.0011 0.0013
Average 0.0000 0.0012 0.0010
Stdev 0.0000 0.0000 0.0005
SEM 0.0000 0.0000 0.0003
Mn 0.0067 0.0000 -0.0010
0.0060 0.0000 -0.0021
0.0067 0.0000 -0.0020
Average 0.0065 0.0000 -0.0020
Stdev 0.0004 0.0000 0.0001
SEM 0.0002 0.0000 0.0000
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PPGKm activity with variable Mg2+ concentrations 
 
 
 
with 100 mM
5mM ATP Inherent substrate 2mM HMP
2mM 0.0183 0.1974 0.3194
0.0191 0.2011 0.3216
0.0189 0.1982 0.3187
Average 0.0188 0.1989 0.3199
stdev 0.0004 0.0020 0.0015
SEM 0.0002 0.0011 0.0009
4mM 0.0483 0.1989 0.3226
0.0501 0.2103 0.3318
0.0485 0.1990 0.3214
Average 0.0490 0.2028 0.3253
stdev 0.0010 0.0065 0.0057
SEM 0.0006 0.0038 0.0033
6mM 0.0172 0.2045 0.3386
0.0177 0.1984 0.3401
0.0188 0.2041 0.3354
Average 0.0179 0.2023 0.3380
stdev 0.0008 0.0034 0.0024
SEM 0.0005 0.0020 0.0014
15mM 0.0198 0.2294 0.3363
0.1102 0.2348 0.3401
0.0199 0.2288 0.3376
Average 0.0499 0.2310 0.3380
stdev 0.0522 0.0033 0.0019
SEM 0.0301 0.0019 0.0011
20mM 0.0088 0.2210 0.4196
0.0087 0.2014 0.4217
0.0090 0.2230 0.4198
Average 0.0089 0.2152 0.4204
stdev 0.0002 0.0119 0.0011
SEM 0.0001 0.0069 0.0007
30mM 0.0113 0.2180 0.4255
0.1211 0.2201 0.4301
0.0145 0.2180 0.4246
Average 0.0490 0.2187 0.4267
stdev 0.0625 0.0012 0.0030
SEM 0.0361 0.0007 0.0017
40mM 0.0259 0.2028 0.4213
0.0261 0.2111 0.4301
0.0236 0.2035 0.4201
Average 0.0252 0.2058 0.4238
stdev 0.0014 0.0046 0.0055
SEM 0.0008 0.0027 0.0031
50mM 0.0392 0.2171 0.4152
0.0403 0.2211 0.4216
0.0398 0.2198 0.4164
Average 0.0398 0.2193 0.4177
stdev 0.0006 0.0020 0.0034
SEM 0.0003 0.0012 0.0020
 159 
 
 
 
 
 
 
 
 
 
 160 
 
 
 
 
 161 
 
 
Thermal stability assay for PPGKm activity 
 
 
 
 
Heated for 10 minutes with 0.5mM glucose
5mM ATP inherent substrate 2mM HMP
At 40˚C 0.0650 0.0000 0.0000
0.0685 0.0000 0.0000
0.0701 0.0000 0.0000
AVERAGE 0.0679 0.0000 0.0000
stdev 0.0026 0.0000 0.0000
SEM 0.0015 0.0000 0.0000
At 45˚C 0.0625 0.0000 0.0000
0.0575 0.0000 0.0000
0.0569 0.0000 0.0000
AVERAGE 0.0589 0.0000 0.0000
stdev 0.0031 0.0000 0.0000
SEM 0.0018 0.0000 0.0000
At 50˚C 0.0644 0.0000 0.0000
0.0588 0.0000 0.0000
0.0631 0.0000 0.0000
AVERAGE 0.0621 0.0000 0.0000
stdev 0.0029 0.0000 0.0000
SEM 0.0017 0.0000 0.0000
At 55˚C 0.0626 0.0000 0.0000
0.0636 0.0000 0.0000
0.0667 0.0000 0.0000
AVERAGE 0.0643 0.0000 0.0000
stdev 0.0022 0.0000 0.0000
SEM 0.0013 0.0000 0.0000
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Heated for 10 minutes with 100 mM glucose
5mM ATP inherent substrate 2mM HMP
At 40˚C 0.0951 0.1483 0.3883
0.1102 0.1552 0.4211
0.0988 0.1503 0.3675
AVERAGE 0.1014 0.1513 0.3923
stdev 0.0079 0.0036 0.0270
SEM 0.0046 0.0021 0.0156
At 45˚C 0.0701 0.0868 0.3000
0.0660 0.0932 0.3216
0.0695 0.0897 0.3011
AVERAGE 0.0685 0.0899 0.3076
stdev 0.0022 0.0032 0.0122
SEM 0.0013 0.0019 0.0070
At 50˚C 0.0656 0.0141 0.0627
0.0687 0.0150 0.0675
0.0701 0.0148 0.0701
AVERAGE 0.0682 0.0146 0.0668
stdev 0.0023 0.0005 0.0038
SEM 0.0013 0.0003 0.0022
At 55˚C 0.0487 0.0000 0.0000
0.0532 0.0000 0.0000
0.0497 0.0000 0.0000
AVERAGE 0.0505 0.0000 0.0000
stdev 0.0024 0.0000 0.0000
SEM 0.0014 0.0000 0.0000
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Heated for 30 minutes with 100 mM glucose
5mM ATP inherent substrate 2mM HMP
At 40˚C 0.0916 0.1174 0.3574
0.1102 0.1351 0.4211
0.0984 0.1198 0.3876
AVERAGE 0.1001 0.1241 0.3887
stdev 0.0094 0.0096 0.0318
SEM 0.0054 0.0055 0.0184
At 45˚C 0.0701 0.0615 0.2271
0.0660 0.0685 0.2654
0.0714 0.0675 0.2451
AVERAGE 0.0692 0.0658 0.2459
stdev 0.0028 0.0037 0.0192
SEM 0.0016 0.0022 0.0111
At 50˚C 0.0155 0.0000 0.0000
0.0167 0.0000 0.0000
0.0201 0.0000 0.0000
AVERAGE 0.0174 0.0000 0.0000
stdev 0.0024 0.0000 0.0000
SEM 0.0014 0.0000 0.0000
At 55˚C 0.0135 0.0000 0.0000
0.0143 0.0000 0.0000
0.0139 0.0000 0.0000
AVERAGE 0.0139 0.0000 0.0000
stdev 0.0004 0.0000 0.0000
SEM 0.0002 0.0000 0.0000
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Heated for 30minutes with 0.5mM glucose
5mM ATP inherent substrate 2mM HMP
At 40˚C 0.0689 0.0000 0.0000
0.0712 0.0000 0.0000
0.0696 0.0000 0.0000
AVERAGE 0.0699 0.0000 0.0000
stdev 0.0012 0.0000 0.0000
SEM 0.0007 0.0000 0.0000
At 45˚C 0.0660 0.0000 0.0000
0.0721 0.0000 0.0000
0.0685 0.0000 0.0000
AVERAGE 0.0689 0.0000 0.0000
stdev 0.0031 0.0000 0.0000
SEM 0.0018 0.0000 0.0000
At 50˚C 0.0622 0.0001 0.0000
0.0597 0.0000 0.0000
0.0615 0.0000 0.0000
AVERAGE 0.0612 0.0000 0.0000
stdev 0.0013 0.0000 0.0000
SEM 0.0008 0.0000 0.0000
At 55˚C 0.0304 0.0000 0.0000
0.0290 0.0000 0.0000
0.0306 0.0000 0.0000
AVERAGE 0.0300 0.0000 0.0000
stdev 0.0009 0.0000 0.0000
SEM 0.0005 0.0000 0.0000
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Subcellular fractionation assay 
 
 
100mM GLUCOSE
Nucleii Mitochondrial Lysosomal Microsomal PF
 ATP 0.0002 0.0423 0.0003 0.0005 0.0180
0.0002 0.0411 0.0003 0.0004 0.0172
0.0002 0.0389 0.0003 0.0005 0.0179
Average 0.0002 0.0408 0.0003 0.0005 0.0177
stdev 0.0000 0.0017 0.0000 0.0001 0.0004
SEM 0.0000 0.0010 0.0000 0.0000 0.0003
inherent substrate 0.6005 0.1231 0.1029 0.0864 0.1681
0.5973 0.1301 0.1031 0.0901 0.1546
0.6105 0.1254 0.1026 0.0859 0.1701
Average 0.6028 0.1262 0.1029 0.0875 0.1643
stdev 0.0069 0.0036 0.0003 0.0023 0.0084
SEM 0.0040 0.0021 0.0001 0.0013 0.0049
HMP 0.6869 0.1298 0.1883 0.0001 0.1833
0.8211 0.1321 0.1763 0.0002 0.1841
0.6754 0.1342 0.1896 0.0001 0.1854
Average 0.7278 0.1321 0.1848 0.0001 0.1843
stdev 0.0810 0.0022 0.0073 0.0001 0.0011
SEM 0.0468 0.0013 0.0042 0.0000 0.0006
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Assay with 0.5mM glucose
Nucleii Mitochondrial Lysosomal Microsomal PF
 ATP 0.0070 0.0131 0.0651 0.0000 0.1334
0.0062 0.0143 0.0682 0.0000 0.1372
0.0072 0.0136 0.0675 0.0000 0.1401
Average 0.0068 0.0137 0.0669 0.0000 0.1369
stdev 0.0005 0.0006 0.0016 0.0000 0.0034
SEM 0.0003 0.0003 0.0009 0.0000 0.0019
inherent substrate 0.0014 0.0002 0.0002 0.0002 0.0002
0.0011 0.0002 0.0001 0.0002 0.0002
0.0013 0.0002 0.0002 0.0003 0.0002
Average 0.0013 0.0002 0.0002 0.0002 0.0002
stdev 0.0002 0.0000 0.0000 0.0000 0.0000
sem 0.0001 0.0000 0.0000 0.0000 0.0000
 HMP 0.0000 0.0000 0.0000 0.0000 0.0000
0.0000 0.0000 0.0000 0.0000 0.0000
0.0000 0.0000 0.0000 0.0000 0.0000
Average 0.0000 0.0000 0.0000 0.0000 0.0000
stdev 0.0000 0.0000 0.0000 0.0000 0.0000
SEM 0.0000 0.0000 0.0000 0.0000 0.0000
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PPGKm activity assay in 20 sheep livers 
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PPGKm activity in 20 different ovine liver samples assayed with 100 mM glucose
Sample ATP Inherent substrate HMP
1 0.04440 0.36600 0.72100
0.04530 0.38400 0.75300
0.05430 0.35400 0.68900
Average 0.04800 0.36800 0.72100
stdev 0.00547 0.01510 0.03200
SEM 0.00316 0.00872 0.01848
2 0.03100 0.37620 0.85200
0.03400 0.42130 0.90100
0.04200 0.34210 0.85100
Average 0.03567 0.37987 0.86800
stdev 0.00569 0.03973 0.02858
SEM 0.00328 0.02294 0.01650
3 0.06390 0.23100 0.46100
0.06850 0.24100 0.50100
0.05780 0.23100 0.57100
Average 0.06340 0.23433 0.51100
stdev 0.00537 0.00577 0.05568
SEM 0.00310 0.00333 0.03215
4 0.07040 0.38600 0.74900
0.07410 0.41030 0.91030
0.06870 0.37950 0.75100
Average 0.07107 0.39193 0.80343
stdev 0.00276 0.01623 0.09255
SEM 0.00159 0.00937 0.05344
5 0.08500 0.14800 0.48200
0.09120 0.15512 0.51213
0.08861 0.14693 0.47612
Average 0.08827 0.15002 0.49008
stdev 0.00312 0.00445 0.01932
SEM 0.00180 0.00257 0.01115
6 0.09450 0.31520 0.75610
0.10110 0.35100 0.76150
0.09650 0.30140 0.81240
Average 0.09737 0.32253 0.77667
stdev 0.00338 0.02560 0.03106
SEM 0.00195 0.01478 0.01793
7 0.04700 0.04500 0.75110
0.05200 0.05400 0.81250
0.04900 0.04800 0.78910
Average 0.04933 0.04900 0.78423
stdev 0.00252 0.00458 0.03099
SEM 0.00145 0.00265 0.01789
8 0.06300 0.24800 0.52200
0.06610 0.26130 0.55110
0.06340 0.25620 0.50120
Average 0.06417 0.25517 0.52477
stdev 0.00169 0.00671 0.02506
SEM 0.00097 0.00387 0.01447
9 0.06600 0.26410 0.51410
0.06830 0.28400 0.55100
0.07130 0.26610 0.53150
Average 0.06853 0.27140 0.53220
stdev 0.00266 0.01096 0.01846
SEM 0.00153 0.00633 0.01066
10 0.08000 0.15410 0.65100
0.07600 0.21030 0.71200
0.07900 0.17620 0.66400
Average 0.07833 0.18020 0.67567
stdev 0.00208 0.02831 0.03213
SEM 0.00120 0.01635 0.01855
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11 0.06600 0.12300 0.50700
0.07100 0.14150 0.55120
0.06800 0.12620 0.48900
Average 0.06833 0.13023 0.51573
stdev 0.00252 0.00989 0.03201
SEM 0.00145 0.00571 0.01848
12 0.08890 0.20800 0.45110
0.09120 0.22100 0.47100
0.07890 0.22500 0.50160
Average 0.08633 0.21800 0.47457
stdev 0.00654 0.00889 0.02544
SEM 0.00378 0.00513 0.01469
13 0.06000 0.12230 0.46500
0.05891 0.13216 0.50132
0.06210 0.12613 0.47751
Average 0.06034 0.12686 0.48128
stdev 0.00162 0.00497 0.01845
SEM 0.00094 0.00287 0.01065
14 0.06850 0.22300 0.44310
0.07120 0.24200 0.47100
0.06830 0.30100 0.45120
Average 0.06933 0.25533 0.45510
stdev 0.00162 0.04067 0.01435
SEM 0.00094 0.02348 0.00829
15 0.05290 0.21900 0.49700
0.05510 0.22400 0.52150
0.04860 0.25100 0.54110
Average 0.05220 0.23133 0.51987
stdev 0.00331 0.01721 0.02210
SEM 0.00191 0.00994 0.01276
16 0.08600 0.12700 0.32100
0.09110 0.14200 0.36310
0.08800 0.12810 0.33410
Average 0.08837 0.13237 0.33940
stdev 0.00257 0.00836 0.02154
SEM 0.00148 0.00483 0.01244
17 0.02700 0.21100 0.54210
0.03230 0.24100 0.55810
0.02910 0.21810 0.57410
Average 0.02947 0.22337 0.55810
stdev 0.00267 0.01568 0.01600
SEM 0.00154 0.00905 0.00924
18 0.23600 0.28720 0.59600
0.22000 0.32100 0.63130
0.18960 0.29860 0.58700
Average 0.21520 0.30227 0.60477
stdev 0.02357 0.01720 0.02342
SEM 0.01361 0.00993 0.01352
19 0.05790 0.56300 1.11000
0.06210 0.58100 1.21000
0.05890 0.55700 1.18000
Average 0.05963 0.56700 1.16667
stdev 0.00219 0.01249 0.05132
SEM 0.00127 0.00721 0.02963
20 0.07500 0.28100 0.56400
0.08300 0.31650 0.60400
0.07700 0.28810 0.58120
Average 0.07833 0.29520 0.58307
stdev 0.00416 0.01878 0.02007
SEM 0.00240 0.01085 0.01158
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With 0.5mM glucose
Sample 5mM ATP Inherent substrate 2mM HMP
1 0.04010 0.00002 0.00011
0.03720 0.00002 0.00023
0.04120 0.00001 0.00012
Average 0.03950 0.00002 0.00015
Stdev 0.00207 0.00000 0.00007
SEM 0.00119 0.00000 0.00004
2 0.03110 0.00001 0.00003
0.02800 0.00002 0.00002
0.03500 0.00001 0.00002
Average 0.03137 0.00001 0.00003
Stdev 0.00351 0.00001 0.00000
SEM 0.00203 0.00000 0.00000
3 0.05390 0.00001 0.00002
0.04720 0.00001 0.00001
0.05510 0.00001 0.00001
Average 0.05207 0.00001 0.00001
Stdev 0.00426 0.00000 0.00000
SEM 0.00246 0.00000 0.00000
4 0.04040 -0.00100 0.00001
0.04410 -0.00110 0.00001
0.04250 -0.00200 0.00001
Average 0.04233 -0.00137 0.00001
Stdev 0.00186 0.00055 0.00000
SEM 0.00107 0.00032 0.00000
5 0.07512 0.00004 0.00013
0.08102 0.00003 0.00016
0.07814 0.00004 0.00016
Average 0.07809 0.00004 0.00015
Stdev 0.00295 0.00001 0.00002
SEM 0.00170 0.00000 0.00001
6 0.07450 -0.00001 0.00001
0.08131 -0.00001 0.00002
0.07842 -0.00002 0.00002
Average 0.07808 -0.00001 0.00002
Stdev 0.00342 0.00000 0.00001
SEM 0.00197 0.00000 0.00000
7 0.02700 -0.00001 0.00000
0.02400 -0.00001 0.00001
0.03100 -0.00001 0.00001
Average 0.02733 -0.00001 0.00001
Stdev 0.00351 0.00000 0.00000
SEM 0.00064 0.00000 0.00000
8 0.04324 -0.00002 0.00001
0.04700 -0.00001 0.00002
0.03813 -0.00002 0.00002
Average 0.04279 -0.00002 0.00002
Stdev 0.00445 0.00000 0.00000
SEM 0.00257 0.00000 0.00000
9 0.05600 -0.00002 0.00003
0.06200 -0.00001 0.00002
0.05800 -0.00002 0.00003
Average 0.05867 -0.00002 0.00003
Stdev 0.00306 0.00000 0.00001
SEM 0.00176 0.00000 0.00000
10 0.05000 -0.00002 0.00001
0.04912 -0.00003 0.00001
0.04631 -0.00002 0.00002
Average 0.04848 -0.00002 0.00001
Stdev 0.00193 0.00000 0.00001
SEM 0.00111 0.00000 0.00000
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11 0.04600 0.00003 0.00002
0.04841 0.00002 0.00003
0.04510 0.00003 0.00002
Average 0.04650 0.00003 0.00002
Stdev 0.00171 0.00000 0.00000
SEM 0.00099 0.00000 0.00000
12 0.06890 0.00001 0.00004
0.07210 0.00002 0.00003
0.06680 0.00001 0.00004
0.06927 0.00001 0.00004
Average 0.00267 0.00001 0.00001
Stdev 0.00154 0.00000 0.00000
SEM 0.00089 0.00000 0.00000
13 0.04321 -0.00001 0.00003
0.03900 -0.00002 0.00004
0.03611 -0.00002 0.00004
Average 0.03944 -0.00002 0.00004
Stdev 0.00357 0.00000 0.00000
SEM 0.00206 0.00000 0.00000
14 0.04850 -0.00001 0.00003
0.05120 -0.00002 0.00003
0.04621 -0.00001 0.00003
Average 0.04864 -0.00001 0.00003
Stdev 0.00250 0.00000 0.00000
SEM 0.00144 0.00000 0.00000
15 0.04290 -0.00002 0.00001
0.04410 -0.00002 0.00002
0.05131 -0.00002 0.00001
Average 0.04610 -0.00002 0.00001
Stdev 0.00455 0.00000 0.00001
SEM 0.00263 0.00000 0.00000
16 0.06600 -0.00002 0.00002
0.06821 -0.00003 0.00003
0.07311 -0.00002 0.00003
Average 0.06911 -0.00002 0.00003
Stdev 0.00364 0.00000 0.00001
SEM 0.00210 0.00000 0.00000
17 0.03700 -0.00002 0.00004
0.04430 -0.00003 0.00004
0.03521 -0.00003 0.00005
Average 0.03884 -0.00003 0.00004
Stdev 0.00481 0.00000 0.00000
SEM 0.00278 0.00000 0.00000
18 0.23600 0.00003 0.00003
0.25311 0.00002 0.00004
0.31523 0.00003 0.00003
Average 0.26811 0.00003 0.00003
Stdev 0.04169 0.00000 0.00000
SEM 0.02407 0.00000 0.00000
19 0.03790 0.00001 0.00001
0.04112 0.00002 0.00001
0.03855 0.00001 0.00001
Average 0.03919 0.00001 0.00001
Stdev 0.00170 0.00001 0.00000
SEM 0.00098 0.00000 0.00000
20 0.06300 -0.00001 0.00003
0.06816 -0.00002 0.00002
0.06641 -0.00002 0.00003
Average 0.06586 -0.00002 0.00003
Stdev 0.00262 0.00000 0.00000
SEM 0.00152 0.00000 0.00000
